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The current clinical standard for breast cancer screening is mammography.
However, this technique has a low sensitivity which results in missed cancers. Dy-
namic contrast-enhanced magnetic resonance imaging (DCE-MRI) has recently emerged
as a promising technique for breast cancer diagnosis and has been reported as be-
ing superior to mammography for screening of high-risk women and evaluation of
extent of disease. At the same time, low and variable specificity has been docu-
mented in the literature as well as a rising number of mastectomies possibly due
to the increasing use of DCE-MRI. In this study, we developed and characterized a
dual-modality, x-ray and DCE-MRI, anthropomorphic breast phantom for the quan-
titative assessment of breast imaging protocols. X-ray properties of the phantom
were quantitatively compared with patient data, including attenuation coefficients,
which matched human values to within the measurement error, and tissue structure
using spatial covariance matrices of image data, which were found to be similar in
size to patient data. Simulations of the phantom scatter-to-primary ratio (SPR)
were produced and experimentally validated then compared with published SPR
predictions for homogeneous phantoms. SPR values were as high as 85% in some
areas and were heavily influenced by the heterogeneous tissue structure. MRI prop-
erties of the phantom, T1 and T2 relaxation values and tissue structure, were also
quantitatively compared with patient data and found to match within two error bars.
Finally, a dynamic lesion that mimics lesion border shape and washout curve shape
was included in the phantom. High spatial and temporal resolution x-ray measure-
ments of the washout curve shape were performed to determine the true contrast
agent concentration as a function of time. DCE-MRI phantom measurements using
a clinical imaging protocol were compared against the x-ray truth measurements.
MRI signal intensity curves were shown to be less specific to lesion type than the
x-ray derived contrast agent concentration curves. This phantom allows, for the first
time, for quantitative evaluation of and direct comparisons between x-ray and MRI
breast imaging modalities in the context of lesion detection and characterization.






Dissertation submitted to the Faculty of the Graduate School of the
University of Maryland, College Park in partial fulfillment




Dr. Aldo Badano, Chair/Advisor
Dr. Jacco A. de Zwart









for his support and common human decency
at a time when both were in short supply.
To Gene O’Bryan
for always being positive.
ii
Acknowledgments
Perhaps more than most, this project was a huge collaborative effort that
was only made possible through the willingness of countless people to selflessly
devote their time, resources, and advice to my seemingly endless requests for help.
I would like to thank everyone that helped me along the way, because without their
generosity this project would never have gotten off the ground. In particular, thanks
to...
...Aldo Badano (FDA) for his overall guidance throughout the entire project
and for supporting my idea of a dual-modality phantom. Kyle Myers (FDA) for
her support and guidance, helping me to always keep the big picture in mind, and
encouraging me to dream big.
...All of my co-authors:
In Chapter 2: Jacco A. de Zwart (NIH; MRI expertise, data acquisition and
analysis and advice, coding the T1/T2 imaging sequence), Jennifer T. Loud (NCI;
providing the patient MRI data), Riham H. El Khouli (NIH; acquiring the phantom
MRI images used in the covariance analysis), Kyle J. Myers (overall guidance and
advice on covariance calculations), Mark H. Greene (NCI; providing the patient MRI
data), Jeff H. Duyn (NIH; MRI expertise), and Aldo Badano (overall guidance).
In Chapter 3: Stuart Miller (RMD Inc.; providing SEM images of the screens
and advice on their manufacture and testing), Katherine Tang (FDA; system setup
and data acquisition), and Aldo Badano (mantis simulations and expertise and
overall guidance).
iii
In Chapter 4: Subok Park (FDA; mathematical advice), and Aldo Badano
(mantis simulations and expertise and overall guidance)
In Chapter 5: Andreu Badal (FDA; Monte Carlo simulations and advice),
Robert J. Jennings (FDA; advice with the experimental setup), Hugo de las Heras
(FDA; x-ray lab setup and help with phantom data acquisition), Kyle J. Myers
(overall guidance), and Aldo Badano (mantis simulations and overall guidance)
In Chapter 6: Jacco A. de Zwart (MRI expertise, data acquisition and analysis
and advice), Prasanna Hariharan (FDA; fluid transfer simulations), Matthew R.
Myers (FDA; fluid transfer simulations and pump advice), and Aldo Badano (overall
guidance)
...Eugene O’Bryan (FDA) for help with literally everything (electronic exper-
tise, design and implementation of the high voltage power supply triggering, super-
human material acquisition efforts, and discussions of roadblocks and design issues).
He was the glue that kept this project together and part of the inspiration that kept
me going. Randy Bidinger and Bruce Fleharty (FDA) for all of their machining and
design help and for their good nature in tolerating all of my last minute requests.
...Jacco A. de Zwart for devoting so much of his time and expertise to help me
with the MRI data acquisition and analysis and Jeff Duyn for his MRI advice and
especially for giving my project a chance. Without their help this project would
never have happened.
...Han Wen (NIH) for generously providing MRI scan time for the project.
David Bluemke (NIH) for facilitating my access to a scanner in the NIH clinical
center. Use of facilities in Radiology and Imaging Sciences, NIH Clinical Center.
iv
Rachel Brem (GWU Hospital), Brian Garra (FDA), and Eileen Thompson (GWU
Hospital) for acquisition of GE clinical images of the phantom. Marios Gavrielides
(FDA) for acquiring the phantom CT data and FDA/Center for Veterinary Medicine
for access to their CT scanner. Bonita Damaska (NIH) for help arranging data
acquisition at the NIH Clinical Center. Hellmut Merkle (NIH) for saving the day
during the dynamic MRI data acquisition by providing noise reduction filters for
the fluid pump. John Boone (UC Davis) for acquiring CT images of the phantom
and providing patient CT data.
...Jennifer T. Loud and Mark H. Greene for providing the coded, archived
patient mammograms. Gretchen Gierach (NCI) for helping me make the connec-
tion with Jennifer Loud and Mark Greene. Dr. Lazzari (Ospedale Pistoia) and
co-authors, especially Dr. Belli (Azienda Ospedaliero Universitaria Careggi), for
providing the data for the clinical detector from their 2007 paper. Melanie Chellman-
Jeffers (Cleveland Clinic) and Maryellen Giger (U. Chicago) for providing patient
data. Maria Altbach (U. Arizona) for providing volunteer data for the maximum
likelihood segmentation project.
...Brandon Gallas (FDA) for discussions on covariance matrices and maximum
likelihood estimation. Christian Graff (FDA) for discussions on bounded maximiza-
tion and general MRI issues.
...Annie Saha (FDA) for initial experimental x-ray PRF measurements. Mary
Walker (FDA) for help with the x-ray tube and polaroid camera. Bob Jennings
for discussions of film and x-ray measurements. Ilko Ilev, Erik Gorman, and Boris
Vassilev (FDA) for help in taking the digital optical microscopy images. Glenn
v
Link (FDA) for help with the electronic components. Samta Thacker (RMD Inc.)
for useful discussions regarding the details about the microscopic structures in CsI
columnar screens.
...Glenn Link and Al Taylor (FDA) for the use of their chemical wetlab. Benita
Dair (FDA) for access to her wetlab and chemistry advice. Coleman Richardson
(FDA) for helping me find wetlab space and Irada Isayeva (FDA) for basic chemistry
advice.
...Frank Samuelson (FDA) for his generous advice on the cluster and computer
issues. Jonathan Boswell (FDA) for help with the cluster. Fred Jordan and John
Wellington (FDA) for helping me move the huge optical table, letting me constantly
borrow things, and with all of my shipping requests. Jacqueline Haynes (FDA) for
administrative support and help with purchasing. Ron Varsaci and Tom Vegella
(FDA) for safety advice. Stephen Retta (FDA) for fluid handling advice.
...everyone in the Division of Imaging and Applied Mathematics/OSEL/FDA
for their support and kind words.
...Matthew Kupinski, Lars Furenlid, Harry Barrett, Don Wilson (U. Arizona),
and everyone at CGRI at the University of Arizona for creating such a great working
environment and for helping me get my optical science Master’s work out the door.
...Drs. Aldo Badano, Jacco A. de Zwart, Jeff H. Duyn, Yu Chen (UMCP),
Yang Tao (UMCP), and Wolfgang Losert (UMCP) for serving on my dissertation
committee and for their helpful comments.
...This study was supported in part by a research grant from the Office of
Women’s Health at the Food and Drug Administration, funding from the intramu-
vi
ral program at NIBIB, and an appointment to the Research Participation Program
at the Center for Devices and Radiological Health administered by Oak Ridge Insti-
tute for Science and Education through an interagency agreement between the U.S.
Department of Energy and the U.S. Food and Drug Administration.
My journey to complete this Ph.D. has been a long and difficult one and it
would have been impossible to reach this point without the people that lifted my
spirits and encouraged me to keep going. Thanks to...
...my parents for being such great role models and confidants. For being suc-
cessful without playing the game. For never putting me down. For being so good at
balancing work and life. For raising me to be completely ignorant of society’s expec-
tations of me. For being the best source of professional advice. For understanding
everything. For making me laugh.
...my brothers for having the courage to follow their dreams.
...Julio for picking me up every day without making me feel like it cost him
anything, for always making time to help, and for understanding everything.
...Phil Hinz, to whom this dissertation is dedicated, for standing up for me
and for believing in me. Every single day was a struggle to keep going and it was
his support that, in the end, pushed me forward. If there was one person that was
pivotal in getting me this far, it was him.
...Andreu for being a friend.




List of Tables xi
List of Figures xii
List of Abbreviations xiv
1 Introduction 1
2 Experimental validation of Monte Carlo (MANTIS) simulated x-ray re-
sponse of columnar CsI scintillator screens 10
2.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
2.2 Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . 13
2.2.1 Experiments . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.2.1.1 Relative light output . . . . . . . . . . . . . . . . . . 16
2.2.1.2 Point response function . . . . . . . . . . . . . . . . 16
2.2.1.3 Screens . . . . . . . . . . . . . . . . . . . . . . . . . 18
2.2.1.4 X-ray source . . . . . . . . . . . . . . . . . . . . . . 21
2.2.1.5 Pinhole . . . . . . . . . . . . . . . . . . . . . . . . . 21
2.2.2 Simulations . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.2.2.1 Relative light output . . . . . . . . . . . . . . . . . . 23
2.2.2.2 Point response function . . . . . . . . . . . . . . . . 23
2.2.3 Figure of merit . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
2.3.1 Relative light output . . . . . . . . . . . . . . . . . . . . . . . 31
2.3.2 Point response functions . . . . . . . . . . . . . . . . . . . . . 32
2.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40
2.4.1 Accurate knowledge of screen details . . . . . . . . . . . . . . 43
2.4.2 Variation in screen properties . . . . . . . . . . . . . . . . . . 46
2.4.3 Accurate x-ray source and pinhole geometry . . . . . . . . . . 46
2.4.4 Blur due to FOP . . . . . . . . . . . . . . . . . . . . . . . . . 48
2.4.5 Columnar tilt angle and incident x-ray beam . . . . . . . . . . 49
2.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50
3 A fast, angle-dependent, analytical model of CsI detector response for opti-
mization of 3D x-ray breast imaging systems 52
3.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 52
3.2 The model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
3.2.1 Depth-dependent absorption of incident x rays . . . . . . . . . 57
3.2.2 Conversion of absorbed x rays into emitted optical photons . . 60
3.2.3 Self-absorption and photo-detector absorption of the emitted
optical photons . . . . . . . . . . . . . . . . . . . . . . . . . . 62
3.2.4 Depth-dependent spread of optical photons . . . . . . . . . . . 63
3.2.5 Integrate model . . . . . . . . . . . . . . . . . . . . . . . . . . 70
viii
3.3 Calculating best fit coefficient values and comparison with mantis . . 71
3.4 Comparison against experimental results . . . . . . . . . . . . . . . . 81
3.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
4 MRI properties of the anthropomorphic, dual-modality phantom 88
4.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 88
4.2 Materials and methods . . . . . . . . . . . . . . . . . . . . . . . . . . 91
4.2.1 Phantom construction . . . . . . . . . . . . . . . . . . . . . . 91
4.2.2 T1 and T2 relaxation parameter measurements . . . . . . . . . 94
4.2.3 Comparison of image structure . . . . . . . . . . . . . . . . . 97
4.2.4 Enhancing lesion . . . . . . . . . . . . . . . . . . . . . . . . . 102
4.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 104
4.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
4.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 115
5 X-ray properties of the anthropomorphic, dual-modality phantom 117
5.1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 117
5.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120
5.2.1 Phantom construction . . . . . . . . . . . . . . . . . . . . . . 121
5.2.2 X-ray attenuation coefficient . . . . . . . . . . . . . . . . . . . 122
5.2.2.1 Human values . . . . . . . . . . . . . . . . . . . . . . 122
5.2.2.2 Phantom values . . . . . . . . . . . . . . . . . . . . . 124
5.2.3 Tissue structure . . . . . . . . . . . . . . . . . . . . . . . . . . 124
5.2.3.1 Stationary covariance matrix . . . . . . . . . . . . . 125
5.2.3.2 Patient and phantom data . . . . . . . . . . . . . . . 126
5.2.3.3 Influence of anti-scatter grid on stationary covariance 128
5.2.4 X-ray scatter . . . . . . . . . . . . . . . . . . . . . . . . . . . 128
5.2.4.1 Simulations . . . . . . . . . . . . . . . . . . . . . . . 129
5.2.4.2 Experimental validation . . . . . . . . . . . . . . . . 131
5.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 132
5.3.1 Phantom construction . . . . . . . . . . . . . . . . . . . . . . 132
5.3.2 Attenuation coefficient . . . . . . . . . . . . . . . . . . . . . . 132
5.3.3 Tissue structure . . . . . . . . . . . . . . . . . . . . . . . . . . 137
5.3.4 X-ray scatter . . . . . . . . . . . . . . . . . . . . . . . . . . . 140
5.3.4.1 Simulations . . . . . . . . . . . . . . . . . . . . . . . 140
5.3.4.2 Experimental validation . . . . . . . . . . . . . . . . 141
5.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 143
5.5 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
6 MRI dynamic lesion for the anthropomorphic, dual-modality phantom 148
6.1 Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 148
6.2 Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
6.2.1 Lesion mold . . . . . . . . . . . . . . . . . . . . . . . . . . . . 152
6.2.1.1 Distribution of contrast agent . . . . . . . . . . . . . 154
6.2.1.2 Border shape . . . . . . . . . . . . . . . . . . . . . . 156
ix
6.2.2 Washout curve shape . . . . . . . . . . . . . . . . . . . . . . . 156
6.2.2.1 Human washout curves . . . . . . . . . . . . . . . . . 156
6.2.2.2 Fluid pump . . . . . . . . . . . . . . . . . . . . . . . 158
6.2.3 X-Ray measurement of washout curve . . . . . . . . . . . . . . 159
6.2.3.1 Experimental setup . . . . . . . . . . . . . . . . . . . 159
6.2.3.2 Derivation of average lesion contrast concentration . 161
6.2.3.3 Flow rate measurements . . . . . . . . . . . . . . . . 164
6.2.3.4 Benign and malignant curves . . . . . . . . . . . . . 164
6.2.4 MRI measurements . . . . . . . . . . . . . . . . . . . . . . . . 164
6.2.5 MRI signal behavior . . . . . . . . . . . . . . . . . . . . . . . 165
6.3 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
6.3.1 Lesion molds . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
6.3.2 X-ray measurements of washout curves . . . . . . . . . . . . . 167
6.3.3 MRI measurements . . . . . . . . . . . . . . . . . . . . . . . . 170
6.3.4 MRI signal behavior . . . . . . . . . . . . . . . . . . . . . . . 171
6.4 Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 172
7 Conclusion 178
8 Future Work 180
A Integrating the PRF equation over depth 183
B Influence of different detectors on covariance comparison of patient and phan-
tom data 189
B.0.1 Comparison of covariance matrices . . . . . . . . . . . . . . . 189
B.0.2 Clinical detector: H and stationary Kn . . . . . . . . . . . . . 191
B.0.3 Laboratory detector: H and stationary Kn . . . . . . . . . . . 192
B.0.4 Comparison of clinical and laboratory detectors . . . . . . . . 193





2.1 Manufacturer specifications and model parameters of the four mea-
sured CsI scintillator screens. . . . . . . . . . . . . . . . . . . . . . . 20
2.2 Simulation parameters of the mantis model . . . . . . . . . . . . . . 24
2.3 Measured and simulated relative screen output for screens with graphite
and aluminum coated substrates. All values are normalized to Screen
1 at 10% reflectivity. . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
3.1 Definition of model variables. . . . . . . . . . . . . . . . . . . . . . . 56
3.2 Best-fit coefficient values for a 25 keV monochromatic beam, 150 μm
thick CsI screen, and angles in the range of 0 to 45 degrees. These
coefficients should be valid for any detector location as long as the
same screen model applies. The results reported here correspond to
the PRFs shown in Figures 3.9 and 3.10. . . . . . . . . . . . . . . . 76
5.1 Comparison of elemental composition (reported as percent by weight)
of human tissue and phantom materials. . . . . . . . . . . . . . . . . 134
6.1 Definition of variables for Section 6.2.3.2 and Appendix C. . . . . . . 162
xi
List of Figures
2.1 Schematic of CCD setup with a 30 degree pinhole holder. . . . . . . . 15
2.2 SEM measurements of all screens. . . . . . . . . . . . . . . . . . . . . 19
2.3 Spectra used in mantis simulations of the experimental PRFs . . . . 25
2.4 SEM of Screen 1 and schematic of mantis model of the same screen. 27
2.5 Experimental and Simulated PRFs for Screens 1-4. . . . . . . . . . . 30
2.6 FOMs for all screens, energies, and incidence angles. . . . . . . . . . . 35
2.7 Comparison of experimental, mantis, and Gaussian fit PRFs at zero
degrees for 40 kVp. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
2.8 The normalized difference of the PRFs as a function of incidence angle
for all screens, energies, and incidence angles. . . . . . . . . . . . . . 37
2.9 Images showing the spatial distribution of the normalized differences
for all incidence angles of Screens 1 and 3 with the 40 kVp spectrum. 38
3.1 Schematic of model geometry and coordinate system. . . . . . . . . . 56
3.2 Mass attenuation coefficient as a function of energy for CsI as simu-
lated in PENELOPE. . . . . . . . . . . . . . . . . . . . . . . . . . . . 59
3.3 Comparison of exponential x-ray absorption profile with a least-squares
linear approximation for 25 keV. . . . . . . . . . . . . . . . . . . . . . 61
3.4 Percent of emitted optical photons at a specific depth that reach the
photo-detector. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 63
3.5 The normalized, radially-averaged simulated optical photon spread
from mantis for two different depths. . . . . . . . . . . . . . . . . . . 66
3.6 Analysis to determine the functional form of the spread of optical
photons that reach the detector after being generated at a specific
depth. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
3.7 FWHM of Lorentzian fits to mantis data as a function of depth
where the optical photons were generated. . . . . . . . . . . . . . . . 69
3.8 Fractional change in the overall FOM during the 2D fitting process
as a function of the iteration number of the fitting program. . . . . . 75
3.9 Comparison of mantis-generated PRFs with PRFs from the analyt-
ical model after the 2D fit. . . . . . . . . . . . . . . . . . . . . . . . . 78
3.10 Comparison of mantis-generated PRFs with PRFs from the analyt-
ical model before the 2D fit. . . . . . . . . . . . . . . . . . . . . . . . 80
3.11 Comparison of the analytical model with experimental PRFs. . . . . 83
3.12 Line spread functions calculated from the PRFs presented in Fig-
ure 3.11. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 85
4.1 Example patient and phantom MR images. . . . . . . . . . . . . . . . 104
4.2 Comparison of phantom T1 and T2 values with human data from the
literature. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
4.3 Fractional change in T1 and T2 relaxation times of lard and egg whites
as a function of time since phantom production date. . . . . . . . . . 107
xii
4.4 Example patient and phantom ROIs of fat-suppressed, T1-weighted
MRI data. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
4.5 Overall stationary covariance matrices for the patient and phantom
data sets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
4.6 Cuts through the patient and phantom overall stationary covariance
matrices. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110
4.7 RMS variation in the stationary covariance estimate due to Rician
instrumentation noise only as a function of the number of ROIs used
in the estimation. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 111
4.8 Photographs of phantom lesions and example MRI images of phantom
with lesions inserted. . . . . . . . . . . . . . . . . . . . . . . . . . . . 112
5.1 Results of segmentation algorithm on a central slice of the phantom
for inclusion in the x-ray scatter simulations. . . . . . . . . . . . . . . 130
5.2 Photograph of compressed phantom, example x-ray image of phan-
tom, and example patient mammogram. . . . . . . . . . . . . . . . . 132
5.3 Comparison of x-ray mass attenuation coefficients for breast adipose
tissue and adipose-mimicking phantom material and for breast glan-
dular tissue and glandular-mimicking phantom material. . . . . . . . 136
5.4 Example patient and phantom ROIs. . . . . . . . . . . . . . . . . . . 138
5.5 Overall stationary covariance matrices for the patient and phantom
data sets. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 138
5.6 Cuts through the patient and phantom overall stationary covariance
matrices (shown in Figure 5.5) in the anterior-posterior and superior-
inferior directions. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
5.7 Influence of scatter on stationary covariance matrix. . . . . . . . . . . 140
5.8 Monte Carlo simulations to estimate the amount of scatter produced
by the phantom. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 141
5.9 Validation of the Monte Carlo simulated scatter results for the het-
erogeneous phantom. . . . . . . . . . . . . . . . . . . . . . . . . . . . 142
6.1 Dynamic lesion phantom design overview. . . . . . . . . . . . . . . . 153
6.2 Two preliminary lesion mold designs. . . . . . . . . . . . . . . . . . . 155
6.3 Comparison of contrast agent distribution in two different mold de-
signs as a function of time. . . . . . . . . . . . . . . . . . . . . . . . . 168
6.4 Demonstration of ability to produce lesion molds with different border
shapes mimicking different mass-like lesion types. . . . . . . . . . . . 168
6.5 Comparison of washout curves for different fluid flow rates. . . . . . . 169
6.6 Average normalized contrast agent concentration curves for two curve
shapes; benign and malignant. . . . . . . . . . . . . . . . . . . . . . . 170
6.7 Comparison of x-ray truth measurements and MRI results acquired
with different spatial and temporal resolutions. . . . . . . . . . . . . . 171
6.8 Influence of varying MR imaging sequence parameters on measured





ACR American College of Radiology
AIF arterial input function






DTPA diethylene triamine pentaacetic acid
FOM figure of merit
FOP fiber-optic plate
FWHM full width at half the maximum
Gd gadolinium
HVL half value layer
IR inversion recovery
L-BFGS limited-memory Broyden-Fletcher-Goldfarb-Shanno
LSF line spread function
mantis monte carlo x-ray electron optical imaging simulation
MRI magnetic resonance imaging
MPE mean photon energy
MTF modulation transfer function
NCI National Cancer Institute
NNPS normalized noise power spectrum
PET positron emission tomography
PRF point response function
PSF point spread function
QIBA Quantitative Imaging Biomarkers Alliance
RMS root mean squared
ROC receiver operating characteristic
ROI region-of-interest
rpm rotations per minute
RSNA Radiological Society of North America
SE spin echo
SEM scanning electron microscope
SNR signal-to-noise ratio










With 12% of the US female population expecting to be diagnosed with breast
cancer in their lifetime [1], effective screening and early diagnosis of this disease is
a major public health concern. The current standard for breast cancer screening
and diagnosis is palpation and mammography [2, 3]. A review, published in 2002
by the U.S. Preventative Services Task Force [4], of eight randomized, controlled
trials found that x-ray mammography is effective at reducing mortality for women
aged 40 and over. Evidence for a benefits of screening was stronger for older women
(aged 50-69 years) than for younger women (aged 40-49 years). However, x-ray
mammography has a relatively low sensitivity (69-90%) [5], which results in many
missed cancers. This is particularly true for young patients with dense breasts
that complicate the interpretation of mammograms due to the masking effect of
glandular tissue [9, 10]. Additionally, dense breast tissue results in a larger radiation
dose during mammography [3] and has been correlated with an elevated risk for
developing breast cancer [6, 7, 8]. Therefore, the group with the highest risk of
developing breast cancer suffers the highest dose from x-ray mammography while
receiving the lowest diagnostic advantage.
With this as a backdrop, breast MR has been rapidly gaining momentum in
the breast imaging community. While initial studies in the 1980s using intrinsic tis-
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sue contrast methods yielded unimpressive results [5], the introduction of dedicated
breast coils, higher magnetic field systems, and Gd-based contrast agents have trans-
formed breast MR into a high-sensitivity method capable of detecting 77-100% of
cancers [11]. Dedicated breast coils and higher field systems have helped to increase
signal-to-noise, while Gd-based contrast agents have allowed MR to overcome the
overlap of intrinsic T1 and T2 relaxation values of cancerous and benign tissues. Gd-
based contrast agents preferentially increase the signal in lesions as well as provide
information about the vasculature around any suspicious regions when time-resolved
data is acquired. In this way, DCE-MRI can provide both morphological and kinetic
information about a suspected lesion. The inclusion of both of these components
has been shown to improve the detection of invasive lesions. A study by Schnall et
al. [12] showed that the best area under the receiver operating characteristic (ROC)
curve (AUC) for a single morphology feature was 0.78 and for a single kinetic feature
was 0.66. But when both morphology and kinetic information were combined into a
multivariate model, an AUC of 0.88 was achieved. DCE-MRI has been shown to be
useful in screening of high-risk women [13, 14] as well as in evaluating the extent of
disease [14, 15, 16, 17, 18, 19]. Studies of screening in high-risk women have shown
that DCE-MRI can detect cancers that are not visible in either x-ray mammography
or ultrasound. In a review of the literature, Kuhl [14] showed that, for screening of
high-risk women, the sensitivity of MR imaging ranged from 71-100% as compared
to 0-59% for x-ray mammography. For evaluating the extent of disease after diag-
nosis, MR helps identify additional cancers in 14-27% of patients and unsuspected
synchronous cancer in the opposite breast in 3-6% of patients [14].
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In response to these recent advancements in breast MR, there has been an
enthusiastic reaction both in the medical/scientific community as well as in the
public. In 2007, the American Cancer Society released guidelines recommending
screening MRI as an adjunct to x-ray mammography for women with a 20-25%
lifetime risk of developing breast cancer [11]. A dedicated breast MRI system,
manufactured by Aurora Imaging Technology, Inc., has also been approved by the
FDA and, as of March 29, 2007, 23 units have been installed at facilities worldwide,
with more than double that number expected by the end of that year [20]. In
addition, some insurance companies have started to reimburse the cost of breast
MR for high-risk patients [21], overcoming a major hurdle for widespread use of the
technology. The diagnosis of actress Christina Applegate in August 2008 has also
helped bring breast MR into the public eye since MRI was considered key in the
early detection of her breast cancer [22].
However, despite the many advances made in DCE-MRI, there are numerous
issues that have yet to be fully addressed. Although DCE-MRI demonstrates high
sensitivity, it has a well-documented low and highly variable specificity (26%-97%)
[17, 23, 24]. A lower specificity results in more false positives which lead to more
unnecessary and costly biopsies and procedures. In addition to the obvious burden
of additional cost and time incurred from these unnecessary procedures, they also
lead to increased patient anxiety. In some cases, after a false positive result from
breast MR, patients have opted for mastectomies rather than undergo additional
biopsies to verify the test results [25]. DCE-MRI has also been shown to overesti-
mate margins and produce false positives when used in preoperative assessment of
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local extent of cancer [17, 18]. Perhaps one of the most compelling controversies
of DCE-MRI has been the recent recognition of a link between increased MR use
in breast cancer evaluation and an increased number of mastectomies being per-
formed. As a result of studies showing that survival for breast conserving surgery
followed by radiotherapy was equivalent to survival after mastectomy, the number
of mastectomies being performed had been steadily decreasing during the 1990s and
early 2000s [26, 27]. However, the increasing use of MR for breast cancer staging
seems to be correlated with an unsettling trend towards a rate of mastectomies that
approaches the previous level [26]. Several studies have shown that the addition of
DCE-MRI to the evaluation of patients with breast cancer results in more extensive
surgery (7.8-33.3%), where a significant fraction (0-53%) of that change in surgical
management is later proved unnecessary at histology [25, 28, 29, 30, 31, 32].
In addition to MRI, other emerging x-ray technologies that are under de-
velopment include breast tomosynthesis and dedicated breast CT. Both of these
modalities attempt to improve on the sensitivity of mammography by including ad-
ditional three-dimensional information and removing some of the confounding tissue
overlap that makes interpretation of high breast density mammograms so problem-
atic. Preliminary studies using tomosynthesis have shown improved lesion visibility
and reduced recall rate, but may require additional dose [33, 34, 35]. The use of
breast CT seems to improve visualization of masses at the expense of visualiza-
tion of microcalcifications and the use of an intravenously administered, iodinated
contrast medium can further improve lesion and malignant microcalcification (ma-
lignant lesion that manifests as a microcalcification in mammography) conspicuity
4
[36, 37].
With such a variety of technologies available, each with its own unique advan-
tages and disadvantages, the ability to perform quantitative performance compar-
isons is critical in determining the optimal imaging parameters and clinical utility
of each modality. The ideal platform for quantitative comparisons would be a well-
characterized phantom that can be used to evaluate lesion detection across all of
the available modalities. The requirements for such a phantom include the ability
to mimic image contrast, tissue structure, and lesion characteristics present in the
breast. Image contrast is produced via two different mechanisms in MRI and x-ray
imaging which are characterized by different inherent tissue properties; T1 and T2
relaxation times for MRI and attenuation coefficient for x ray. Therefore, phantom
materials must simultaneously mimic both of these inherent tissue properties. In
addition, it is important that the phantom mimics the complex structure between
fibroglandular and adipose tissues present in the human breast since this provides a
confounding signal that can obscure or emulate lesions, complicating the diagnosis.
Lesions included in the phantom must mimic properties that clinicians use to diag-
nose breast cancer, including border shape and dynamic contrast uptake profiles for
MRI. The border shape and dynamic contrast uptake profiles for the lesion model
must be well known so that acquired data, and estimations derived from that data,
can be quantitatively compared against the true lesion properties.
In this dissertation, we present a phantom that addresses all of the above-
described requirements for multi-modality imaging assessment. In Chapter 2, the
response of indirect x-ray detectors used in breast imaging systems including mam-
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mography breast tomosynthesis, and breast CT are explored. Current modeling
efforts in indirect detector response are summarized. Detailed understanding of the
influence of x-ray detectors on acquired images is useful for research and development
and system optimization. The knowledge gained from investigations presented in
this chapter will be applied to the analysis of x-ray phantom images for the quantifi-
cation of tissue structure in Chapter 5 and to the measurements of the true lesion
washout curves in Chapter 6. In this chapter, experimental measurements were
made of point responses and light output for CsI scintillator screens and the results
were used to validate Monte Carlo predictions using the program mantis. Experi-
mental data were acquired at four difference incidence angles and with two different
spectra for four screens with different scintillator thicknesses, columnar tilt angles,
and substrate types. A quantitative comparison was performed between experimen-
tal and simulated PRFs showing that the simulated PRFs provide a better match
to the experimental data than symmetric two-dimensional (2D) Gaussians fit to the
experimental data itself. Therefore, mantis predictions are more representative of
experimental data than commonly assumed 2D Gaussian functions and can be used
to provide more accurate studies of system characterization and optimization and
can be incorporated into image reconstruction approaches.
Chapter 3 is an extension of Chapter 2 and describes the development of an an-
alytical model for indirect detector point response functions. This model can be used
to provide more rapid predictions of deterministic CsI detector PRFs than mantis
and makes real-time system optimizations and reconstructions using this informa-
tion feasible. The analytical model is x-ray energy and incidence angle dependent
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and draws on results from mantis to indirectly include complicated interactions
that are not explicitly included in the mathematical model. Once the mathematical
expression was derived, values of the coefficients were adjusted using a 2D fit to
mantis-generated results based on a figure-of-merit (FOM) that measures the nor-
malized differences between the mantis and analytical model results averaged over
a region of interest. This analysis was performed for a monochromatic x-ray energy
of 25 keV, a CsI scintillator thickness of 150 μm, and four incidence angles (0, 15,
30, and 45 degrees). The analytical model was found to match mantis results much
better than a 2D Gaussian fit to the zero-angle PRF. A comparison was also made
against experimental data for a 170 μm thick CsI screen and an x-ray energy of 25.6
keV. The analytical model was shown to fit the experimental data about as well as
mantis. This performance is achieved in less than one millionth the computation
time required to generate a comparable PRF with mantis.
In Chapter 4, we present the static MRI properties of the phantom. A brief
overview of the literature, including a discussion of existing MR breast phantoms,
is provided. The phantom construction procedures are discussed as well as the mo-
tivation for the choice of phantom materials. T1 and T2 relaxation times of the
phantom materials were estimated at 1.5 T from inversion recovery and spin-echo
scans, respectively, using maximum likelihood methods. Comparison of the phan-
tom relaxation times with human values from the literature shows good agreement,
particularly for T1 values, which are most important for the T1-weighted images
typically used for breast MRI. Stability of the relaxation times was also evaluated
over 9 months. Tissue structure of the phantom was quantitatively evaluated by
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calculating and comparing spatial covariance matrices of phantom and patient im-
ages. Comparison of the phantom and patient covariance matrices shows that they
have similar image structure within uncertainties due to measurement error and
population variations. Finally, a static, enhancing lesion was introduced by creating
a hollow, plastic mold with stereolithography and filling it with a gadolinium-doped
water solution.
In Chapter 5, we characterize the x-ray properties of the phantom and describe
the production of a phantom with a compressed shape as used in mammography.
A review of anthropomorphic x-ray phantoms is provided. Mass attenuation co-
efficients of the phantom materials were estimated using elemental compositions
from the USDA National Nutrient Database for Standard Reference and the atomic
interaction models from the Monte Carlo code PENELOPE and compared with hu-
man values from the literature. The image structure was examined quantitatively
by calculating and comparing spatial covariance matrices of phantom and patient
mammography images. Finally, a computerized version of the phantom was created
by segmenting a computed tomography scan and used to simulate x-ray scatter of
the phantom in a mammography geometry. Mass attenuation coefficients of the
phantom materials were within 20% and 15% of the values for adipose and glandu-
lar tissues, respectively, which is within the estimation error of these values. Tissue
structures in the phantom have a similar size to those in patient data, but are slightly
larger on average. Correlations in the patient data appear to be longer than those
in the phantom data in the anterior-posterior direction, however they are within
the error bars of the measurement. Simulated scatter-to-primary ratio values of the
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phantom images were as high as 85% in some areas and were strongly affected by
the heterogeneous nature of the phantom. Since the MRI properties of the phantom
have been previously evaluated in Chapter 4, these measurements complete a set of
comprehensive evaluation tests of the phantom for quantitative evaluation of two-
and three-dimensional x-ray and MRI breast imaging modalities.
Chapter 6 describes the development of the dynamic lesion component of the
phantom for evaluation of dynamic contrast-enhanced MRI. Existing dynamic MR
phantoms are discussed. Models for both lesion border shape and washout curve
shape are described. The washout curve shape is controlled via a fluid pump that
varies the amount of contrast agent solution in the lesion as a function of time.
High spatial and temporal resolution x-ray measurements were used to calculate the
true concentration of contrast agent in the lesion model over time. The optimal
fluid flow rate and the ability of the fluid pump to reproducibly create benign and
malignant-shaped washout curves were evaluated. Finally, MRI data were acquired
with a clinical imaging sequence and a variety of spatial/temporal resolutions. MRI
signal intensity curves are shown to be flatter and less specific to lesion type than
the true contrast agent concentration curves, as verified by x rays. Methods for
improving the match between the MRI data and the contrast agent concentration
curves are discussed.




Experimental validation of Monte Carlo (MANTIS) simulated x-ray
response of columnar CsI scintillator screens
2.1 Overview
Thallium-activated1 cesium iodide (CsI:Tl) scintillator screens coupled with
optical readout arrays are currently the most commonly implemented detection
method for digital x-ray imaging [86]. X rays are absorbed by the CsI:Tl crystal,
which then produces a shower of optical photons that are detected with a flat-
panel array of amorphous Silicon photodiodes. The crystal itself has a complex
columnar structure that directs the optical photons down the thickness of the crystal
and improves the detector resolution as compared with unstructured crystals [86,
87, 88]. This columnar structure also affects the point response function (PRF)
of the detector in a complex manner that is difficult to model. The PRF fully
describes the blurring behavior of the scintillator and is simply the image that
results from x rays that are incident on the detector at a single, infinitesimally
small point. This definition of the PRF is ambiguous since x rays with different
incidence angles will result in dissimilar responses. This fact has lead investigators
to provide a more formal analysis of the response function of x-ray detectors that
include directionality of the primary beam (see for instance Ref. [89]). Therefore, for
1Work in this chapter published in Medical Physics [85].
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the purpose of the analysis included in this paper, our definition of PRF includes the
direction of the incoming x rays. Proper modeling of the PRF and its dependence
on scintillator properties is critical to performing rigorous system optimizations that
correctly predict image quality and forward-problem image reconstructions that
accurately reproduce the imaged object.
To the authors’ knowledge, the only computational model that provides a de-
tailed treatment of the internal structure of CsI:Tl columnar scintillators and is
capable of predicting the full two-dimensional PRF as a function of the scintillator
properties is a package called mantis (Monte Carlo x-rAy electroN opTical Imaging
Simulation) [90]. Several studies have investigated models of detector performance
for megavoltage photons for radiotherapy applications [91, 92, 93, 94, 95]. These
studies focus on single- or segmented-crystal scintillators and have been used to sim-
ulate light output as well as symmetric detector spread via the modulation transfer
function (MTF). Experimental validation of both light output and symmetric de-
tector response has been reported in the cited works. A recently developed Monte
Carlo code, PHOTON, for simulating optical photon transport in scintillation de-
tectors was used to model the light output of a single-crystal plastic scintillator for
662 keV gamma rays and was validated with experimental data [96]. The main dif-
ference between the code mantis and the work cited above is the fact that mantis
uses a list-mode approach for accounting of energy depositions and optical photon
generation in the scintillator and can accommodate a structure with a large number
of columns in the scintillator device. A recent study by Blakesley and Speller[97]
implemented a Monte Carlo-based model of the full x-ray detection process in flat
11
panel arrays (both indirect and direct detection types) from generation of the x-ray
photons to charge readout and electronic noise in the photodiode layer. However,
their model was meant to provide broad comparisons between theoretical detectors
and not to give detailed descriptions of detector image quality. For this reason,
while their model does provide a simplified treatment of the scintillator internal
columnar structure, their model does not produce two-dimensional PRFs capable of
fully capturing the blurring behavior of the detector.
mantis is a publicly available Monte Carlo simulation code capable of tack-
ling the problem of detailed simulation of the imaging properties of these columnar
CsI:Tl scintillator screens [90]. It provides a complete Monte Carlo simulation of the
entire experimental setup including sources and objects in their respective geome-
tries and is the only tool that can accurately predict the anisotropic nature of the
columnar scintillator response. Comprehensive validation of the code is necessary
to have confidence in the derived results. Once validated, mantis can be used to
perform system optimizations and accurate reconstructions of data for a variety of
applications. It has already been applied to characterize breast tomosynthesis [98]
and breast computed tomography (CT) systems [99]. Incorporation of the complete,
anisotropic scintillator response has the potential to substantially improve system
design and reconstruction techniques.
Previous validation work on this and other detector models has focused on
reproducing summary measures of the scintillator performance (i.e., MTF, Swank
factor) [92, 93, 95, 98, 100]. In this paper, we approach the validation of the mantis
package from the perspective of comparing the complete PRFs of the system, while
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maintaining the information (Swank) factor I and the light output consistent with
previously published data. Typically, experimental measures of detector PRFs are
performed using edge or slit devices, which can not completely reproduce angular
variations in the true PRFs [89]. Here, we use a pinhole-based experimental setup
to perform a complete measurement of the PRFs of four different CsI:Tl screens
at four incidence angles (0, 15, 30, and 45 degrees) and two x-ray spectra (40 and
70 kVp). In addition, simulated PRFs, that incorporate the detailed experimental
setup parameters and CsI:Tl structural information, are produced by mantis for
each of these screens. A quantitative comparison of the experimental and analogous
simulation results is then performed. Note that while the pinhole-based measure-
ments (using a 30 μm diameter pinhole) provide an approximation to the true PRF,
since the true PRF requires an infinitesimal incidence point, the simulated data uses
the same system setup and therefore also produces an analogous response.
Section 2.2 provides a description of the experimental setup and mantis code.
The results are presented in Section 2.3 and a discussion is given in Section 2.4.
Finally, conclusions are given in Section 2.5.
2.2 Materials and methods
Validation of columnar CsI detector response as simulated by mantis was
performed by experimentally measuring both relative light output and PRF shape
using two different experimental setups. Simulations mimicking those experimental
setups as closely as possible were then performed with mantis and the results were
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compared. In the following subsections we first describe the experimental setups
then the corresponding mantis simulations, and the FOM used for evaluating the
data.
2.2.1 Experiments
We have designed a custom imaging system that allows us to capture high-
resolution images of screen output with the additional benefit of having an open
faceplate where different screens can easily be mounted. The optical detector setup
consists of a high-resolution CCD camera with a 1-to-1 fiber optic faceplate (FOP)
that allows measurements on different screens by providing an interface between
the detector inside of the thermoelectrically cooled vacuum dewar and the outside
environment. The CCD is a Quantix 6303 Photometrics 3072×2048 imaging array
with 9×9 μm-pixels. A standard Quantix 6303 camera was modified with a 4.5 cm
length 1-to-1 fiber optic faceplate, with 4.5 μm fibers, bonded to the CCD chip
on one side, and leaving the other side accessible (outside the vacuum) so that
scintillator screens can be positioned and measured (see Figure 2.1).
Individual scintillator screens are held in pressure contact with the FOP by
a piece of dense foam inserted between the 0.635 mm thick beryllium window cap
and the screen. The use of optical index-matching fluid was investigated to improve
contact between the screen and FOP (data not shown), but did not improve the
image quality. The indices of refraction were 1.48 for the FOP (Incom, Inc., Charl-
ton, MA) and 1.55 for the optical index-matching fluid (NYE optical fluid OCF-455,
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Figure 2.1: Schematic of CCD setup with a 30 degree pinhole holder (not to scale).
Diverging x-rays enter from the right. The pinhole is mounted in a caphead screw
and positioned in an aluminum holder at the desired angular orientation. lead lining
within the aluminum holder provides shielding from background signal and has a
hole oriented to allow the primary signal through. The signal then passes through
a Be window and compressed foam before impacting the screen and producing the
optical signal that travels down the FOP to the optical detector. A cross-sectional
view (not to scale) of the pinhole disk is shown in the inset [101]. The manufacturer
specifies L=75 μm±10 μm and D=30 μm±5 μm for the 30 μm pinhole. Note that,
when drawn to scale, the size of the straight edged portion of the pinhole is much
smaller than the angled opening.
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NYE Lubricants, Inc., Fairhaven, MA).
2.2.1.1 Relative light output
For the light output experiments, four different screens (Screens 1-4) were
investigated (see Section 2.2.1.3 for more detail on the screens). Two screens were
placed directly against the FOP of the CCD camera, side-by-side, at the same time
and a set of 11 exposures was taken with the x-ray tube at 70 kVp (see Section 2.2.1.4
for more details about the x-ray source) and an exposure of 50 mA and 100 ms.
One of the screens was always Screen 1, so that the light output relative to Screen 1
could be measured. The light output was then calculated, on the median of the 11
exposures, as the ratio of the average of values within a circular region-of-interest
(ROI) on the screen area.
2.2.1.2 Point response function
For the PRF experiments, an additional aluminum cap with lead shielding
was bolted onto the beryllium window cap to hold a pinhole (see Section 2.2.1.5
for details about the pinhole) as close to the screen as possible. A total of four
aluminum caps were manufactured, each holding the pinhole at a different, fixed
angle (0, 15, 30, and 45 degrees) with respect to the screen. Figure 2.1 shows a
schematic of the 30◦ pinhole holder in place. These four angles were chosen to cover
the range of typical incidence angles seen in mammography, tomosynthesis, and
breast CT systems (see Ref. [98]). Additional shielding is provided by a lead sleeve
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that fits around the outside of the camera and a lead window near the end of the
CCD assembly.
This entire camera/screen/pinhole assembly is bolted to a motorized rotation
stage controlled via a LabView program to allow accurate angular alignment with the
x-ray source. Alignment at zero degrees is achieved with a laser assembly between
the beryllium window cap and the x-ray tube window. A small laser is mounted in a
circular cap that bolts onto the window cap and a circular mirror is secured in front
of the x-ray tube window with two plastic pressure tabs. Positions of the x-ray tube
and detector are adjusted until the reflected laser beam coincides with the original
laser beam location. Once this condition is achieved all stages controlling the x-ray
tube and detection position are locked in place except for the rotational stage that
controls the angle of the CCD camera. For all measurements, the distance from the
source to the pinhole was 130.0 cm. The distance from the screen to the pinhole
varied in the range 17.78-25.4 mm, depending on what angle was being measured
and the thickness of the measured screen.
PRFs were measured on all four screens with 40 and 70 kVp spectra for each
of the four incidence angles (0, 15, 30, and 45 degrees). Eleven images were acquired
for each of the experimental conditions so that error bars could be estimated from
the sample variance. Pixels in the individual experimental images that were more
than 5 standard deviations from the median over all 11 images were replaced with
the median value for that spatial pixel location before further analysis.
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2.2.1.3 Screens
A total of four different columnar CsI scintillator screens (provided by Ra-
diation Monitoring Devices, Inc., Watertown, MA) were measured. Their man-
ufacturer’s specifications are given in Table 2.1. In order to characterize screen
morphology, cross-sectional views were imaged with a scanning electron microscope
(SEM, model ISI SS40, now Topcon, Tokyo)2. This allowed measurements of not
only the thickness of the CsI layer, but also of the approximate diameter and angle
of the columns relative to the substrate. Note that, while SEM measurements pro-
vide a means of probing the internal structure of the screens, they do have several
important shortcomings. First, an SEM can never be acquired of exactly the same
position that is used to acquire an image. Second, only a very small number of SEM
measurements can be performed on a single screen, resulting in a poor sampling
of the crystal structure. Finally, the act of acquiring the SEM image for a cross-
sectional view can modify the structure of the crystal itself. All of these shortcoming
arise from the fact that acquisition of an SEM image for a cross-sectional view re-
quires the screen to be physically broken, and is, therefore, inherently destructive.
Figure 2.2 shows the SEM measurements of each of the screens. From this figure we
can see how the tilt angles and layer thicknesses vary between the different screens.
In addition, we can see the transition from columnar to amorphous CsI close to the
substrate. This figure demonstrates the variety of structures seen in the different
screens as well as allows the reader to evaluate the ability of the simulation code to
2by Stuart Miller
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Figure 2.2: SEM measurements of all screens. The physical size of the white scale
bar at the bottom of each SEM as well as the magnification are given following the
screen number. a) Screen 1 (77.4 μm, 200x), b) Screen 2 (56.44 μm, 300x), c) Screen
3 (151.36 μm, 100x), and d) Screen 4 (151.36 μm, 100x)
reproduce these complicated structures.
The measured screens cover a range of different properties including reflective
and absorptive substrates, thin and thick columnar scintillator layers, a variety
of different layer structures, and varying columnar tilt angles. An estimate of the
columnar tilt angle of each of the screens was performed by using a graphics program
to measure the angle of a line drawn over the SEM following a column judged to be
representative of the area imaged by the SEM. The error in estimation of this tilt
angle was approximately ±0.5 degrees. In Section 2.4.5 we discuss the importance
of accurately determining this parameter and find that an error of as large as ±6
degrees does not significantly affect the results.
For one of the screens (Screen 3), a second SEM measurement was taken at
a different orientation (data not shown), approximately perpendicular to the first
orientation, to provide a more accurate characterization of the CsI structure. For
the two corners of Screen 3, the measured columnar tilt angles were 2.5 and 6.0
degrees. The combination of these two tilt angles gave the final tilt angle of 6.5





























































































































































































































































































































































































































































































































































due to the fact that the tilt angle varied over the area imaged in the SEM. Overall,
the measured tilt angles of the screens varied from between approximately 2.0 and
6.5 degrees. In all but one of the screens (Screen 3) the magnitude of the tilt angle
was only measured in one direction and is therefore a lower limit to the true tilt
angle at that location. Additional uncertainty arises from the fact that the columnar
tilt angle may vary over the screen surface. See Section 2.4.1 for further discussion
of errors associated with quantification of the SEM structure.
2.2.1.4 X-ray source
The x-ray source is a Varian B180 (Varian Corp., Salt Lake City, UT) x-ray
tube with a tungsten anode, a 0.3 mm focal spot, 1.0 mm Al internal filtration, and
no additional filtration. For the current measurements, data were taken with peak
energies of 40 kVp and 70 kVp.
2.2.1.5 Pinhole
The pinhole assembly consists of a small, 90:10 Gold-Platinum alloy disk with
a pinhole aperture machined through the center of the disk face and mounted in
the head of a cap screw (Fluke Biomedical X-Ray Pinhole Assembly #07-613, Ev-
erett, WA). The manufacturer’s specifications are shown in the inset of Figure 2.1
(L=75±10 μm, D=30±5 μm) [101].
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2.2.2 Simulations
The simulations were performed using mantis3, a tool for modeling x-ray
imaging systems with CsI:Tl columnar scintillator screens. mantis simulates the
transport of x-ray photons, electrons, and optical photons within the same geometric
model[102, 103]. The code mantis, which is publicly available online4, incorporates
the penelope [104] physics for x ray and electron interaction physics models, along
with the optical transport models and geometry descriptors. For validation of pre-
vious versions of the code, we have focused on the statistics of the screen optical
signal using Swank factor measurements[100]. Results of that validation show that
the predictions of mantis are well within the uncertainties of experimental mea-
surements.
In this paper, we have incorporated the detailed geometrical structure of each
specific scintillator screen (see Table 2.1). Additional parameters, such as material
and surface optical properties and columnar packing density, remain unchanged
from previous simulations and are listed in Table 2.2. Details we can model include
scintillator thickness, additional top and bottom layers that are present in the overall
detector such as the substrate and protective layers, and uniform tilt angle and
direction of the CsI:Tl columns. For this study, each individual PRF was produced
with 5x105 histories and required approximately 14 minutes of CPU time on a 768-
core Linux cluster with mantis version 2.0. This number of histories produced PRFs
3by Aldo Badano
4A current version of the code, tutorials, and examples are available from
http://code.google.com/p/mantismc.
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with low enough uncertainties to allow for precise comparisons of the figures-of-merit
(FOMs) for the different cases compared in this study.
2.2.2.1 Relative light output
Relative light output values were calculated by counting the number of de-
tected optical photons from PRF simulations for 0 degrees and 70 kVp and dividing
by the value for Screen 1 with a substrate reflectivity of 10%. Reflectivities of 10%,
17%, and 40% were investigated for the graphite substrates and 35%, 80%, and 90%
for the aluminum-coated substrates. A range of reflectivities was investigated in
simulation since it was not possible to directly measure the substrate reflectivities
of the actual screens.
2.2.2.2 Point response function
Here, the incoming beam was modeled a parallel beam from a circular source
of 100 μm diameter. The x-ray spectra used in the simulations were calculated using
IPEM Report 78 [105] for 40 kVp and 70 kVp spectra with 1.0 mm Al filtration. The
spectra are shown in Figure 2.3. The mean photon energy (MPE) and half-value
layer (HVL) for the 40 kVp spectrum are 25.6 keV and 0.8926 mm Al respectively.
For the 70 kVp spectrum, the MPE and HVL are 36.5 keV and 1.593 mm Al.
The pinhole disk and Be window were both simulated using the exact material



















































































































































































































Figure 2.3: Spectra used in mantis simulations of the experimental PRFs: 40 kVp
(solid line) and 70 kVp (dashed line). Both spectra include 1.0 mm Al filtration.
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Measurements of the columnar tilt angle and layer thicknesses for each indi-
vidual screen, as described in Section 2.2.1.3, were incorporated in the geometric
model implemented in mantis. In the current version of the code (version 2), the
columnar shape and tilt angle are required to be constant for the entire array of
columns across the screen. From inspection of Figures 2.2 and 2.4 we can see that
this is an oversimplification since both the columnar shape and tilt angle can change
in a complicated manner over the screen surface. We are currently working on more
sophisticated geometrical models for future versions of the code. Figure 2.4 shows a
side-by-side comparison of the SEM measurement of Screen 1 and the corresponding
model structure used in mantis. All of the measured screens were modeled with
4 different layers; a 4 μm planar protective layer of organic polymer, a variable
thickness layer (depending on the SEM-derived thickness of the individual screens)
of columnar CsI, a layer of homogeneous CsI crystal with 20% the thickness of the
total CsI layer, and a 1-mm-thick substrate of either graphite or aluminum-coated
graphite depending on the individual screen. The CsI columns in the columnar layer
had a uniform diameter and tilt angle over the entire screen. The tilt angle of the
columns was along the same direction as the oblique angle of x-ray incidence. The
reflectivities of the graphite and aluminum-coated graphite substrates were assumed
to be 10% and 90% respectively in mantis.
The photodiode layer was placed immediately following the screens. This
was then followed by as a solid glass slab (PENELOPE material 171) to model
the FOP. We chose to model the FOP and photodiode layer in this manner to
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Figure 2.4: (left) SEM of Screen 1 (white scale bar = 77.4 μm, magnification=200x)
(right) Schematic of mantis model of the same screen (to scale). The thin layer
at the top of the image represents the organic polymer. The organic polymer layer
is followed by the columnar zone, where light gray indicates CsI and dark grey is
the inter-columnar space. The next layer is the homogeneous CsI and, finally, the
bottom layer is the substrate.
capture the scatter associated with the FOP. We are currently unable to simulate
the transmission properties of the FOP itself. Although in reality, the photodiode
layer is after the FOP, we do not expect this inconsistency to significantly affect the
results, as discussed later in Section 2.4.4.
Using the above-mentioned parameters, PRFs were simulated on all four screens
with 40 and 70 kVp spectra for each of the four incidence angles (0, 15, 30, and 45
degrees). Eleven images were simulated for each of the cases to allow for estimation
of error bars.
2.2.3 Figure of merit
A quantitative comparison of the experimental and simulated PRFs was per-
formed by computing a FOM for each of the eleven pairs of experimental and sim-
ulated images for each different screen/spectrum/incidence angle combination. The
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mean and standard deviation of the eleven independent FOMs were taken as esti-







where NROI is the number of pixels in the ROI and Δ is the normalized difference.
The normalized difference is defined as
Δi = 1 − si/
∑
i si
(ei − b) /
∑
i (ei − b)
, (2.2)
where b is a background value calculated by summing the values in a corner of the
image where there is no signal and si and ei are elements of the vectors s and e
that contain all the simulated and experimental PRF values, respectively, within
the selected ROI. The vectors s and e are defined by
s = {PRFsim; PRF expj ≥ 50 σ and PRF simj > 0, j ∈ [1, NPRF ]} (2.3)
and
e = {PRFexp; PRF expj ≥ 50 σ and PRF simj > 0, j ∈ [1, NPRF ]}, (2.4)
respectively, where PRFsim is the simulated PRF, PRFexp is the experimental PRF,
PRF expj is an element of the experimental PRF image, PRF
sim
j is an element of the
simulated PRF image, NPRF is the number of pixels in the PRFs (the simulated
and experimental PRFs have the same number of pixels), and σ is the noise in the
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experimental image calculated as the standard deviation of the lower left corner of
the image. Therefore, the ROI is identical for both the simulated and experimental
images and consists of those pixels with a signal-to-noise ratio (SNR), PRF expj /σ,
of greater than or equal to 50 in the experimental data and a non-zero value in the
simulated data. This ROI was chosen so that pixels in the peak and tails of the
ROI contributed equally to the FOM. Note that the ROI is not square or circular,
rather it only includes pixels that satisfy the SNR condition. The extent of the ROI
is indicated in Figure 2.5. Figure 2.9 in Section 2.3.2 gives an indication of the ROI
size since all pixels outside of the ROI are set to zero in these images. The number
of pixels in the ROI ranged from 206 to 736 pixels (equivalent to 16686 to 59616
μm2) over all PRFs investigated.
To ensure that the two PRFs were correctly aligned before calculation of the
FOM, the maximum of the two-dimensional (2D) cross-correlation function was
used to determine the optimal relative shifts and rotations of the two images prior
to calculation of the FOM. The resolution of the cross-correlation algorithm was one
pixel (9 μm) for x and y shifts and one degree for rotations.
Finally, to provide a benchmark to put the FOM values in context, the same
FOM was also calculated using a symmetric 2D Gaussian, fit to the zero-angle
experimental data, as the simulated data. The Gaussian fit was performed using a
modified version of the program gauss2dfit in the software package IDL (ITT Visual
Information Solutions, Boulder, CO) that forced the widths of the 2D Gaussian in
the x and y directions to be equal.
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Figure 2.5: Experimental and Simulated PRFs for Screens 1-4. (1st column) 40 kVp,
Experimental (2nd column) 40 kVp, Simulations from mantis (3rd column) 70 kVp,
Experimental (4th column) 70 kVp, Simulations from mantis (5th column) 40 kVp,
Horizontal cuts through the center of the PRFs, experimental data are shown with
a solid line and mantis results are shown as a dashed line. The solid vertical lines
indicate the size of the ROI. The different screens are labeled as well as the incidence
angles. Only incidence angles of 0 and 45 degrees are shown. Contour lines shown
on the plots are for levels of 0.01, 0.05, 0.1 (the maximum is always 1). All PRFs
are 101 × 101 pixels with 9 μm/pixel.
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2.3 Results
2.3.1 Relative light output
The experimental light output values were compared with light output val-
ues derived from mantis simulations with a variety of substrate reflectivities. The
substrate reflectivities used in mantis for the PRF comparisons were 10% for the
graphite substrates and 90% for the aluminum-coated substrates. We have inves-
tigated additional reflectivities (17% and 40% for graphite and 35% and 80% for
aluminum) to observe their effect on the light output values. The measured and
simulated relative light output values for graphite and aluminum-coated substrates
are shown in Table 2.3. For the graphite substrates, we only have a single inde-
pendent measurement of light output (for Screen 4). The results seem to indicate
that a very large reflectivity (much greater than 40%) is necessary to match the ex-
perimental results. For the aluminum-coated substrates, we have two independent
measurements of light output (Screens 2 and 3) and we see that no single reflectivity
value can reproduce the experimental results of both of the screens. Results from
Screen 2 seem to indicate an aluminum reflectivity of between 80% and 90%, while
Screen 3 implies a reflectivity of much greater than 90%, however these results are
less discordant since the simulated light output values at 80% and 90% are the same
to within two error bars. This inconsistency is probably a result of one of two or both
effects; the fact that reflectivity is only one of numerous parameters in mantis that
affects the light output of a screen and the fact that different screens from different
manufacturing batches can have highly variable light outputs depending on slight
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differences in the manufacturing process that are not easily controlled or quantified.
See Section 2.4.2 for a discussion of variability of screen performance with man-
ufacturing process. In future studies it will be important to provide independent
measurements of substrate reflectivity to reduce the number of variables needed
to validate light output. However, these measurements must be carefully controlled
since substrate reflectivity can vary depending on handling conditions and substrate
production methods. For all other mantis-generated PRFs presented in this paper,
we have used substrate reflectivities of 10% for graphite and 90% for aluminum-
coated graphite because those values were used in previous validation efforts and
have been crucial in matching Swank factors (see Ref. [98]). In the future, we plan
to perform reflectivity measurements on the individual substrates themselves during
the screen production process, so that these values can be included in mantis and
the number of unknown parameters in the simulations can be reduced.
2.3.2 Point response functions
Figure 2.5 shows the experimental and simulated PRFs for the screens in
Table 2.1 at 40 and 70 kVp x-ray source energies and 0 and 45 degree incidence
angles. Here, the eleven individual experimental and simulated results have been
combined to produce a single PRF for each spectrum/incidence angle combination.
The PRFs have all been normalized by their maximum value and contours at 0.01,
0.05, and 0.1 times the maximum value are shown. Also shown are plots of horizontal





































































































































































































































































































































































data is shown with a solid line and the simulated data is shown with a dashed line.
The sharp cutoffs seen in the simulated data of Screens 3 and 4 are because the
simulations were not run past this spatial location. The most noticeable quality
of the PRFs is their highly non-Gaussian shape at large incidence angles. This
tear-drop shape, seen especially well in the thick screens, is due to the increasing
spread of the secondary photons produced by x-rays deposited at shallow depths
in the CsI crystal. There is also a large variation evident between the individual
screens. These large differences make it clear that one PRF model does not fit all
CsI scintillator screens and that each screen must be individually modeled according
to its specific structure. In particular, we can see that mantis clearly does a better
job of reproducing experimental data for the thinner screens (Screens 1 and 2).
Figures 2.6-2.9 show the results of quantitative comparisons between exper-
imental and simulated data. Figure 2.6 shows a plot of all the FOMs for all the
screens, energies, and angles investigated. We see that the FOMs comparing exper-
imental data with mantis simulations are between about 0.1929 and 0.4775 for all
cases. There does not seem to be a significant difference in the FOM values with
energy. For the thicker screens (Screens 3 and 4), mantis tends to reproduce PRFs
with larger incidence angles better than those with smaller incidence angles. In this
case, the cause may be due to the principal determinant of the PRF shape. At large
incidence angles, the PRF shape is largely determined by the geometry of the system
(the angle of the x ray entering the crystal), whereas at small incidence angles the
principal determinant of the PRF shape is the optical transport. Since geometry is
much easier to model than optical transport, PRFs at large angles may be easier to
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Figure 2.6: FOMs for all screens, energies, and incidence angles. Black indicates
the results from the comparison of experimental data with mantis-generated PRFs
and green indicates the results from the comparison with a 2D symmetric Gaussian
fit to the zero-angle experimental data. The values displayed are means of FOMs
calculated from 11 independent experimental and simulated images, while the error
bars represent the standard deviation of those 11 different FOMs.
predict. For the same substrate type and energy, mantis tends to perform better
for thin screens than for thick screens at small incidence angles.
For the comparison with Gaussian fits, we find that the FOM ranges between
about 0.2068 and 0.8029. It is notable that the FOM for the Gaussian fits to the
experimental data are, in general, worse than the mantis simulated PRFs. The
exception is that the symmetric Gaussian fit tends to match the experimental data
better for the thicker screens than for the thinner screens at small incidence angles,
which suggests that as the screens get thicker their response becomes more Gaussian.
Note that, for the thicker screens, mantis still outperforms the Gaussian fit for
larger incidence angles. It’s interesting to note that, for the thinner screens, even at
an incidence angle of zero degrees, mantis outperforms the Gaussian fit. Figure 2.7
shows a closer examination of the experimental data, mantis simulations results,
and Gaussian fits at zero degrees for 40 kVp. Horizontal, one-dimensional cuts
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Figure 2.7: Comparison of experimental, mantis, and Gaussian fit PRFs at zero
degrees for 40 kVp. One-dimensional, horizontal cuts through the center of the PRFs
are shown for each screen. The experimental data are shown as a solid line, mantis
as a dashed line, and the Gaussian fits as a dotted line. We can see in all cases
that the Gaussian fit underestimates the peak of the PRF. For the thicker screens
(Screens 3 and 4), mantis provides a much sharper PRF than the experimental data
and, as a result, the FOM calculation indicates a better match to the experimental
data for the Gaussian fit than mantis.
through the centers of the PRFs are shown for each of the four screens. We can see
in all cases that the Gaussian fit underestimates the peak of the experimental data
and mantis provides a better estimate of the PRF shape. Therefore, the better
performance of the Gaussian fit for small incidence angles for the thicker screens
seems to be due to the fact that mantis is underestimating the width of the PRF.
Figures 2.8-2.9 show a more detailed breakdown of the normalized differences
(Δi as given in Equation 2.2). In Figure 2.8 the normalized difference is plotted
on the y axis and the angle of incidence on the x axis for every screen and energy
investigated. The objective of this plot is to show the distribution of normalized
difference values that make up the single FOM values. The FOM is calculated by
taking the RMS of the normalized difference values. The box plots show the me-
dian normalized difference (in the ROI) as the filled circle, the bottom and top of
the box are the 1st and 3rd quartile, and the bottom and top error bars show the
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Figure 2.8: The normalized difference of the PRFs is plotted as a function of inci-
dence angle for all screens, energies, and incidence angles. Normalized differences
from the comparison with mantis are plotted in black, while normalized differences
from the 2D Gaussian fit are plotted in green. The box plots show the median nor-
malized difference (in the ROI) as the filled circle, the bottom and top of the box
are the 1st and 3rd quartile, and the bottom and top error bars show the minimum
and maximum normalized difference.
minimum and maximum normalized difference. Results for the mantis comparison
are shown in black and for the Gaussian fit are shown in green. A selected set of
the corresponding images are displayed in Figure 2.9 that show the spatial distribu-
tion and relative magnitude of the normalized differences for each incidence angle
investigated. In these plots the normalized difference is shown in the ROI where a
normalized difference of zero is mapped to black, negative differences are shown as
shades of blue, and positive differences are shown as shades of red. The images are
all scaled to the minimum and the maximum of the normalized differences for each
particular PRF. Therefore, Figure 2.9 shows the spatial distribution of the normal-
ized differences over the ROI, while Figure 2.8 shows the distribution of the actual
numerical normalized difference values. These figures allow a more detailed analysis
of the differences between the experimental and mantis model data.
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Figure 2.9: Images showing the spatial distribution of the normalized differences
for all incidence angles of Screens 1 and 3 with the 40 kVp spectrum. Images
from the comparison of experimental data with mantis are outlined in black and
labeled “MANTIS”, while images from the comparison with the 2D Gaussian fit
are outlined in a green box and labeled “Gauss”. Negative normalized differences
are mapped to shades of blue, positive to shades of red, and zero to black. The
images are all scaled to have red, blue, and black as corresponding to the most
positive, most negative, and zero data values, respectively. As a result, these images
simply indicate the spatial location and relative magnitude of differences and not
the absolute magnitude of the difference which is indicated in Figure 2.8.
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As an example of the type of information conveyed in Figure 2.8, we can
compare Screen 1 at 70 kVp and 0 degrees with Screen 3 at 40 kVp and 45 degrees.
From Figure 2.6 we can see that the FOMs of the comparison with the Gaussian
is larger than the FOMs from the comparison with mantis results in both cases.
Now, if we examine Figure 2.8 we can see that the reason for the disparity in FOMs
of the two cases (Screen 1/70 kVp/0 degrees versus Screen 3/40 kVp/45 degrees) is
very different. In the case of Screen 1 (70 kVp/0 degrees), the average normalized
differences are very similar and the difference in FOM arises from the fact that the
range of normalized difference values is much larger for the Gaussian comparison
than for the mantis comparison. Conversely, for Screen 3 (40 kVp/45 degrees)
the range of the normalized difference values are very similar for the Gaussian and
mantis comparisons, but the difference in FOMs arises from the fact that the mean
normalized difference values are very different. The data in Figures 2.8 and 2.9 also
demonstrate that the main reason for the differences between the experimental and
mantis PRFs is that mantis tends to produce PRFs that are too sharp compared
to the experimental data. This can be seen particularly well in Figure 2.9 in the
images with the black outline (labeled “MANTIS”) since the central portion of the
difference image tends to be blue (or negative) and the outer region tends to be
red (or positive). In fact, this effect is also easily visualized in the individual PRF




Examination of the experimental and mantis-generated PRFs shows that
mantis provides a good fit to the experimental data for all energies, incidence
angles, and screens measured. The match between experimental and mantis PRFs
is especially good for the thinner screens. However, we do see that a 2D Gaussian fit
to the zero incidence angle data outperforms mantis for small incidence angles for
the thicker screens. In addition, mantis consistently predicts sharper PRFs than
those measured experimentally.
Another point that should be made is that, for this study, the parameters
used in mantis were taken from previous studies where pulse-height spectra had
been validated. The only parameters that were modified were related to geometry
of the system components. In effect, this approach answers the question of how well
mantis can predict detector performance with only basic geometrical information
about the screen and no additional modification of the other model parameters.
We anticipate that mantis can match experimental data more closely by optimiz-
ing various parameters of the code (e.g., reflectivities, bulk absorption, amorphous
layer fraction), however, unless these parameters are obtained through physical mea-
surements, this would not indicate the ability of the code to predict performance.
Therefore, the results presented in this study represent a conservative estimate of
accuracy for the estimation of the PRF of CsI screens.
To our knowledge, only two other models have been validated against exper-
imental data from columnar CsI scintillators [97, 106]. In the model produced by
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Blakesley and Speller [97], zero incidence angle simulation results were compared
against experimental data from two systems with different columnar CsI screens.
The validation was performed by overplotting the experimental MTF with simu-
lated results, no quantitative FOM was used. For one of these systems, the screen
had an unspecified thickness, so the model was adjusted to provide the best fit to
the experimental data. For the other system, simulations were compared with two
CsI screens that had the same thickness, but were deposited on different substrates.
Their model predicted a MTF that was in between the experimental measurements
of the two screens. The authors emphasize the inability of the model to include all
the details of the screen properties and the fact that properties of screens with the
same thickness and scintillator material can vary widely due to a variety of factors.
In the first system they discuss, the experimental data itself was used to deter-
mine the model parameters and is, therefore, not a representation of the predictive
abilities of the model. In the second case, the model parameters were determined
independent of the experimental data, but the model was not detailed enough to
distinguish between the two types of screens investigated. The authors acknowledge
that there are many different parameters not included in the model that can affect
screen performance. In our validation efforts, we have avoided using the experimen-
tal data to determine any model parameters so that the validation addresses the
predictive abilities of the model. In addition, we have attempted to include more
parameters that may affect screen performance, such as the detailed structure of
the CsI crystal. However, our validation efforts are still subject to a number of
uncertainties as will be discussed in the following subsections.
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Mainprize et al.[106] developed an analytical model for the one-dimensional
MTF of a scintillator as a function of angle of incidence of an incoming x-ray beam.
This was compared with experimental MTFs measured on a structured CsI flat
panel detector at four different incidence angles and two different x-ray spectra
after dividing by the zero-angle MTF. In this case, since the thickness of the CsI
was not known, it was determined by a fit with the experimental data itself. Again,
the model was validated by qualitatively comparing the MTFs of the simulated and
experimental data. In this study, the experimental data was also used to determine
model parameters since the thickness of the CsI was not known. Therefore, as in the
Blakesley and Speller [97] study, the validation is not of the predictive ability of the
model. In addition, the model was only meant to simulate the effects of incidence
angle and did not include optical transfer properties of the crystal.
Our study is a validation of the predictive abilities of the mantis software
since the experimental results were not used to determine model parameters. In
addition, mantis includes effects of both optical transfer as well as incidence angle
and details of the columnar structure of the CsI crystal. In order to fully characterize
the asymmetric detector blur that can be generated with mantis, we have chosen
to validate the model against 2D experimental PRFs, which are not subject to the
limitations of MTF analysis. In addition, we have developed a quantitative FOM
to facilitate comparison of different screens and imaging systems. Examination of
this FOM across the four investigated screens has shown that although mantis
provides a good fit to the experimental data, there still exist some uncertainties
that cause mantis to predict sharper PRFs than those seen experimentally. In the
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following sections we discuss possible sources of error that may contribute to the
differences seen in Section 2.3 between the experimental data and mantis model
results. Details of the scintillator screen layers and their geometry, variation in
screen properties due to the manufacturing process, geometry of the x-ray source
and pinhole, blur due to the FOP, and orientation between the columnar tilt angle
and the incoming x-ray beam are all considered.
2.4.1 Accurate knowledge of screen details
The ability of mantis to incorporate detailed structure of the CsI scintillator
screens requires that the true structure be accurately quantified. For this purpose,
SEM measurements were taken and analyzed. However, there are limitations in
both the ability of mantis to incorporate high levels of detail, and for the SEMs
to accurately quantify the CsI structure. In the case of mantis, the CsI crystal
must be cleanly divided into two regions, a homogeneous region (in contact with
the substrate) and a columnar region that extends beyond that. In reality there is
a smooth transition between the solid and columnar structures in the CsI crystal.
mantis also requires that the columns all have the same circular diameter and tilt
angle and that all layers have a uniform planar thickness. However, inspection of
the SEM images clearly shows that all of these characteristics are, at some level,
inaccurate. In reality, the CsI columns have irregular, non-circular cross-sections
that vary along the depth of the CsI layer, the thicknesses of layers can vary over the
crystal width, some deposited layers form a non-planar surface that dips down into
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the layers below, and tilt angles of the columns are non-uniform even over the small
field of view of the SEM images. While these inaccuracies do exist, the reasonable
approximation employed by mantis should allow for representative results.
With respect to the size and shape of the columnar bases, our previous work
has shown that column base shape does not affect medium or long range blur (>
10μm)[107] for a model that does not include columnar tilt. However, the effect
of intra-columnar spacing, presence of cracks and dislocations in the columns, and
presence of contact between the columns remains to be investigated.
We are currently working to improve the ability of mantis to simulate ran-
dom columnar tilt and shape by developing a geometry definition that generates
the columnar structure on-the-fly as it follows the interaction sites of x rays and
electrons. It is possible that the artificial regularity of the Monte Carlo geometry
used in this work is contributing to a bias in the resulting PRF images. One way
that we have approached this limitation is by introducing variations in the columnar
walls to represent the variability in the columnar shape seen in the SEMs. This is
implemented with a roughness algorithm that was described in our previous papers
[90, 108]. However, the introduction of this variation in the geometry is not based
at the moment on any physical characterization performed on actual screens. To be
consistent with results presented in previous papers, we have used the same amount
of variability (a=0.2, where a is a user-adjustable parameter that defines the amount
of mixing of the surface normal with an isotropic vector) as defined in Ref. [90].
The SEM measurements themselves have some additional sources of error that
affect the thickness calculations of different layers. The approximate error in thick-
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ness estimation from the SEM measurements is ±10%. For most screens (Screens
2, 3, and 4), optical microscopy images were also taken (on a Leitz Laborlux 12 HL
microscope) to provide more accurate thickness measurements (errors of approxi-
mately ±3%). Calculation of tilt angles should be unaffected by these thickness
inaccuracies since there is no measurable distortion in the images. Quantification of
the tilt angles was, however, affected by the limited sampling of the CsI scintillator
screens. For all screens, one or two corners were imaged in a single field to deter-
mine tilt angles and thicknesses. A limited number of samples were used to produce
measurements from the same screens used to collect PRF data. Since the tilt angles
are not necessarily aligned with the imaged plane, the tilt angles calculated from a
single corner represent a minimum tilt angle. Tilt angles calculated from a second
corner (approximately perpendicular to the first imaging plane) provided a more
accurate quantification of the true tilt angle. Of course, these calculations assume
that the tilt angle is uniform over the screen face, which is probably not true in
reality.
The reflectivity of the screen substrate is also a potential source of error. In this
paper, we chose reflectivities of 10% for graphite substrates and 90% for aluminum-
coated substrates. However, experimental measurements of substrate reflectivity
should provide more accurate estimates of this parameter and, in the future, we
hope to arrange such measurements for incorporation into the simulations.
While these uncertainties mean that mantis can not exactly reproduce all
of the complex details of the SEM structure, the level of complexity modeled in
mantis represents the most complete modeling of CsI scintillator screens to date
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and should provide representative results that properly simulate trends in the PRF
structure.
2.4.2 Variation in screen properties
Variation in screen properties due to the manufacturing process may be a
significant source of error when comparing experimental data with simulations. To
quantify this variation, the MTF was measured for a total of 11 screens produced
during four different deposition runs (2-3 screens per deposition run) with an average
CsI thickness of 240 μm. All screens were deposited on a graphite substrate. The
range of MTF values at 5.0 lp/mm for each of the four deposition runs were 0.130-
0.134, 0.273-0.327, 0.228-0.321, and 0.316-0.337. Similarly, at 8.1 lp/mm the MTF
values were 0.035-0.038, 0.109-0.148, 0.083-0.156, and 0.146-0.164. There are large
variations both within a single deposition as well as between the different deposition
runs. The factors responsible for these types of differences may not be included in
the mantis models and, as a result, may be responsible for some of the discrepancies
seen.
2.4.3 Accurate x-ray source and pinhole geometry
Accurately modeling the x-ray source and pinhole geometry is a critical step in
the modeling process. Our previous validation work has shown that simplifying the
x-ray source and pinhole structure combination to a perpendicular incoming beam
produces results that are much sharper than those produced with the correct x-ray
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source and pinhole geometries[109].
For these simulations, the x-ray focal spot was modeled as a circle with 100μm
diameter and a parallel beam. The true focal spot has a similar shape, but with two
bright lobes and does not emit parallel rays. Images of the experimentally measured
focal spot of the x-ray tube used in this paper can be found in Figure 6a of Ref.[110].
In order to verify the pinhole structure, digital optical microscopy images
(High-Magnification Digital Microscope System VHX-100, Keyence Corporation of
America, Woodcliff Lake, NJ) were taken of the front and back surfaces of the
pinhole disk. Measurements from the digital images give a diameter of 35.5 μm for
the small end of the 30 μm pinhole and a diameter of 215 μm for the large end.
These diameters are within approximately two times the pinhole manufacturer’s
errors.
Although the actual pinhole diameters were measured before the simulations
were performed, the pinhole diameters used in the simulations were taken directly
from the manufacturer’s specifications. This decision was made because the optical
microscopy measurements did not allow for measurement of the internal structure
of the pinhole. However, the measured pinhole outer diameters did deviate slightly
from the manufacturer’s specifications (35.5 μm versus 30±5 μm for the smaller
diameter and 215 μm versus 229±5 μm for the larger diameter).
In order to determine the error incurred by an incorrectly modeled pinhole
diameter, we re-ran simulations similar to those described in Section 2.3.2 with a
pinhole diameter of 36 μm for Screen 1 at 0 degrees and 70 kVp. The resultant
FOM was 0.3528 ± 0.0089 as compared to 0.3552 ± 0.0133 for the original diameter
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(30 μm). The difference between these two values is 0.0024 ± 0.0160, so the change
in the FOM calculation is negligible. The small change in the FOM with pinhole
diameter is due to the fact that the diameter of the pinhole is only determined by a
very thin layer at the end of the pinhole, and the majority of the pinhole structure
is a larger cone that is unaffected by the specified diameter.
Another potential source of error is the positional error incurred by the manner
in which the pinhole is mounted in the cap screw head. This is done by applying
super glue between the pinhole disk and the hole machined in the screw head and
positioning them by hand. Although the machined hole in the screw head guides the
pinhole, it is not an exact fit because the machined hole is somewhat over-sized. We
anticipate the error in the pinhole disk position to be less than ±0.5 mm horizontally
and less than ±1 degree in angle.
2.4.4 Blur due to FOP
The FOP is a potential source of image degradation, although its effect should
be small given that the fibers are 4.5 μm in diameter. To quantify the image
degradation imposed by the FOP, a resolution phantom (Edmund Optics 1951 USAF
Resolution Target 2” Square Negative #NT38-256, Barrington, NJ) was placed in
pressure contact with the FOP and a polychromatic, diffuse light source was placed
in front of the resolution phantom. The light source was constructed by placing a set
of light emitting diodes inside of a white Styrofoam box with a diffuser placed at the
output. Note that the resolution phantom was made of glass and of a similar size to
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the CsI scintillator screens, making the contact of the resolution phantom similar to
that of the CsI scintillator screens. In this phantom, the pattern representing 45.3
line pairs per mm (lp/mm) (Group 5, Element 4) is resolvable in both axes of the
detector. A resolution of 45.3 lp/mm corresponds to a resolution of 11.0 μm, only
slightly greater than the pixel size of the detector (9.0 μm). Therefore, while the
FOP may induce a slight blur on the image, its effect should be on the order of the
size of a single CCD pixel.
2.4.5 Columnar tilt angle and incident x-ray beam
For the simulations presented in this paper, the tilt angle of the columns was
always along the same direction as the oblique angle of x-ray incidence. Experi-
mentally, however, the true orientation of the columns with respect to the incoming
x-ray beam is unknown. This leads to a possible inconsistency between the exper-
imental and simulated data that may affect the comparison between the two. To
investigate the magnitude of this effect, we also simulated PRFs with a columnar
tilt angle directly opposite the oblique angle of the incident x-ray beam (180 degrees
rotated from the original data) to explore a range of possible orientations. This was
done for Screen 2 with a 40 kVp spectrum and all of the incidence angles. For the
original PRFs the FOMs were 0.3901 ± 0.0209, 0.4124 ± 0.0310, 0.3932 ± 0.0086,
and 0.3685 ± 0.0208 for 0, 15, 30, and 45 degrees, respectively. For the new PRFs,
with the modified tilt angle, the FOMs were 0.4015 ± 0.0091, 0.3830 ± 0.0038,
0.3997 ± 0.0079, and 0.4583 ± 0.0400 for 0, 15, 30, and 45 degrees. If we take the
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difference of each of these values divided by the error in the difference we get 0.5001,
0.9413, 0.5566, and 1.9918 for 0, 15, 30, and 45 degrees, respectively. This means
that changing the orientation of the columnar tilt angle will change the FOM by
about the same order as the error in the measurements. Therefore, we do not expect
this effect to significantly affect the results.
2.5 Conclusion
The results presented in this paper provide experimental validation of the
mantis package for a variety of experimental conditions. Investigators applying
mantis to various imaging systems now have a better understanding of both its
strengths and limitations. Such detailed models of scintillator screen response have
important implications in the optimization of x-ray imaging systems and recon-
struction of three-dimensional images from planar data. Optimization that does
not take into account accurate detector properties may produce misleading results
and the inclusion of models like mantis can result in more accurate reconstructions
since the forward problem is better characterized. Improvements in optimization
and reconstructions of x-ray data have the potential to improve image quality and,
as a result, detection of abnormalities and disease in these types of images. While
the long timescales of mantis simulations make rigorous optimizations difficult at
present, we are currently developing a fast, analytical model to approximate PRFs
produced by mantis [111]. Such a model will allow for rapid generation of detector
PRFs and make inclusion of these detailed detector simulations in complex opti-
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A fast, angle-dependent, analytical model of CsI detector response
for optimization of 3D x-ray breast imaging systems
3.1 Overview
Optimization1 of three-dimensional (3D) breast x-ray imaging systems and
3D image reconstruction methods rely on assumptions about detector performance.
The deterministic blur introduced by the detector can be quantified by the point
response function (PRF), which is the resultant image of an infinitely thin x-ray
pencil beam. The current approach to modeling detector performance assumes that
the PRF has a symmetric shape that is invariant over the detector area [112, 113].
In some cases, detector blur is ignored altogether [114, 115]. However, recent studies
[106, 117, 108] have demonstrated that there are large variations in the PRF across
the detector face and that it can be highly asymmetric for large incidence angles. A
recent study measured the MTF of an experimental bench-top tomosynthesis system
with a flat panel indirect detector as used in a GE Senographe 2000D system [106].
The source-detector distance was 112 cm and the object-detector distance was 5 cm.
X-ray incidence angles of 0, 10, 20, 30, 40, and 50 degrees were investigated for two
different x-ray spectra (26 kVp Mo/Mo and 40 kVp Rh/Al with an additional 1 mm
Al filter). A decreasing MTF with incidence angle demonstrated that the detector
1Work in this chapter published in Medical Physics [111].
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performance deteriorates significantly as the incidence angle increases.
In addition, the recent development of a detailed Monte Carlo simulation code
(mantis [90, 116])2 for studying the imaging performance of modern CsI columnar
phosphor screens has demonstrated similar variations in the PRF over the detector
face for both breast tomosynthesis and CT-like geometries. Badano et al. [117]
investigated a tomosynthesis geometry with a source-to-detector distance of 60 cm
and an angle between the chest wall and the edge of the x-ray beam of 11.3 degrees.
The detector was a small mammography detector with a size of 24×12 cm and a
phosphor screen thickness of 150 μm. The x-ray tube was allowed to rotate on
an arc centered about the detector plane with an angular range of ±20 degrees.
Three different x-ray spectra were considered (Mo/Mo at 28 kVp, Rh/Rh at 28
kVp, and W/Al at 42 kVp) as well as three different breast thicknesses (3, 4, and
6 cm). This geometry resulted in x rays entering the phosphor screen at angles of
up to 45 degrees. The PRFs showed significant anisotropy and increased blurring
as compared to normal x-ray incidence. In another paper, simulations were carried
out for a breast CT system [108]. This system had a source-to-isocenter distance
of 44 cm, a source-to-detector distance of 88 cm, and a 30 × 40 cm detector with
a 600 μm thick phosphor screen, with x-ray energies of 30 to 70 keV. Increases in
blur with respect to normal x-ray incidence were measured by performing a two-
dimensional (2D) Gaussian fit to the PRFs and dividing the major axis of the fitted
Gaussian with the major axis of the fitted Gaussian at zero degrees incidence. For
2A current version of the code, tutorials, and examples are available from
ftp://150.148.3.14/mantis
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the investigated x-ray energies and incidence angles, the measured blur values were
as high as 1.86. Also, the maximum aspect ratios of the PRFs ranged from 1.14
to 2.53 depending on the contour level for the height of the PRF chosen for the
analysis.
Unfortunately, because of the long simulation times required for the detailed
mantis code (approximately 200 hours on a single 3 GHz CPU for a PRF with
500,000 primary x rays), accurate PRFs have yet to be incorporated into optimiza-
tion and reconstruction schemes. In this work, we have developed a closed-form,
deterministic, analytical model that approximates the detailed Monte Carlo simu-
lations in less than one millionth of the computation time (about 0.1 s). The model
describes the depth-dependent deterministic response of the detector. In addition,
our model could be used to simulate the noise component present in indirect de-
tectors due to variations in the optical processes. The analytical model has been
developed for a single CsI phosphor thickness (150 μm), x-ray energy (25 keV), and
four incidence angles (0, 15, 30, and 45 degrees). Future expansion of the model to
a larger range of parameters will allow for rapid, on-the-fly generation of PRFs that
will enable the inclusion of realistic detector performances in system optimization
and reconstruction.
In Section 3.2 the detailed derivation of the PRF model is presented. Cal-
culation of the best fit coefficient values as well as a quantitative comparison with
mantis-generated PRFs is discussed in Section 3.3. Section 3.4 gives the results of
a comparison of the analytical model with experimental data. Finally, conclusions
are provided in Section 3.5.
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3.2 The model
The objective of this analytical model is to produce a deterministic PRF for
a given set of system parameters. Therefore, all incident x rays are specified to
arrive at the same location, (x, y, z) = (0, 0, 0), and with the same incidence angle,
(θ, φ). Additionally, we assume a monochromatic incident beam with energy, E.
The general approach used in this model can be broken down into two major steps.
In the first step (discussed in the remainder of this section), we model the physics of
the interaction between the incoming x-ray beam and the CsI crystal. This analysis
produces an analytical expression that describes the shape of a PRF for a given set
of input parameters. In the second step (see Section 3.3), the free parameters in
the analytical expression are adjusted by fitting that expression to PRFs produced
using mantis.
In the first step, we have ignored the columnar structure of the CsI crystal in
the mathematical formulation and made the assumption that it is a homogeneous,
solid slab. Although the effects of columnar structure are not explicitly included
in the mathematics, they are indirectly included by using mantis data as a guide
to choosing the functional forms of the relevant physical properties. In addition,
the second step incorporates the columnar structure and other secondary effects by
adjusting the free parameters in the model based on mantis data. Figure 3.1 shows
a schematic of the model geometry and coordinate system, while Table 3.1 gives
definitions for variables used in the derivation of the model.
Four separate effects in the x-ray detection process are modeled in the first
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Figure 3.1: Schematic of model geometry and coordinate system. The view is a
vertical cut through the CsI crystal looking from the side with the air interface on
the top and the detector layer at the bottom of the schematic. The infinitely thin
incident x-ray beam enters at an angle 90 degrees minus θ from the x axis (φ, 90
degrees minus the angle between the x-ray beam and the y axis, is assumed to be
zero in this diagram). The y axis is going out of the page in this view.
Table 3.1: Definition of model variables.
Symbol Definition
(x, y, z) ≡ x ray interaction location
(z = depth in crystal)
(0, 0, 0) = x-ray crystal entrance
l ≡ Position along x ray travel direction
(=0 at x-ray crystal entrance)
=
√
x2 + y2 + z2
θ ≡ 90 deg minus the angle between the l and x axes
(sin θ = x/l)
φ ≡ 90 deg minus the angle between the l and y axes
(sin φ = y/l)
zmax ≡ Thickness of crystal
μpe(E) ≡ Photoelectric attenuation coefficient of CsI
[cm−1]
μtot(E) ≡ Total attenuation coefficient of CsI [cm−1]
E ≡ Energy of incident x rays [keV]
No ≡ Number of incident x ray photons
γ ≡ X ray to optical photon gain factor [keV−1]
56
step of our approach. The first is the depth-dependent absorption of the incident x
rays. The second is the conversion of absorbed x rays into emitted optical photons
by the CsI crystal. The third is the self-absorption of the emitted optical photons
in the CsI crystal and the absorption of the photodiode layer. Finally, the fourth
is the depth-dependent spread of the optical photons collected at the exit plane of
the crystal. The following subsections describe each of these effects in detail and
then integrate the final depth-dependent model over the crystal thickness to get an
analytical expression for the overall PRF.
3.2.1 Depth-dependent absorption of incident x rays
Gallas et al. [118] derived a model for image formation with indirect x-ray
powder-phosphor based detectors. Following their analysis, the rate at which x-ray
photons interact with the crystal as a function of crystal depth is given by
Ni(z, θ, φ, E) = No ηxray(z, θ, φ, E), (3.1)
where ηxray(z, θ, φ, E) is the x-ray interaction probability for a given depth.
Here we restrict our analysis to consider only x rays that interact with the
crystal via the photoelectric effect to produce an optical-photon shower that can
subsequently be detected with a photodiode array. Therefore, we can further write
Npe(z, θ, φ, E) =
μpe(E)
μtot(E)
Ni (z, θ, φ, E) (3.2)
as the number of photons that interact with the CsI crystal to produce an optical-
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photon shower, where μpe(E) is the photoelectric attenuation coefficient of the crys-
tal. Figure 3.2 shows the importance of different interaction types at energies appli-
cable to breast imaging. The total mass attenuation coefficient as well as the contri-
butions to the total mass attenuation coefficient due to the photoelectric, Rayleigh,
and Compton effects are shown as a function of energy in the range of 5-100 keV.
These values were calculated using pure CsI in the Monte Carlo simulation package
PENELOPE [104, 119]. The photoelectric effect is the dominant interaction type
for this energy range and constitutes 89.3 - 99.4% of the total mass attenuation
coefficient. Note that the fitting algorithm discussed in Section 3.3 should help
compensate for the Compton and Rayleigh contributions to the detected signal that
are not included in the model.
To calculate ηxray(z, θ, φ, E) as a function of depth, we can start by writing
from first principles the same expression as a function of position along the travel
direction
ηxray(l, θ, φ, E) = μtot(E) exp (−μtot(E)l). (3.3)




cos2 θ − sin2 φ
(3.4)
and replace l by z in Equation 3.3 to get
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Figure 3.2: Mass attenuation coefficient as a function of energy for CsI as simulated
in PENELOPE. The photoelectric, Rayleigh, Compton, and total mass attenuation
coefficients are shown. The photoelectric effect is the dominant interaction over the
energy range of 5-100 keV.
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ηxray(z, θ, φ, E) = μtot(E) exp
(
− μtot(E) z√
cos2 θ − sin2 φ
)
. (3.5)
This equation describes the expected behavior of the crystal. However, inclu-
sion of this full form in the analytical model makes the solution intractable. As a
result, we approximate the exponential behavior with a linear function given by
ηxray(z, θ, φ, E) ≈ a0 (E) z + a1 (E) (3.6)
so that
Npe(z, θ, φ, E) ≈ No μpe(E) [a0 (E) z + a1 (E)] . (3.7)
Figure 3.3 shows a comparison of a least-squares linear approximation with the
full exponential form for an energy of 25 keV corresponding to that typically used
in mammography and breast tomosynthesis. Final values for a0 and a1 will be
determined by the 2D fit as described in Section 3.3. For lower energies Equation 3.6
may be extended to include a z2 term, however due to the increased complexity of
the solution, we maintain the linear solution for this study.
3.2.2 Conversion of absorbed x rays into emitted optical photons
We assume that, on average, the number of optical photons produced per x
ray is given by a function of x-ray energy, K(E), so that the average number of
optical photons produced at a given z is written as
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Figure 3.3: Comparison of exponential x-ray absorption profile with a least-squares
linear approximation for 25 keV. The exponential profile is indicated with a solid
line and the linear approximation with a dashed line.
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Nopt(z, θ, φ, E) = K(E) Npe(z, θ, φ, E). (3.8)
Following Gallas et al. [118], K(E) = γE, where γ is a material dependent gain
factor and has units of keV−1. For CsI γ ≈ 60 photons/keV [120, 121].
3.2.3 Self-absorption and photo-detector absorption of the emitted
optical photons
Some of the optical photons that are produced do not reach the photo-detector
because of crystal self-absorption, absorption efficiency of the photodiode layer,
scatter, or other effects. We can express the number of collected optical photons
that reach the base of the CsI crystal as
Ncollect(z, θ, φ, E) = Nopt(z, θ, φ, E) ζ(z), (3.9)
where ζ(z) is the optical collection efficiency or the percent of emitted optical pho-
tons that are detected. The notation ζ(z) is taken from Gallas et al. [118]. To
determine the functional form of ζ(z) we can use mantis as a guide. Figure 3.4
shows the results of simulations in mantis3 where optical photons are generated at
different depths in the CsI crystal and the optical collection efficiency is recorded.
mantis takes into account the reflectivity of the photodiode layer as well as the
photodiode absorption efficiency as a function of wavelength. The mantis results
are shown as black dots and a linear least-squares fit is shown as a solid line. Given
3by Aldo Badano
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Figure 3.4: Percent of emitted optical photons at a specific depth that reach the
photo-detector. Results from mantis simulations are shown as black dots, and a
linear fit to that data is also shown. This information resulted in the use of a linear
model for the crystal self-absorption.
this data we assume that the functional form of the optical collection efficiency is
linear and given by
ζ(z) = b0 z + b1. (3.10)
3.2.4 Depth-dependent spread of optical photons
Once an optical-photon shower is produced, those photons are detected by the
photodiode with a specific spread that depends on the depth at which the optical
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photon shower was initiated. To determine the functional form of this spread, a
series of mantis simulations were run4 in which optical-photon showers, with 10,000
optical photons each, were initiated at different depths in a 150 μm thick CsI crystal
and the resulting photon spreads were recorded. The depths probed were from 0 to
145 μm at intervals of 5 μm.
For the CsI crystal simulated in mantis, depths of 0 to 120 μm had a columnar
structure and depths of 120 to 150 μm corresponded to homogeneous CsI. This choice
for the transition between the columnar and homogeneous layers was motivated by
previous work where scanning electron microscope images were taken of a variety of
screens to characterize the screen layers (see Chapter 2). Three different functional
forms of the photon spread were considered; Gaussian, exponential, and Lorentzian.
Each of these was fit to the normalized, radially-averaged mantis-generated optical-
photon spread at each probed depth. The normalization was performed by dividing
by the maximum of the radially-averaged profile. Figure 3.5 shows examples of these
fits for two different depths (5 μm and 145 μm). The radially-averaged mantis
spread is shown as a solid line while the Gaussian, Lorentzian, and exponential fits
are shown as dotted, dashed, and dashed-dotted lines respectively. The difference
in width of the spreads at the two different depths is clearly demonstrated in this
figure and qualitatively we can see that the Lorentzian appears to fit the mantis
data better than either the Gaussian or exponential. In particular, the Lorentzian
curve is much better than either the exponential or the Gaussian at matching the
mantis results in the tails of the curves. The root mean squared (RMS) deviations
4by Aldo Badano
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from the mantis simulation results for each of these three functional forms are
shown in Figure 3.6. This figure verifies that the Lorentzian gives a better fit, in
terms of RMS deviation on the radially-averaged data, than either the Gaussian or
exponential functional forms for every depth investigated. Therefore, we chose to
model the optical photon spread as a Lorentzian function. If we look at the fits
in more detail (see Figures 3.5 and 3.6), we can see that the Lorentzian performs
somewhat better for optical photons that are absorbed deep in the crystal, but still
located in the columnar zone. When the optical photons are produced closer to the
crystal exit plane, the Lorentzian tends to overestimate both the tails and the peak
of the spread, while for optical photons produced further from the optical detector,
the Lorentzian tends to underestimate both the tails and the peak.




1 + c21 [(x − c2)2 + (y − c3)2]
, (3.11)
where c0 is the amplitude of the Lorentzian, c1 is
2
Γ
, Γ is the FWHM of the
Lorentzian, c2 is the shift of the Lorentzian in the x direction, and c3 is the shift of
the Lorentzian in the y direction. Comparing with our PRF model, we find that
c0 = Ncollect(z, θ, φ, E), (3.12)
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Figure 3.5: Plots showing the normalized, radially-averaged simulated optical pho-
ton spread from mantis for two different depths; (top) 5 μm and (bottom) 145 μm
with a zoom of the tails in the inset plot. The depth refers to the distance in the
z direction between where the x-ray beam enters the CsI crystal and where the x
ray is absorbed and produces the optical shower. The black lines show the radially
averaged mantis results normalized to the maximum of the radially averaged pro-
file. Fits of Gaussian, exponential, and Lorentzian functions are also shown. The
Lorentzian shows the best overall fit to the data. In general, for optical photons
produced deeper in the crystal, the Lorentzian tends to overestimate both the tails
and the peak, while for shallower depths, it tends to underestimate both the tails
and the peak.
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Figure 3.6: Analysis to determine the functional form of the spread of optical pho-
tons that reach the detector after being generated at a specific depth. mantis
simulated data were generated for depths in the crystal between 0 and 145 μm and
Gaussian, exponential, and Lorentzian fits were performed to the radial average of
the mantis results to determine the functional form of the spread. The RMS of
the residuals of these fits are shown as a function of the depth at which the opti-
cal photon shower was generated. The Lorentzian function gives the smallest RMS
residuals for all depths.
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c2 = z tan θ, (3.13)
and
c3 = z tan φ. (3.14)
In order to determine the functional form of Γ as a function of depth, we
plotted the FWHM of the Lorentzian fits as a function of depth (see Figure 3.7).
The reader can see that this is a complicated relationship that is poorly described
by a simple analytical form. Nonetheless, in order to allow for a fully analytical
solution, we approximate this relationship by a linear functional form given by
Γ = g0z + g1. (3.15)
Note that this approximation matches the mantis data well over the bulk of
the crystal, but poorly at both very small and large depths in the crystal. Further
research is needed to understand the physical origin of the downturn of Figure 3.7
at small depths, however, it is likely related to the transport of photons near the
interface of the organic polymer layer (a protective top coat) with the layer of
columnar CsI. At very large depths, there is a sharp spike in the width because of the
fact that the columnar to homogeneous CsI transition is modeled as a discontinuous
change in mantis. Since this transition is more gradual in reality, we expect the
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Figure 3.7: FWHM of Lorentzian fits to mantis data as a function of depth where
the optical photons were generated. The mantis data are shown as dots, while a
linear fit is shown as a solid line. A linear relationship was used to model the width
of the spread as a function of depth in the mathematical model.
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linear approximation to apply better to experimental data. Also, note that the
majority of x rays are absorbed at shallow depths in the crystal because of the
exponential x-ray absorption, and optical photons generated at very shallow depths
in the crystal are more likely to be re-absorbed before they can reach the photodiode
layer. As a result, we expect the majority of signal that makes up the PRF to arise
from interactions in the middle of the crystal depth, where our linear approximation
most accurately reproduces the mantis data.
3.2.5 Integrate model
The final analytical expression for the depth-dependent PRF, PRFz, can be
derived by combining Equations 3.7-3.15 to get
PRFz(x, y, z, θ, φ, E) =






[(x − z tan θ)2 + (y − z tanφ)2]
.
(3.16)
In order to obtain the overall PRF we must integrate this equation over depth,
PRF (x, y, θ, φ, E) =
∫ zmax
0
PRFz(x, y, z, θ, φ, E) dz. (3.17)
The solution to this integral is given in Appendix A. Because of the length of the
solution it is not reproduced here. Note that the contribution to the PRF from
any given depth is symmetric. The asymmetry in the overall PRF comes from the
depth-dependent shift of each of these contributions due to the incidence angle of
the incoming x-ray beam.
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3.3 Calculating best fit coefficient values and comparison with man-
tis
The analytical solution for the PRF (derived in Appendix A) requires the
following variables to be specified by the user; incident angles of x-ray beam (θ,
φ), energy of incident x-ray beam (E), and the thickness of the CsI screen (zmax).
The remaining variables are p (≡ γENoμpe(E)) from Eqn. A.3, a0 (E) and a1 (E)
from Eqn. 3.6, b0 and b1 from Eqn. 3.10, and g0 and g1 from Eqn. 3.15. Recall
that p controls the maximum value of the overall PRF, a0 and a1 are the slope and
intercept of the function that describes the absorption of x rays in the CsI crystal
as a function of depth, b0 and b1 are the slope and intercept of the function that
describes the optical collection efficiency, and g0 and g1 are the slope and intercept of
the function that describes the width of the depth-dependent optical photon spreads
at the exit plane.
While approximate values for each of these variables could be taken from
the analysis in Sections 3.2.1, 3.2.3, and 3.2.4, the analysis of those Sections was
intended solely to determine an appropriate functional form for the physical process
being analyzed. As a result, to determine the optimal values of these variables we
have performed a fit of the full two-dimensional PRF solution to two-dimensional
mantis generated PRFs. The results of Sections 3.2.1, 3.2.3, and 3.2.4 are used as
initial guesses to this fit. The 2D fitting process allows factors that have not been
explicitly included in the analytical model (i.e., columnar crystal structure, reflective
substrates, k-fluorescent x rays) to be indirectly accounted for. For example, we
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expect columnar structure in the CsI crystal to decrease the width of the optical
spread functions as compared with a homogeneous crystal slab. By allowing the
width of the spread to vary as a free parameter, this property of the crystal can be
taken into account albeit without explicit inclusion in the derivation of the analytical
form of the PRF.
Two dimensional fits of the analytical model to the mantis-generated PRFs
were performed using a figure-of-merit (FOM) equal to the the RMS normalized dif-
ference of the two PRFs within a region-of-interest (ROI). A smaller FOM indicates
a better fit. A mathematical definition of the FOM was given in a previous study
(see Chapter 2), were it was used to compare mantis PRFs to experimental data.
Here, the ROI was chosen by selecting all pixels with a signal of at least a fortieth of
the maximum of the mantis PRF. This ROI was chosen to include some of the tails
of the PRFs without including regions that were noisy in the mantis simulations
due to the number of simulated primary x rays. A sparse sampling method was
used to perform the fit and was calculated as follows:
1. For each of the 7 coefficients to be fit (p, a0 (E), a1 (E), b0, b1, g0, g1), choose
5 evenly spaced initial guesses. For p the initial guess was chosen as the
maximum value of the mantis-generated PRF, while initial guesses for the
other 6 coefficients were taken from the analysis in Sections 3.2.1, 3.2.3, and
3.2.4. The range of the 5 initial guesses was chosen to reasonably cover the
likely possible values.
2. Generate analytical PRFs at each angle of interest (0, 15, 30, and 45 degrees
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in this study) for every possible coefficient combination and calculate the cor-
responding FOMs for each angle. Calculate an overall FOM equal to the sum
of the FOMs for each angle. Note: In this fitting scheme all 7 coefficients are
forced to be the same for all angles.
3. Identify the coefficient combination with the lowest calculated overall FOM.
4. Select a new set of 5 evenly spaced trial coefficient values, where three of those
new trial coefficient values are the coefficient value with the lowest overall
FOM and its two nearest neighbors. The final two trial coefficient values are
directly in between the other three values. If the coefficient with the lowest
overall FOM is on the edge of the grid, the grid is expanded to include a larger
range of coefficient values.
5. Return to Step 2 unless the difference between the trial coefficient values is
less than 10−6 for p, 10−8 for a0 (E), and 10−5 for a1 (E), 10−2 for b0, 10−2
for b1, 10
−4 for g0, 10−2 for g1. These thresholds were chosen to achieve a
specific accuracy of the fitted parameter that seemed reasonable for its physical
meaning. It was confirmed that the choice of these thresholds resulted in an
overall FOM that stabilized during the fitting process (see text below). Once
a single coefficient value has dropped below the threshold, it’s value is fixed
at that value and the other coefficients continue to be varied.
In this study, we have performed fits to a limited number of input parameters
to demonstrate the ability of the analytical model to fit mantis-generated PRFs.
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Specifically, we have focused on a CsI scintillator thickness of 150 μm, an x-ray
energy of 25 keV, and incidence angles of 0, 15, 30, and 45 degrees. The remainder
of the CsI screen model parameters are identical to those presented in Badano et
al.[117] except for the reflective backing, where a reflectivity value of 95% was used
in the current study. These input parameters are similar to system parameters
found in mammography and tomosynthesis measurements. In a future study, we
will perform fits over a larger range of different angles, energies, and CsI thicknesses
and provide relationships to determine the optimal coefficient values for the entire
range of explored input parameters. Figure 3.8 shows how the overall FOM changed
over the course of the fitting process. Fractional change in the FOM is plotted as a
function of iteration number of the 2D fitting program for the combination of 0, 15,
30, and 45 degrees incidence angles. The overall FOM decreases monotonically and
reaches a stabilized value well before the end of the fitting process. The pre- and
post-fit coefficient values for the investigated set of parameters and choice of CsI
screen are given in Table 3.2. Please note that these coefficients are not appropriate
descriptors for a general imaging CsI screen and should not be used as representative
values. The coefficients are valid only for a monoenergetic x-ray beam of 25 keV,
a CsI scintillator screen with a thickness of 150 μm and similar properties to those
mentioned in Badano et al.[117], and incidence angles ranging from 0 up to 45
degrees. Also, note that we have performed a comparison here for incidence angles
in the direction of φ=0. We expect the analytical model to perform equally well
for incidence angles in the φ and θ directions. The only physical effect modeled in
mantis that changes between the θ and φ directions is the columnar tilt and this
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Figure 3.8: Fractional change in the overall FOM during the 2D fitting process as
a function of the iteration number of the fitting program. Data are shown for a 25
keV monochromatic incoming beam, 150 μm thick CsI screen, and the combination
of 0, 15, 30, and 45 degree incidence angles. The overall FOM stabilizes well before
the end of the fitting procedure.
has been shown previously to have a small effect when integrating over large pixels
(100 μm or more) (see Chapter 2). The model should also be valid for all detector
locations assuming that the structure of the detector is independent of location.
Figure 3.9 shows a comparison between the mantis-generated PRFs and the
analytical model PRFs after performing the 2D fitting process. All of the PRFs
shown have been generated with a CsI scintillator thickness of 150 μm, an incident
x-ray energy of 25 keV, and 500,000 primary x rays. The left-most column indicates
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Table 3.2: Best-fit coefficient values for a 25 keV monochromatic beam, 150 μm
thick CsI screen, and angles in the range of 0 to 45 degrees. These coefficients
should be valid for any detector location as long as the same screen model applies.
The results reported here correspond to the PRFs shown in Figures 3.9 and 3.10.
Coefficient Pre-fit Value Best-fit Value
(25 keV, 150 μm CsI)
p 0.00878561 0.000878561
a0 (E) -2.3649709e-5 1.1078126e-5





the incidence angle of the incoming x-ray beam. The corresponding PRFs from
mantis and the analytical model are shown in the following columns as well as the
FOMs comparing those PRFs. FOM values and their errors were calculated as the
mean and standard deviation of comparisons of the analytical model results with
11 independent mantis-generated PRFs. The right-most column shows the FOMs
from a comparison between mantis and a 2D symmetric Gaussian fit to the zero
angle mantis PRF. These numbers are provided to give a reference for the FOMs
comparing mantis and the analytical model. A 2D symmetrical Gaussian fit to the
zero degree data was chosen as a comparison since the use of symmetric Gaussian
functions to simulate detector blur is one type of approach that is currently used in
the literature [113]. The Gaussian fit was performed using a modified version of the
program gauss2dfit in the software package IDL (ITT Visual Information Solutions,
Boulder, CO) that forced the widths of the 2D Gaussian in the x and y directions
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to be equal.
Qualitatively, from the PRF images in Figure 3.9, we see that the analytical
model does a good job of reproducing the mantis-generated PRFs at all angles
investigated in this study. The analytical PRFs appear to be slightly narrower
than the mantis PRFs and fail to reproduce a sharp peak (near the top of the
PRFs) evident in the mantis PRFs. The tendency of the analytical model to
appear slightly narrower is most likely due to the fact that the Lorentzian function
underestimates the tails of the spread of the optical photons at the exit plane of
the scintillator (see Section 3.2.4) for the majority of x-ray absorption depths. This
is the case for absorption depths from 0 to about 115 μm, where approximately
86% of 25 keV x rays that contribute to the overall PRF would be absorbed for a
150 μm thick crystal. We would expect this effect to be more dramatic for both the
Gaussian and exponential models since they underestimate the tails of the optical
photon spread even more than the Lorentzian model. The analytical model fails to
reproduce a bright peak evident in the mantis PRFs due to the linear approximation
made in Section 3.2.4 and shown in Figure 3.7. In that figure, a sharp increase in
the width of the Lorentzian distribution is seen between 120 and 140 μm and clearly
poorly fit by the linear approximation. As described earlier, the reason for this sharp
increase in the mantis model is because of the discontinuous transition between
the homogeneous layer and the columnar layer. Since the transition is much more
gradual in reality, we do not expect this sort of behavior in experimental data (see
Section 3.4 as a demonstration).
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Figure 3.9: Comparison of mantis-generated PRFs with PRFs from the analytical
model after the 2D fit. All PRFs have been generated with a CsI thickness of
150 μm and an x-ray energy of 25 keV. The incident x-ray beam is modeled in
mantis as an infinitesimal pencil beam. The incidence angle of the x-ray beam is
indicated in the left-most column followed by the corresponding mantis-generated
PRFs, analytical model PRFs, FOMs from the comparison between the mantis and
analytical PRFs, and, finally, the FOM from the comparison between mantis and
2D symmetric Gaussian fits to the normal incidence mantis PRF. All PRFs are
0.315 × 0.315 mm with 9 μm pixels. Contours are shown for levels of 0.01, 0.05,
and 0.1 times the maximum of the PRF.
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For a more quantitative comparison, we can examine the FOM values com-
paring the mantis and analytical PRFs (shown in Figure 3.9). These FOM values
range from 0.1951 to 0.2416 for all of the incidence angles investigated. Notably,
these FOM values are relatively constant over the different incidence angles, mean-
ing that the analytical model does a good job of reproducing the mantis results
for all incidence angles. As a comparison, we can examine the FOMs comparing
mantis and a 2D symmetrical Gaussian fit to the mantis PRF at zero degrees.
This analysis gives FOMs of 0.6234 ± 0.0020, 0.9058 ± 0.0029, 1.491 ± 0.012, and
2.757 ± 0.039 for 0, 15, 30, and 45 degrees respectively. Comparing with the FOMs
for the analytical model, the analytical model outperforms the Gaussian fit for all
incidence angles. Interestingly, the analytical model even outperforms the 2D Gaus-
sian fit at an incidence angle of 0 degrees. This is likely due to the fact that a
Gaussian function severely underestimates the tails of the PRF at all depths as
illustrated in Figure 3.5.
Figure 3.10 is identical to Figure 3.10 except the pre-fit coefficient values are
used instead of the post-fit coefficient values. Although the pre-fit coefficient values
make more sense in a physical context, they do not fit the mantis data as well
as the post-fit coefficients. The pre-fit analytical PRFs have FOMs ranging from
0.3026 to 0.4538, whereas the post-fit analytical PRF FOMs range from 0.1951 to
0.2416. This is expected since the fit allows the analytical model to take into account
information provided by the more detailed mantis simulations.
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Figure 3.10: Comparison of mantis-generated PRFs with PRFs from the analytical
model before the 2D fit. All PRFs have been generated with a CsI thickness of
150 μm and an x-ray energy of 25 keV. The incident x-ray beam is modeled in
mantis as an infinitesimal pencil beam. The incidence angle of the x-ray beam is
indicated in the left-most column followed by the corresponding mantis-generated
PRFs, analytical model PRFs, FOMs from the comparison between the mantis and
analytical PRFs, and, finally, the FOM from the comparison between mantis and
2D symmetric Gaussian fits to the normal incidence mantis PRF. All PRFs are
0.315 × 0.315 mm with 9 μm pixels. Contours are shown for levels of 0.01, 0.05,
and 0.1 times the maximum of the PRF.
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3.4 Comparison against experimental results
In a previous study (see Chapter 2), we compared the mantis code against ex-
perimental PRFs acquired with 40 and 70 kVp x-ray spectra (mean photon energies
of 25.6 and 36.5 keV respectively) at 0, 15, 30, and 45 degree incidence angles for
four different CsI phosphor screens. In that study, PRFs were generated in mantis
by including details of the experimental setup in the Monte Carlo simulations. The
x-ray focal spot was modeled as a 200 μm diameter circle, the pinhole and a beryl-
lium window were modeled according to the manufacturer’s specifications, details
of the CsI screen layers and columnar structure were modeled based on scanning
electron microscope measurements and manufacturer’s specifications, and a fiber
optic plate connecting the CsI screen to the optical detector was modeled as a solid
plate of glass.
Here, we perform 2D fits of the analytical model to that same mantis data
and then compare the resultant analytical model to the corresponding experimental
data. The objective of this analysis is to evaluate the ability of the analytical model
to reproduce experimental results when fit to mantis. We did not fit the analytical
model directly to the experimental data since this will, in general, not be available.
In addition, acquisition of the experimental data is achieved with a pinhole, not
an infinitely small incident x-ray beam, which means it is not technically a PRF.
We have completed this analysis for one of the screens (denoted Screen 2 in that
paper) with a CsI thickness of 170 μm and an aluminum-coated graphite substrate
(manufactured by Radiation Monitoring Devices, Inc.). Only the data taken at
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40 kVp (25.6 keV mean photon energy) is considered here. For the analytical model,
the CsI thickness and x-ray energy values in the final analytical model solution were
updated to 170 μm and 25.6 keV respectively. Because of the small change in
thickness between 150 and 170 μm, the assumption was made that the functional
forms of the individual components of the analytical model were the same as for the
150 μm case. However, the reader is cautioned against using the analytical model
for thicknesses other than 150 μm since further research is required to ensure that
the functional forms derived in Sections 3.2.1 to 3.2.4 hold for other thicknesses.
The results of the comparison between the analytical model and experimental data
are shown in Figure 3.11. Note that, as described in Chapter 2, the experimental
data was taken with a 30 μm pinhole and a 40 kVp x-ray spectrum, so there is
additional blurring as compared with the analytical model which assumes that all
the x rays are incident on the CsI crystal at the exact same position and that the
incoming x-ray beam is monochromatic. The effect of the finite pinhole was partially
compensated for by convolving the analytical model with a 30 μm diameter incident
beam before fitting to mantis. The mantis data did take both the 30 μm pinhole
and the 40 kVp x-ray spectrum into account, so this should partially mitigate the
limitations of the analytical model.
The FOM values were calculated in the same way described in Section 3.3,
but with an ROI that included all the points where the experimental data had a
pixel signal-to-noise ratio of 50 or greater. It is important to note that because of
the change in the definition of the ROI, which was necessary because of the change
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Figure 3.11: Comparison of the analytical model with experimental PRFs. The
experimental data were taken at 40 kVp (25.6 keV mean photon energy) with a
170 μm thick CsI scintillator and a 30 μm pinhole. The analytical model was
convolved with a 30 μm incident beam profile and then fit to mantis data that was
generated by taking into account all the details of the actual CsI screen geometry.
The mantis data was generated with a 100 μm diameter pencil beam incident on
a 30 μm pinhole. The incidence angle of the incoming x-ray beam is indicated in
the left-most column followed by the corresponding experimental PRFs, mantis-
generated PRFs, analytical model PRFs, and FOMs from the comparison between
the experimental and analytical data. The analytical model was fit to the mantis
results then a comparison was performed between the analytical model and the
experimental data. This procedure was followed as opposed to fitting the analytical
model to the experimental data since experimental PRFs will not be available for
typical applications. All PRFs are 0.315 × 0.315 mm with 9 μm pixels. Contours
are shown for levels of 0.01, 0.05, and 0.1 times the maximum of the PRF.
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in the type of data involved, the FOM values in this Section and Section 3.3 are
not comparable. In future work, we plan to investigate alternative ways of defining
the FOM such that data sets with different noise characteristics can be directly
compared. Mean FOM values and their errors were calculated as the mean and
standard deviation of FOM values calculated for 11 independent experimental data
sets and 11 independent mantis-generated PRFs. The FOM values comparing the
analytical PRFs with the experimental data are 0.3457 ± 0.0036, 0.3281 ± 0.0057,
0.3422 ± 0.0023, and 0.3677 ± 0.0041 for 0, 15, 30, and 45 degrees respectively.
FOMs comparing mantis-generated PRFs with experimental PRFs for the exact
same screen investigated here were presented in Chapter 2 and are: 0.2944± 0.0027,
0.2387 ± 0.0039, 0.2816 ± 0.0025, and 0.2665 ± 0.0032 for 0, 15, 30, and 45 degrees
respectively. These FOMs are about the same magnitude as the FOMs comparing
the analytical model with the experimental data. Therefore, the analytical model is
able to reproduce the experimental data about as good as mantis is able to repro-
duce the experimental data. This is not surprising since the analytical model was
able to reproduce mantis-generated PRFs well. Figure 3.12 shows the same data
from Figure 3.11, but presented in terms of the line spread function (LSF) rather
than the full PRF. These LSFs were calculated by summing the PRFs along the di-
rection perpendicular to the incoming x-ray beam and normalizing by the maximum
of the summed vector. This direction is shown because it captures the anisotropy
of the PRF. From these images we can see that mantis tends to produce a width
that is too narrow at the peak and too wide at the tails. In addition, the analyt-
ical model seems to match mantis better than mantis matches the experimental
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Figure 3.12: Line spread functions calculated from the PRFs presented in Fig-
ure 3.11 (25.6 keV, 170 μm thick CsI). The PRFs were summed along the direction
perpendicular to the incoming x-ray beam and then normalized by the maximum.
Experimental data, mantis-generated PRFs, and analytical PRFs are plotted with
solid, dashed, and dotted lines respectively. Incidence angles of 0, 15, 30, and 45
degrees are presented from left to right. mantis tends to underestimate the width
of the peak and overestimate the width of the tails. The analytical model matches
mantis better than mantis matches the experimental data. The slight shift be-
tween the analytical model and experimental data in the plot for 45 degrees is due
to the cross-correlation algorithm used to match the data. This provides the best
match between the analytical and experimental PRFs when the entire PRF is taken
into account.
data. The slight shift between the analytical model and experimental data in the
plot for 45 degrees is due to the cross-correlation algorithm used to match the data.
This provides the best match between the analytical and experimental PRFs when
the entire PRF is taken into account and shifts the experimental data to the right
because of the asymmetric nature of the analytical PRF. In addition, the difference
in width between the analytical and experimental PRFs, shown in Figure 3.11, is
deemphasized in the LSFs, shown in Figure 3.12, because the LSF inherently mixes
signal from the tails with signal from the peak. In order to improve the match
between the experimental data and the analytical model, we plan to extend the
analytical model to incorporate polychromatic incoming beams in future versions.
Modification of the mantis input parameters to improve its match to experimental
data may also help the analytical model to better match experimental data.
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Finally, to demonstrate if the analytical model may be useful for describ-
ing the response of thicker screens, we performed the same analysis as above on
Screen 3 (450 μm and an aluminum-coated graphite substrate) from Chapter 2. The
FOMs comparing the analytical model and experimental data were 0.5847 ± 0.0079,
0.2220 ± 0.0190, 0.3144 ± 0.0363, and 0.2840 ± 0.00625 for angles 0, 15, 30, and 45,
respectively. The validation FOM values between MANTIS-generated PRFs and the
same experimental data were 0.4380 ± 0.0039, 0.2360 ± 0.0098, 0.2592 ± 0.0064,
and 0.2421 ± 0.0079. These initial results suggest that the analytical model de-
scribed in this paper could provide reasonably accurate predictions of the response
of CsI screens with thicknesses comparable to those encountered in other x-ray imag-
ing systems, such as CT. A study is currently underway to investigate in detail the
application of the model to thicker screens.
3.5 Conclusion
In this study, we have developed a detailed, deterministic analytical model
to approximate mantis (Monte Carlo) generated PRFs of CsI scintillator screens
for indirect x-ray detectors of 3D breast imaging systems. We have demonstrated,
using quantitative FOMs, that the analytical model is able to reproduce mantis-
generated PRFs well for a range of incidence angles and much better than a simple
2D symmetric Gaussian fit to the zero-angle mantis data. In addition, comparisons
of the analytical model against experimental data show that the analytical model is
able to reproduce experimental data about as well as mantis. Therefore, the ana-
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lytical model produces PRFs that are comparable to those generated by mantis and
that capture the anisotropy effects seen at large incidence angles. Most importantly,
because the analytical model is a (relatively) simple mathematical expression, it can
generate a PRF in only 0.1 sec on a single CPU, which is less than one millionth the
computational time required by mantis to produce a comparable (but still noisy)
PRF (200 hours on a single CPU). The ability of the analytical model to generate
PRFs in such a short time will allow for inclusion of the detailed PRF structure
that has been demonstrated with mantis in rigorous optimization algorithms and
rapid 3D image reconstructions. This has the potential to improve lesion detection
in future 3D breast imaging systems by including accurate detector blur functions
in optimization of the system geometry. In addition, more detailed knowledge of the
forward problem with respect to detector performance will allow for reconstructed
images that are a more faithful representation of the true object.
The current work has investigated a limited set of parameters (25 keV x rays,
150 μm thick CsI, and incidence angles of 0, 15, 30, and 45 degrees) and has demon-
strated generation of only four individual PRFs. In future studies, we will extend
this work by performing fits of the analytical model to mantis-generated PRFs for
a larger, but still discrete, set of parameters (x-ray energies, CsI crystal thicknesses,
and incidence angles). In addition, we will develop relationships that allow for gen-
eration of the appropriate analytical model coefficient values over the entire range
of investigated values so that model PRFs can be easily generated for optimization
and reconstruction algorithms. The current model can also be used to derive noise
transfer properties of indirect imaging detectors.
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Chapter 4
MRI properties of the anthropomorphic, dual-modality phantom
4.1 Overview
Dynamic1 contrast-enhanced (DCE) MRI with Gd-DTPA has been shown to
be useful in screening women at high-risk of breast cancer as well as in evaluating the
extent of disease [13, 39]. In 2007, the American Cancer Society released guidelines
recommending screening MRI as an adjunct to x-ray mammography for women with
a 20-25% lifetime risk of developing breast cancer [11] and DCE-MRI has been used
increasingly in the clinic [40, 41]. Despite recent advances, many issues remain to be
fully addressed in DCE-MRI. Although DCE-MRI demonstrates high sensitivity, it
has a well-documented low and variable specificity (26-97%) [17, 23, 24]. In addition,
there has been debate over a possible link between increased MR use in breast cancer
imaging and an increase in the number of more extensive surgeries and mastectomies
being performed at some institutions [25, 26, 27, 28, 29, 30, 31, 42, 43, 44].
In response to these issues, recent standardization efforts in the breast MR
community have resulted in a breast MR lexicon [45, 46] and a set of standard-
ized quantities and symbols for kinetic analysis of Gd-DTPA tracer washout [47].
Review papers have discussed the variety of protocols used and given general rec-
ommendations regarding which protocol to use for a given clinical scenario [39, 48].
1Work in this chapter tentatively accepted to Medical Physics [38].
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However, standards for specific breast MRI acquisition protocols are still needed. In
particular, quantitative assessment of MR protocols and their efficacy for different
clinical situations has not yet been adequately addressed.
To perform quantitative comparisons of imaging protocols in terms of lesion
detection and characterization, a phantom that mimics anatomical tissue structure
in addition to contrast properties is required. The importance of realistic phantom
structure in the evaluation of imaging systems for the purpose of abnormality de-
tection was demonstrated in a study by He et al.[49], in which both phantom and
patient data were used to perform reader studies evaluating compensation methods
for myocardial SPECT image reconstruction algorithms. They found that phantoms
with more complicated, realistic image structures resulted in performance measures
for defect detection that more closely matched results derived from patient data
than studies with more simplistic phantoms. The optimal reconstruction parame-
ters derived from the more realistic phantoms were significantly different than those
derived from more simplistic phantoms.
In the context of breast imaging, the importance of realistic phantoms was
demonstrated in a study investigating the utility of different imaging modalities to
evaluate silicone breast implants [50]. The authors reported how only a more realistic
and complex phantom revealed important differences between the evaluated imaging
modalities.
A small number of breast MR phantoms have already been described in the
literature [51, 52]. Mazzara et al.[51] and Liney, Tozer, and Turnbull [52] both de-
scribe phantoms where a homogeneous layer of adipose-mimicking material (Crisco
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or lard) surrounds an interior homogeneous region of glandular-mimicking mate-
rial (polysaccharide material TX-151 or a commercial jelly product) in a cylindrical
container. In the Mazzara et al.[51] phantom a version with an implant was also
created. A lesion was included in the Liney, Tozer, and Turnbull [52] phantom as
a capsule filled with Gd-DTPA-doped water. In both cases the T1 and T2 relax-
ation times of the materials were measured and found to be in good agreement with
breast tissue values. In addition, the American College of Radiology (ACR) phan-
tom for accreditation (http://www.acr.org/accreditation/mri.aspx) is available for
the quantitative evaluation of image quality parameters such as resolution, signal
to noise ratio, and the presence of artifacts.
While existing phantoms do address some needs of the imaging community,
there are currently no phantoms available that reproduce the appearance of and
variability in the anatomical structure seen in human images. Similarly, no phan-
toms are available with well-characterized lesions and variable tissue structure. Such
a phantom would allow researchers to investigate how imaging technique parameters
interact with anatomically relevant structure to affect the clinicians end goal, which,
in the case of breast cancer imaging, is lesion detection and characterization. There-
fore, for the quantitative comparison of diagnostic efficacy and for protocol selection,
the appearance and variability of structures in the phantom and its similarity with
patient data become critical aspects of the phantom.
In this study, we describe a physical, tissue-mimicking phantom for the quan-
titative assessment of breast MRI protocols in terms of lesion detection and charac-
terization in the presence of complex, human-like, anatomical structures. Important
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requirements for such a phantom include T1 and T2 relaxation parameters similar to
those in adipose and glandular human breast tissues, a random phantom structure
that mimics anatomical structures in patients, the ability to actively suppress the
signal from the adipose-simulating component in the phantom, and a realistic en-
hancing lesion. In this study, we present a phantom that addresses all of the above
properties.
4.2 Materials and methods
4.2.1 Phantom construction
The phantom was constructed using refined lard to simulate adipose tissue
and coagulated, fresh egg whites to simulate fibroglandular tissue. The lard (Goya
Foods, Secaucus, New Jersey or Marquez Brothers International, Inc., San Jose, Cal-
ifornia) and fresh eggs (Davidsons Safest Choice Pasteurized Shell Eggs, National
Pasteurized Eggs, Inc., Lansing, Illinois) were both purchased from local supermar-
kets.
Lard was chosen to simulate adipose tissue since it has a similar composition, is
very stable, and is readily available. Human white adipose tissue consists mostly of
lipids in the form of triglycerides [53]. Myristic, palmitic, palmitoleic, stearic, oleic,
and linoleic fatty acids make up more than 90% of the triglyceride component [53].
Lard is composed entirely of lipids, 97.9% of which are in the form of triglycerides
[54], where the same six fatty acids make up over 90% of the total lipid content [55].
The shelf-life for lard is indicated by the manufacturer to be at least a year and a
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half with no refrigeration necessary.
Egg whites were chosen to simulate glandular tissue since they have a similar
composition, unique functional properties that aid in structure formation, and are
also readily available. In addition to adipose tissue, the human female breast is also
made up of ducts, lobules, and the associated fibrous stromal compartment [56, 57]
that make up the so-called glandular portion of the breast. Both ducts and lobules
consist of epithelial and myoepithelial cells surrounded by a basement membrane
that is made up of primarily laminin and type IV collagen proteins [58, 59]. The
main extracellular matrix component of the interstitial stromal compartment is type
I collagen protein [59, 60]. Therefore, a large part of the glandular tissue is made
up of proteins.
In addition, we know that a significant fraction of glandular breast tissue is
made up of water. One study showed that normal patient glandular breast tissue
has a water content of 41-76% by weight [61]. Therefore, a glandular-mimicking
phantom material should be high in both water and protein content. The inclu-
sion of cells would be not only expensive, but also unrealistically unstable. Egg
whites provide a good first order match to human glandular tissue makeup. Egg
whites are made up of mostly water (87.6%) and proteins (10.9%) [55]. The ma-
jor proteins are ovalbumin, ovotransferrin, ovomucoid, ovoglobulin G2, ovoglobulin
G3, and lysozyme, which make up about 91.9% of the total protein content of egg
whites [62]. While the types of protein in egg whites and human breast tissue dif-
fer, the elemental composition of different proteins is almost indistinguishable [63].
In addition, all proteins are made up of amino acids, which all bind H in similar
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ways. Therefore, we expect that the MRI signal of the proteins in egg whites would
be similar to those in human breast tissue. In addition to being readily available,
egg whites also have several functional properties that make them ideal for forming
structures with no intervening septum. They coagulate irreversibly after heating
[64] and do not dissolve into the surrounding material. While the shelf-life of egg
whites is markedly less than refined lard, we will heat the egg whites, store them in
an air-tight container, and mix them with a preservative to improve the shelf-life as
much as possible. The true shelf-life of both phantom components will be measured
as described in the next subsection.
A custom, air-tight plastic jar was developed to contain the phantom materials
and simulate the shape of the human breast. The jar shape was defined by a half-
sphere combined with a cylindrical portion, where the total internal volume was
fixed to a typical breast volume of 425 ml [65]. The lid attaches to the jar body via
a ring of 24 screws through a gasketed connection and has two fill ports that are
sealed with teflon tape-coated screw plugs. The half-sphere jar shape was chosen to
approximate the shape of the majority of breast patients based on visual inspection
of clinical breast MRI images and ease of fabrication. Although this approximation
roughly simulates the shape of many patients, there is certainly a large variation
in patient breast shape including conical shapes and shapes distorted due to the
contact of the breast with the coil. Such differences can have important implications
on effective breast shimming [66]. It would be possible to modify the jar shape of
the phantom to mimic some of these other shapes or even to use segmented patient
images to produce irregular jar shapes, but this would not affect the T1 and T2 of
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the phantom material and is outside of the scope of the current study.
To fill the phantom jar, a preservative (0.2% w/v Dowicil 75, The Dow Chem-
ical Company, Midland, Michigan) was added to raw egg whites prior to pouring
into melted lard, and heating for 30 s while stirring at a constant rotational velocity.
The lard was heated until it reached either 100oC or 110oC and stirred at a constant
velocity of either 125 or 350 rpm. These different lard temperatures and stirring
velocities were used to create a set of phantoms with different tissue structures in
an attempt to mimic the type of variation seen in patient data. Air bubbles were
removed by placing the phantom in a vacuum for 20 minutes. The mixture was
then cooled at room temperature in the sealed jar and rotated once during cooling
to help redistribute the egg whites in the lard. This rotation helps create a layer of
lard around the edges of the jar. The phantoms were constructed with a density of
approximately 24% glandular-mimicking material by volume. This breast density
is similar to densities measured on patient populations using MRI. A study that
estimated breast density using MRI in a high-risk cohort of 35 patients found breast
densities ranging from 2 to 71.4% with a mean of 28% [67]. In the future, the density
of the phantom could be varied to match the full range of densities seen in patient
data by simply increasing the amount of egg whites.
4.2.2 T1 and T2 relaxation parameter measurements
For estimation of T1 and T2 values, inversion recovery (IR) and spin-echo (SE)
sequences were used respectively. All scans were performed in a Siemens Magnetom
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1.5 T clinical scanner using an extremity coil2. The scan parameters were TR=25 s,
resolution=2.5 mm x 2.5 mm x 2.5 mm, 5 slices separated by 7.5 mm each, TI=[22,
35, 45, 75, 100, 150, 200, 250, 400, 500, 600, 900, 1000, 1500, 2500, 4500] ms for the
IR sequence, and TE=[15, 20, 25, 30, 35, 40, 50, 70, 75, 95, 100, 120, 150, 200, 300]
ms for the SE sequence.
T1 and T2 relaxation times of the lard and egg compartments were estimated
from reconstructed magnitude images using maximum-likelihood estimation (MLE)
with a Rician data model. The maximization of the likelihood was implemented
using a limited-memory Broyden-Fletcher-Goldfarb-Shanno (L-BFGS) method with
bounds [68] in the R programming language. The Gaussian noise variance, σ2, was
estimated using the MLE equation for estimation from a background region in a
magnitude data set [69]. For our data, two rectangular bands of 11 x 47 pixels on
either side of the imaged sample, located at the edge of the image, were designated
as background voxels and used in the above calculation. The large dimension of the
background regions covered the full image field-of-view and the small dimension was
chosen to select enough pixels to reasonably sample the noise probability distribution
while staying as far away from the object as possible.
For lard, relaxation values were estimated using a lard-filled tube, assuming
mono-exponential signal behavior. Formulas for MLE of mono-exponential T1 and
T2 relaxation times have been presented in the literature [70, 71]. We used the
T2 equations as previously presented and expanded the mono-exponential T1 signal
equation to include an additional parameter to correct for imperfect inversion pulses
2With the help of Jacco A. de Zwart
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since this is known to significantly affect T1 measurements even on 1.5T systems
[72, 73]. All coefficients for fits to lard data were forced to be positive. The mean
and standard deviation of estimated relaxation values for all voxels within a hand-
selected circular region-of-interest (ROI) were taken as the estimated relaxation
value and its error. The number of voxels included in the ROI was typically 145,
which represents the number of voxels included in the user-selected circular ROI
across each of the 5 imaged slices. The circular ROIs were selected to include as
much of the object as possible, while avoiding pixels on the edge of the object that
had partial volume mixing with the surrounding air.
The relaxation values of the egg component were calculated on the phantom
itself since the relaxation values of egg are known to vary with preparation technique
[74]. A double-exponential signal equation was used to fit the data with the T1 and
T2 values of lard fixed to those estimated above; the amounts of egg and lard, the
inversion pulse correction, and the T1 and T2 values of egg are free parameters for
each voxel. All free parameters were forced to be positive during the fitting except
for the T1 value of egg, which was restricted to values between 500 and 5000 ms. The
reported relaxation values and their errors were calculated as the mean and standard
deviation weighted by the egg fraction for all voxels, within a hand-selected, circular
ROI, with an egg fraction of at least 50% and a proton density of at least 50% of
the maximum value in the sample (on average about 480). The circular ROIs were
selected to include as much of the object as possible, while avoiding pixels on the
edge of the object that had partial volume mixing with the surrounding air.
The above process was repeated for three different phantoms manufactured
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using different construction parameters (lard heating temperatures and constant
rotational velocities) to ensure that variations in the production method did not
cause variations in the relaxation values outside of the human range.
The estimated phantom relaxation values were compared with published hu-
man data. All published studies found where both T1 and T2 values were calculated
separately for both adipose and glandular breast tissues on a 1.5 T magnet were
included in our analysis [75, 76, 77, 78]. Error bars were taken directly from the
respective values reported in the publications.
The stability of the relaxation values over time was measured by repeating the
above process approximately every other week over a period of 9 months. During
this time the phantom was stored at room temperature.
4.2.3 Comparison of image structure
The phantoms structure was quantitatively compared with patient data using
covariance matrices. The covariance matrix measures how each pixel in the image
co-varies on average with every other pixel, given a population of such images (from
either phantoms or patients) [79]. The full covariance matrix of a vector (or image)
g with M elements (equal to N2 for an image or ROI with N × N pixels) will be
an M × M matrix with elements given by
Kij = 〈(gi − ḡi) (gj − ḡj)∗〉 , (4.1)
where the overbar indicates an average and the ∗ indicates complex conjugation. If
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gi and gj are statistically independent and i 
= j, then Kij = 0. If i = j, then Kjj is
equal to the variance of gj. Since g is a random vector, we must average over many
instances of g in order to get a good estimate of K.
Since we have a limited number of images available relative to the number of
elements that must be computed for a full covariance matrix, we have averaged the
covariance matrix over all positions within an image ROI, therefore assuming wide-
sense stationarity within that ROI [79] and reducing the variance of the estimate of
K at the expense of position-dependent information. We will refer to this matrix
as the stationary covariance matrix. It represents the average direction-dependent
correlation strength over all positions in the ROI and is an estimate of the texture
in the images to second order. The stationary covariance matrix has a size of






where p and q are offset indices (both ∈ [(N − 1), ..., (N − 1)]) in the x and y
directions, respectively. The physical meaning of p and q is that they are relative
offset values. So, Kstationarypq is the element of K
stationary that holds the average
covariance over all pixel pairs in the ROI that are separated by p pixels in the
x direction and q pixels in the y direction. Another way to state this is that the
covariance element Kstationarypq describes the correlation between any pixel in the ROI
and its neighbor p pixels to the right and q pixels up. The element Kstationary00 is
at the center of the matrix. The two-dimensional indices m and n both run from
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0 to N − 1 over the two-dimensional ROI in the x and y directions, respectively.
The one-dimensional index i is simply a one-dimensional version of the indices m
and n that runs over every pixel in the ROI (∈ [0, ..., N2 − 1]) and is equal to
m+nN. The average over the elements of the full covariance matrix only includes
elements for which a (p, q) offset ROI pixel exists, denoted by the set S. Therefore,
the number of samples that contribute to the calculation of the element Kstationarypq
of the stationary covariance matrix varies with the exact p, q indices and is given
by (N − |p|)(N − |q|). We can see from this equation that stationary covariance
elements describing correlations with more distant pixels pairs (large p and q values)
have fewer samples. Also note that both the full and stationary covariance matrices





To illustrate the calculation of the stationary covariance matrix, let us take the
example of a 3×3 ROI (N = 3). In this case, m, n ∈ [0, 1, 2], i ∈ [0, 1, 2, 3, 4, 5, 6, 7, 8],
and p, q ∈ [−2,−1, 0, 1, 2]. For the (p, q) = (1, 2) element of the stationary covari-
ance matrix, the average takes place only over i ∈ [0, 1] because the other i index
values correspond to ROI pixels that do not have counterparts that are 1 pixel to





(K07 + K18) (4.3)
and has 2 samples. Likewise, the (p, q) = (1,−1) element of the stationary covari-





(K31 + K42 + K64 + K75) (4.4)
and has 4 samples.
For each phantom or patient data set, the largest square ROI was selected
by-hand which still contained only breast tissue. The ROI size varied with breast
size for patient data (between 35×35 and 150×150 voxels), but stayed constant for
phantom data (70×70 voxels). This ROI was applied to a set of slices (between 26
and 92 slices per patient depending on breast size and 61 slices per phantom) of the
left breast where enough breast tissue was present to fill the chosen ROI.
Multiple slices were included in the stationary covariance matrix calculation
by concatenating all ROIs from all slices into a single g vector. This provided a
single, in-plane, stationary covariance matrix for each patient or phantom, which
we will refer to as a patient- or phantom-specific stationary covariance matrix. This
matrix was also normalized by the average voxel variance (the central pixel of the
stationary covariance matrix) to highlight the relative correlation fall-off with spatial
position.
An overall stationary covariance matrix for the entire patient or phantom
population was then calculated by first converting all patient-specific stationary
covariance matrices to the same spatial scale (0.625 mm/voxel) using a cubic con-
volution interpolation with an interpolation parameter of -0.5 [80] if necessary. The
difference between the original and interpolated covariance matrices was negligible.
Finally, all of the resultant matrices were averaged. Error bars on the overall sta-
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tionary covariance matrix were estimated by calculating the standard deviation of
the patient-specific stationary covariance matrices values at each offset position.
To understand whether the difference among patient-specific stationary covari-
ance matrices was due to instrumentation error or anatomical variations, simulated
ROIs were created with only Rician noise. In all cases, the noise variance was
set to one since the final covariance is normalized by its maximum value, which
is equivalent to the average pixel variance. Simulated ROIs were chosen to have
a conservative size of 35×35 voxels, which is equal to the smallest ROI used for
the covariance calculations on the patient data. Sets of between 5 and 95 simulated
ROIs were created to bracket the range of the number of slices selected in the patient
data. The root mean squared (RMS) variation in the simulated, Rician-noise only,
patient-specific stationary covariance estimate was then calculated for 5 different




were within 4 mm of the specified offset. The RMS variation was calculated as a
function of the number of ROIs used in the covariance estimation (corresponding
to the number of patient slices). This process was repeated on eleven independent
realizations to improve the RMS estimates and compare with the variation in the
patient-specific stationary covariance matrices.
Coded patient data were taken from the National Cancer Institute’s (NCI)
Clinical Genetics Branch’s Breast Imaging Study data archive3. Use of the data
was authorized under appropriate IRB approval from both the NCI and FDA. In
the study, a total of 194 high-risk patients were imaged using various MR imaging
3Provided by Jennifer Loud and Mark H. Greene
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protocols and scanner types. Patients were enrolled between June 2002 and February
2007 and included in the study if they were between 25 and 56 years of age and
considered at high genetic risk of developing breast cancer. See Loud et al.[81] for
additional study details.
Seventy-seven patients with MRI data collected on a 1.5T Philips machine
with a 7-channel, dedicated breast coil and with the same pre-contrast imaging
sequence, were selected for additional analysis. Thirteen were excluded because of
the presence of an implant or diagnosis of breast cancer before or during the course
of the NCI breast imaging study. Sixty-four patients remained for the final analysis.
Pre-contrast, T1-weighted, gradient-echo, fat-suppressed images were available for
each patient with an in-plane resolution ranging from 0.586 to 0.664 mm and a slice
thickness ranging from 1.9 to 2.3 mm. Twenty phantoms were fabricated and imaged
using the same scanner type, breast coil, and imaging sequence for comparison with
the patient data4.
4.2.4 Enhancing lesion
An enhancing, mass-like lesion was designed to be included in the phantom.
We have designed and manufactured two simulated lesions using stereolithography
to simulate round and lobular morphologies. The simulated lesions consist of hollow
plastic molds with 0.6 mm thick walls and can be filled with a Gadolinium-doped
water solution. Neither of the plastic molds have any internal structure. The lesion
with the round morphology is a 1 cm internal diameter sphere with an internal
4With the help of Riham H. El Khouli
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volume of 523.6 mm3. The lobular lesion is a 1 cm internal diameter sphere with
three additional lobulations and has an internal volume of 563.2 mm3. The stere-
olithography printer resolution was 0.0508 x 0.0508 x 0.1016 mm for these parts.
An inner diameter of 1 cm was chosen for the lesions since it is small enough to be a
challenge to detect, but large enough to be able to apply morphological descriptors
during lesion characterization. The size of the lesion could easily be varied.
These lesions are suspended in the phantom via small tubes that attach to
the lid of the phantom jar and are added into the phantom itself when the jar is
sealed and allowed to cool. Once the phantom is completely cooled and the lard
and egg whites have solidified, the lesion is filled with 4.5 mM GdCl3 (anhydrous
gadolinium chloride, 99.99%, Sigma-Aldrich, St. Louis, MO) in deionized water.
This concentration of gadolinium was chosen to be similar to that of patients at
the peak of a typical gadolinium contrast agent washout curve. Note that the
concentration of gadolinium in the lesion is a fixed value in the current study. In
future studies, we plan to extend this lesion model to include temporally dynamic
behavior.
We obtained chemically-selective fat-suppressed, 3D gradient-echo MRI images
of phantoms with each of the two lesion types using a Siemens Magnetom 1.5 T
clinical scanner with an extremity coil. The scan parameters were: resolution =
0.75 mm×0.75 mm×0.75 mm, matrix size = 192×192×72, TR = 3.86 ms, TE =
1.36 ms, flip angle = 10 degrees.
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Figure 4.1: Example patient and phantom images. (top row) acquired with a 1.5
T Philips scanner and a dedicated breast coil (bottom row) acquired with a 1.5 T
General Electric scanner and a dedicated breast coil. a) patient, T1-weighted, fat
suppressed, b) patient T1-weighted, no fat suppression, c) patient, T2 SPAIR (spec-
tral adiabatic inversion recovery), fat suppressed, d) phantom, T1-weighted, fat sup-
pressed, e) phantom, T1-weighted, no fat suppression, f) phantom, T1-weighted, no
fat suppression g) phantom, T1-weighted, fat suppressed h) phantom, STIR (short
T1 inversion recovery), fat suppressed, i) phantom, T2-weighted, no fat suppression
j) phantom, T2-weighted, fat suppressed. All scale bars are 10 mm.
4.3 Results
Figure 4.1 shows example patient and phantom images acquired with clinical
systems. T1- and T2-weighted images of the phantom are shown, acquired using
standard clinical breast protocols from two different institutions with two different
clinical scanners (1.5 T Philips and 1.5 T General Electric both with dedicated
breast coils).
T1- and T2-weighted images of the phantom are shown with and without fat
suppression for two different clinical scanners (1.5 T Philips and 1.5 T General
Electric) with dedicated breast coils. Our phantom provides a breast shape and
internal tissue structure that is much improved over currently available phantoms.
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Figure 4.2 shows the comparison of phantom T1 and T2 relaxation parameters
with corresponding published human values. Values for three different phantoms
with different construction parameters are shown. Phantom relaxation values fall
within 2 times the standard error of the human data. The match between the human
and phantom data is particularly good for T1 values, which are more relevant when
evaluating DCE-MRI since the images are T1-weighted. Results of the stability
analysis are shown in Figure 4.3. Over a 9 month period the T1 and T2 values are
stable to within 8% and 15%, respectively, for both lard and egg whites. The data
indicate that the phantom materials may be stable over an even longer time period
since the values have not yet strongly deviated from their values at production time.
We will continue to monitor the stability until the values change significantly. In
Mazzara et al.[51], when their phantom was stored at room temperature for 6 months
they stated that no noticeable degradation was seen and the T1 and T2 values had
less than 10% random variations. For the phantom presented in Liney, Tozer, and
Turnbull [52], data evaluating the shelf-life was not presented and the shelf-life was
stated as being several months when refrigerated. Therefore, our phantom performs
at least as well as currently available breast phantoms in terms of stability.
Figure 4.4 shows example phantom and patient ROIs. A visual comparison
between these ROIs indicates that the phantom has a random structure that resem-
bles the complicated patient data image structure. We observe that the patient data
appear to have a directional preference in the anterior-posterior direction, whereas
the phantom is more isotropic. Furthermore, the fat suppression in the phantom
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Figure 4.2: Comparison of phantom T1 and T2 values with human data from the
literature. Error bars are one standard error. The lines plotted for the Graham et
al.[53] study indicate contours that include a calculated 12.5% and 87.5% probability
of their measured tissues. The T1 and T2 values of the phantom materials fall within
two standard errors of the human data for both the adipose- and fibroglandular-
mimicking compartments. Data points for the phantom materials were measured on
three different phantoms constructed using different lard temperatures and stirring
velocities. The phantom T1 values are a better match to human data than the T2
values and are the primary determinants of image contrast for DCE-MRI studies.
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Figure 4.3: Fractional change in T1 (top) and T2 (bottom) relaxation times of lard
and egg whites as a function of time since phantom production date. All data points
have been normalized by the relaxation value on the phantom production date. T1
and T2 relaxation values of both lard and egg are stable to within 8% and 15%,
respectively, over a period of 9 months. Errors bars are the standard deviation over
all voxels included in the computation for a single data set.
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Figure 4.4: Example ROIs (cropped to 3.5 cm x 3.5 cm) selected from the pa-
tient (top row) and phantom (bottom row) fat-suppressed, T1-weighted data. The
phantom has a statistically random image texture that is similar to the patient
data. Structures in the patient data appear to be more anisotropic than those in
the phantom data and tend to elongate along the anterior-posterior direction. The
phantom data also appears to have slightly better fat-suppression than the patient
data.
images appears to be slightly improved as compared to that of patient data. This
may be due to the fact that there is no torso attached to the phantoms, resulting in
improved shimming of the phantom, or that the spectral shape of the fat signature
in the phantom may be less complicated than that of patients. There may also be
more homogeneity of the material types within a voxel in the phantom than in the
patient data, resulting in the appearance of better fat suppression.
Figures 4.5 and 4.6 compare patient and phantom covariance matrices. Fig-
ure 4.5 shows images of the patient and phantom overall stationary covariance ma-
trices, while Figure 4.6 shows horizontal and vertical cuts through those matrices.
Our data suggest that the covariance length of the patient and phantom images is
similar along the anterior-posterior direction. In the right-left direction, they differ
by about two standard error bars, with the phantom images having a larger corre-
lation length than the patient data. In general, the phantom data is more isotropic
than that of the patient, which tends to have structures that elongate along the
anterior-posterior direction. Interestingly, the error bars of the patient and phan-
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Figure 4.5: Overall stationary covariance matrices for the patient and phantom data
sets. The matrices are scaled to have the same intensity at their peak. The phantom
and patient overall stationary covariance matrices have a similar covariance length
in the anterior-posterior direction. However, the phantom has a larger covariance
length than the patient in the right-left direction.
tom data are similar, which indicates a similar range of variability among the two
populations.
Figure 4.7 shows the results of simulations run to estimate the amount of
instrumentation error included in the error bars in Figure 4.6. RMS variations in
the stationary covariance matrix estimations are plotted as a function of the number
of ROIs used in the estimate. The ROIs were simulated images created with only
Rician noise. Results for five different offset distances are shown. For 26 to 92 ROIs,
the magnitude of the RMS instrumentation error in the stationary covariance ranges
from 0.003 to 0.020 depending on the offset distance and the number of ROIs. The
corresponding error bars in Figure 4.6 range from 0.053 to 0.096 for the same set
of offset distances. The fact that the RMS instrumentation errors are less than the
size of the error bars in Figure 4.6 indicates that these error bars represent mostly
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Figure 4.6: Cuts through the patient and phantom overall stationary covariance
matrices (shown in Figure 4.6) in the right-left and anterior-posterior directions.
The patient and phantom overall stationary covariance matrices are the same to
within their error bars along the anterior-posterior direction, but differ in the right-
left direction. Error bars are the standard deviation of the individual patient- (n=64)
and phantom-specific (n=20) stationary covariance matrices at each distance.
anatomical variation.
Images of the lesions before inclusion in the phantom as well as fat-suppressed,
T1-weighted, gradient-echo MRI images of two phantoms with the two different
simulated lesion types are shown in Figure 4.8. We are able to produce complex
lesion morphologies and to fill those with a gadolinium-doped water solution whose
concentration can be varied by the user to investigate different contrast agent doses.
With the addition of the enhancing lesion, the phantom can be used to study the
effect of image protocol parameters on lesion detection and characterization.
4.4 Discussion
We have described a breast MR phantom, developed for quantitative eval-
uation of breast MRI techniques, which mimics breast tissue properties including
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Figure 4.7: RMS variation in the stationary covariance estimate due to Rician in-
strumentation noise only as a function of the number of 35 x 35 voxel ROIs used in
the estimation. Five different offset distances are shown. Comparing with the size
of the error bars in Figure 4.6, which describe both anatomical and instrumentation
errors, the instrumentation errors shown here are much less than the size of the
error bars in the actual data in Figure 4.6. This indicates that the error bars in
Figure 4.6 represent mostly anatomical variation.
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Figure 4.8: a) Photograph of round-shaped, mass-like simulating lesion (sphere
internal diameter = 10 mm). The three tubes towards the right connect the lesion
with the phantom jar lid and allow for filling of the lesion with contrast agent
as well as future dynamic contrast agent experiments. b) Photograph of lobular-
shaped, mass-like simulating lesion (3 lobulations plus 10 mm internal diameter
sphere diameter). c) Fat-suppressed, T1-weighted, gradient-echo image (0.75 mm
isotropic resolution, coronal slice) of a complete phantom with the round-shaped
simulating lesion inserted and filled with gadolinium-doped water. d) Same as c)
with the lobular-shaped simulating lesion.
T1 and T2 relaxation values, fat suppression, image structure, and lesion morphol-
ogy and peak enhancement. We have also presented a method for quantitatively
comparing the image structure of phantom data with that of patient data. This
method permits formulating approaches to further improve the phantom design and
production methods.
Our phantom design can be used to quantitatively compare T1-weighting
methods and fat suppression techniques of different imaging protocols, coils, con-
trast agent dose, and scanners at 1.5 T in terms of lesion detection. The phantom
could be validated and used to compare performance at other field strengths as well.
Since the lesion volumes are known, the effect of imaging protocol parameters on
the ability to estimate lesion volume can also be investigated. Another important
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application of the phantom is performing direct lesion detectability comparisons
across different institutions since the exact same phantom set can be imaged at a
variety of locations. Such comparisons may help illuminate the cause of variations in
clinical performance among institutions by determining the contribution of scanner
and software variability.
An extension of the phantom design allowing for investigation of dynamic
parameters is underway. This will be achieved by modifying the current static lesion
design to include validated contrast agent washout kinetics. Once the dynamic lesion
is included, the phantom can be applied to the optimization of additional breast MRI
parameters such as spatial vs. temporal resolution tradeoffs. We expect that the
phantom will also be useful for quantitative evaluation of x-ray imaging since the
phantom materials were selected to be similar to human breast tissue components.
We are therefore currently working towards characterizing the x-ray properties of the
phantom. Such a dual-modality phantom would be useful, not only for quantitative
evaluation of separate modalities, but also direct comparisons between x-ray and
MRI modalities to help understand which modality is optimal for a given imaging
situation. Manuscripts are currently in preparation discussing the x-ray properties
of the phantom and a dynamic lesion.
One of the limitations of the phantom design is an improved fat suppression
compared to patient data. In addition, tissue structures in the right-left direction
are, on average, larger in the current phantom design than those in patient data.
Further work is necessary to determine the cause of the difference in fat suppres-
sion between patient and phantom images. If the cause of this is improved field
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homogeneity in the phantom, this could be addressed by purposely mis-adjusting
the shim settings of the MR scanner, or by adding distributed quantities of an
MR-invisible material with a different susceptibility constant to the outside of the
phantom. Another probable explanation for the difference is that human adipose
tissue contains more than only lipids. It also contains vascular cells and is held in a
matrix of collagen fibers. The total lipid content of human adipose tissue is 60-85%,
but adipose tissue also contains 5-30% water and 2-3% protein [53]. In contrast, the
adipose-mimicking material used in our phantom is 100% lipid. A future version of
the phantom may address this discrepancy by mixing additional proteins or other
organic elements found in vascular cells into the adipose-mimicking material, how-
ever the most appropriate materials to be used and their shelf-life must be carefully
considered. Variations in fat suppression due to breast shape could be addressed
by modifying the phantom jar to reproduce different breast shapes, such as conical
shapes and those distorted by contact with the coil.
In terms of tissue structures, the phantom does have more isotropic tissue
structures than those in patient data, however the overall size of these structures is
similar to that of patient data and presents a significant improvement over what is
currently available. The fact that the overall size of structures in the phantom is sim-
ilar to patient data implies that optimizations performed with the phantom should
be appropriate when evaluating detectability as a function of lesion size. Since the
phantom has a more isotropic structure than patient data, we expect isotropic le-
sions to be more difficult to detect in the phantom than in patient data. Similarly,
anisotropic lesions will be easier to detect in the phantom than in patient data. The
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fact that these differences are quantitatively evaluated in the phantom means that
optimization trends derived from the phantom can be intelligently interpreted in
terms of their translation to clinical imaging.
There is some anisotropy in the phantom covariance in the direction perpen-
dicular to the patient data. This suggests that it may be possible to adjust the
phantom production to improve the phantom tissue structure. Some possibilities
include modifying the stirring parameters while the egg is coagulating in the heated
lard, rotating the entire phantom while cooling to room temperature or perhaps
pushing the raw egg whites through a grid while they enter the heated lard in order
to create long, filamentary structures. This approach might also provide fiber-like
structures with some ability to control the corresponding distribution of sizes.
4.5 Conclusion
The breast MRI community currently lacks a realistic, anthropomorphic phan-
tom that can be used to quantitatively evaluate the effect of MRI protocol pa-
rameters on lesion detectability. In this study, we propose a phantom that ad-
dresses this need. Other quantitative MRI phantoms, such as the ACR accred-
itation phantom and the DCE-MRI phantom under development by the Quanti-
tative Imaging Biomarkers Alliance at the Radiological Society of North America
(http://qibawiki.rsna.org), are important tools in MRI technique optimization be-
cause they allow for precise measurement of parameters such as slice thickness,
resolution, and relaxation time estimation. However, these phantoms are intended
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for optimization of specific image quality parameters and have no anthropomorphic
shape or structure. Therefore, they are unable to probe exactly how MRI technique
parameters influence lesion detectability. Anthropomorphic phantoms have been
implemented in other imaging modalities and have been used to demonstrate that
simple, non-anthropomorphic phantoms produce misleading results when used to
optimize imaging systems [49, 82, 83, 84]. The phantom described in this work will
provide a much-needed platform for better understanding the interaction of breast
MRI acquisition parameters with lesion detection and estimation.
Clinical applications of breast MRI have been rapidly evolving and have demon-
strated potential to improve the detection and characterization of breast lesions,
particularly for high-risk patients with dense breast tissue, when compared with
current standard-of-care methods. However, the advantages of breast MRI have
been overshadowed by issues of performance variability and false positive findings.
Our phantom design helps address these issues by allowing quantitative comparisons
across breast MRI systems and protocols and by directly relating image acquisition
parameters to lesion detection and estimation. Such comparisons will contribute to
the standardization of breast MRI and address some of the concerns associated with
its widespread clinical use.
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Chapter 5
X-ray properties of the anthropomorphic, dual-modality phantom
5.1 Introduction
The1 current landscape of breast cancer imaging is changing rapidly as re-
searchers investigate new approaches for lesion detection. Although mammography
has been shown to decrease mortality for women aged 40 and over [4], it has a
low sensitivity for high-risk patients, who tend to have a higher breast density, and
detects only 4 out of every 10 cancers [123].
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has re-
cently emerged as a promising modality for breast cancer detection, particularly
for women with dense breasts where mammography suffers from low sensitivity.
In studies of high-risk women, DCE-MRI consistently outperforms mammography,
with a sensitivity of 71-77% as compared to 36-40% for mammography [123]. As
a result, the American Cancer Society recommended DCE-MRI as an adjunct to
mammography for screening of high risk women in 2007 [11]. However, as compared
with mammography, DCE-MRI has a low and variable specificity [17, 23, 24] that
results in more false positives and unnecessary procedures.
Other cutting-edge technologies that are under development are breast to-
mosynthesis and dedicated breast CT. Both of these modalities attempt to improve
1Work in this chapter submitted to Physics in Medicine and Biology [122].
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on the sensitivity of mammography by including additional three-dimensional in-
formation and removing some of the confounding tissue overlap that makes inter-
pretation of high breast density mammograms so problematic. Preliminary studies
using tomosynthesis have shown improved lesion visibility and reduced recall rate,
but may require additional dose [33, 34, 35]. The use of breast CT seems to improve
visualization of masses at the expense of visualization of microcalcifications and
the use of an intravenously administered, iodinated contrast medium can further
improve lesion and microcalcification conspicuity [36, 37].
With such a variety of technologies available, each with its own unique ad-
vantages and disadvantages, the ability to perform quantitative performance com-
parisons is critical to determining the optimal clinical utility of each modality. The
ideal platform for quantitative comparisons would be a well-characterized phantom
with realistic tissue structure that can be used to evaluate lesion detection across
all of the available modalities.
There are a variety of anthropomorphic physical phantoms already available or
under development for x-ray imaging [82, 124, 125, 126, 127, 128, 129] and a smaller
number available for MR imaging [51, 52]. Interesting work has also been presented
in the area of anthropomorphic, computational phantoms, however these will not be
discussed here since they cannot be used to test clinical systems [130, 131, 132, 133].
Anthropomorphic physical x-ray phantoms include the so-called Rachel phan-
tom [124, 125], a phantom made of plastic spheres [82, 126, 127], and a swirled plastic
slab phantom [128]. The Rachel phantom consists of a base of variable thickness
tissue-equivalent plastic combined with a mercury-enhanced clinical mammogram.
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This phantom is able to produce highly realistic images since its design is based on
clinical mammograms, however it is difficult to manufacture and only appropriate
for mammography. The plastic sphere phantom is made up of a combination of plas-
tic spheres of different diameters contained in a rectangular plastic box. To produce
a variety of different background structures, the spheres are simply stirred between
data acquisitions. Although the texture is not as realistic as the Rachel phantom,
the sphere phantom is very simple to construct and can easily produce different
background realizations. The CIRS slab phantom is made of 6 semi-circular, equal-
thickness slabs, each of which consists of two tissue-equivalent plastic materials that
are swirled together to create a heterogenous structure. The x-ray attenuation co-
efficient values of the two plastic materials are based on the breast tissue elemental
compositions reported in Hammerstein et al.[134]. To create different backgrounds,
the slabs can be rearranged in different orders. Although this phantom does have
a heterogenous texture, it cannot create a large number of different backgrounds.
In addition, it is unclear how realistic the structure is since a comparison of x-ray
properties with human tissue has not been presented. Finally, a phantom is under
development that is based on a computational model that can generate heteroge-
neous breast voxel phantoms of different compositions, sizes, and shapes [129]. It is
produced by first printing the glandular portion of the phantom with a rapid pro-
totyping technique and a tissue-equivalent material. The printing is performed in
slabs to allow access to the empty spaces, which are then filled with an epoxy-based
resin meant to simulate adipose tissue. The slabs are then combined together to
create the final phantom. While this phantom does have a heterogeneous structure
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that is qualitatively similar to clinical images, it is very difficult to manufacture in
its current form.
For MR imaging, the only anthropomorphic breast phantoms that the authors
are aware of have similar designs that consists of a homogenous adipose-mimicking
layer that surrounds a homogenous region of glandular-mimicking material [51, 52].
In both cases, the materials were chosen to match T1 and T2 relaxation values of
human tissue, but do not have any heterogeneous structure and, therefore, have
limited applicability for lesion detection studies.
None of the above phantoms can be used for both x-ray and MR imaging
and, therefore, cannot be used to quantitatively compare the two techniques. In
this study, we propose a dual-modality (x-ray and MRI), anthropomorphic breast
phantom for the quantitative evaluation of lesion detection. The MR properties of
the phantom have been previously presented in Chapter 4. Here, we extend our
analysis to characterize the x-ray properties of the phantom materials.
5.2 Methods
In the following subsections, we describe the methods for construction of the
phantom, comparison of x-ray attenuation coefficients and tissue structure with
patient values, and calculations of x-ray scatter of the phantom.
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5.2.1 Phantom construction
Procedures for construction of the phantom are similar to those described in
Chapter 4. The only difference is a change in the shape of the custom jar to simulate
the compressed breast shape in mammography.
Refined lard (Goya Foods, Secaucus, New Jersey or Marquez Brothers In-
ternational, Inc., San Jose, California) was used to simulate adipose tissue and
coagulated, fresh egg whites (Davidson’s Safest Choice Pasteurized Shell Eggs, Na-
tional Pasteurized Eggs, Inc., Lansing, Illinois) to simulate fibroglandular tissue. As
previously described in Chapter 4, lard and egg whites were chosen because they
both have a similar composition to the human tissues they are meant to simulate.
For this reason, we expect our phantom to be useful for the evaluation of multiple
modalities.
In Chapter 4 a custom jar was developed to simulate the shape of an un-
compressed breast, since MRI is typically performed without compression. Since
breast computed tomography is also performed without compression, the same un-
compressed jar could be used for that modality. However, since mammography is
performed with compression, we have modified the custom jar to have a compressed
shape with a thickness of 4.5 cm. The lid attaches to the jar body via a ring of
24 screws through a gasketed connection and has two fill ports that are sealed with
teflon tape-coated screw plugs.
To fill the phantom jar, a preservative (0.2% w/v Dowicil 75, The DOW Chem-
ical Company, Midland, Michigan) was added to raw egg whites prior to pouring
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into melted lard (heated to 110o C), and heating for 30 s while stirring at a constant
rotational velocity (125 rpm). Air bubbles were removed by placing the phantom
in a vacuum for 20 minutes. The mixture was then cooled at room temperature
in the sealed jar and rotated periodically during cooling to help redistribute the
egg whites in the lard. The percent glandular tissue of the phantoms created for
the current study was 29.5% by volume (including the jar walls). This volumetric
breast density is similar to that of high-risk patients as measured using MRI. In a
study of asymptomatic women in the United Kingdom at high genetic risk of breast
cancer, the volumetric density as estimated with MRI was 25.0 ± 15.2 (N=655,
range: 2.9-87.7%) [136]. The density of the phantom can be modified by adjusting
the amount of egg whites used during its construction. The shelf-life of the phantom
was previously measured to be at least 9 months using the change in MRI T1 and
T2 relaxation values as a metric.
5.2.2 X-ray attenuation coefficient
5.2.2.1 Human values
X-ray attenuation coefficients and elemental compositions of adipose and glan-
dular breast tissues have been measured previously [134, 137, 138, 139, 140].
Johns and Yaffe [137] measured the linear attenuation coefficient (18 to 110 keV)
and density of normal fat and fibrous tissue specimens obtained from ten women
undergoing reduction mammoplasty and three women at autopsy.
Al-Bahri and Spyrou [138] measured linear attenuation coefficients at 59.50 keV
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of adipose and glandular breast tissue samples taken from nine breast cancer menopausal
patients who had undergone mastectomy. Most of the glandular tissue samples were
known to contain fat tissue as well. Since no density measurements were performed,
we have used the density values reported in Johns and Yaffe [137] to convert their
reported linear attenuation coefficients to mass attenuation coefficients.
Poletti et al.[139] measured the linear attenuation coefficients at 17.44 keV,
elemental compositions, and densities of breast adipose (N=4) and glandular (N=3)
tissue samples taken from mastectomies. For comparison with our data, we have
used their measured elemental compositions to calculate theoretical attenuation co-
efficient values for mammographically-relevant energies using the material database
processing software from PENELOPE [104].
Tomal et al.[140] measured the linear attenuation coefficents at 6 discrete ener-
gies (8, 11, 15, 20, and 30 keV) of breast adipose (N=28) and glandular (N=4) tissue
samples taken from mastectomies and breast reduction surgeries. To convert from
linear attenuation coefficient to mass attenuation coefficient, we used the density
values reported in Poletti et al.[139].
Hammerstein et al.[134] measured the density and elemental composition of
adipose (N=8) and glandular (N=5) breast tissue samples taken from mastectomies.
It was found that the carbon and oxygen components of both adipose and glandular
tissues varied greatly between samples, probably due to physiological differences
in the amount of fibrous stroma in adipose tissue and the difficulty of removing
fatty material from the glandular specimens. The mass attenuation coefficients for
these compositions were also estimated using the material database in PENELOPE.
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Uncertainties were estimated in the attenuation coefficients by using the extreme
ranges that were provided for carbon and oxygen.
5.2.2.2 Phantom values
The elemental compositions of lard and fresh egg whites were estimated from
the USDA’s National Nutrient Database for Standard Reference [55]. The mass
attenuation coefficient was derived from these values using the material database
in PENELOPE. The linear attenuation coefficient of egg whites has also been mea-
sured experimentally by Rao and Gregg [141] at several discrete energies from 27
to 662 keV. Measurements were performed using radioisotopes as x-ray sources and
a NaI(Tl) detector. In addition, the specific gravity was measured using a Jolly
balance. No further information was provided about the egg white samples or
their preparation. The measured linear attenuation coefficients for egg white were
0.426 cm−1 at 27 keV and 0.215 cm−1 at 60 keV. No uncertainty estimates were
provided. The specific gravity of egg white was 1.04. Therefore, the mass attenu-
ation coefficient of egg whites, as derived from their measurements, is 0.410 cm2/g
at 27 keV and 0.207 cm2/g at 60 keV.
5.2.3 Tissue structure
The tissue structure of the phantom was quantitatively compared with tissue
structure from patient data using stationary covariance matrices. A brief overview
of the stationary covariance matrix formulation is followed by a description of the
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patient and phantom data used in the comparison and a description of the effect of
the inclusion of an anti-scatter grid on the stationary covariance.
5.2.3.1 Stationary covariance matrix
The same framework for the comparison using stationary covariance matrices
as previously described in Chapter 4 was used here. The stationary covariance
matrices were calculated on left and right cranio-caudal (CC) patient and phantom
mammography images. In order to combine the results for both right and left CC
images, the left CC images were flipped about their vertical axis so that the chest
wall was always on the same side of the image. For the patient images, the largest
square ROI in the constant thickness region of the breast was selected using the
procedure described in Burgess [142]. For the phantom images, the known geometry
of the phantom jar was used to select the largest square ROI in the constant thickness
region of the phantom.
To create an overall stationary covariance matrix for the entire patient or
phantom population, the individual stationary covariance matrices were normalized
by their average pixel variance and averaged together. Error bars on the overall
stationary covariance matrix were estimated by calculating the standard deviation
of the patient-or phantom- specific stationary covariance matrix values at each offset
position.
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5.2.3.2 Patient and phantom data
Coded patient data were taken from the National Cancer Institute’s (NCI)
Clinical Genetics Branch’s Breast Imaging Study data archive. Use of the data was
authorized under IRB approval from both the NCI and FDA. In the study, a total
of 198 high-risk patients were imaged using various mammography machine types.
Patients were enrolled between June 2002 and February 2007 and included in the
study if they were between 25 and 56 years of age and considered at high genetic
risk of developing breast cancer [81]. All patients with digital data available were
selected for further analysis. Eight patients were excluded because of the presence
of an implant or diagnosis of breast cancer before or during the course of the NCI
breast imaging study. Forty patients remained for the final analysis. The digital
data were acquired with a Hologic Lorad Selenia machine and the following system
parameters: 28.9 mean kV (range: 24 - 38), 66 cm source-to-detector distance,
0.3 mm focal spot size, molybdenum anode target, and 70 × 70 μm detector pixel
size. An anti-scatter grid was used during data acquisition. For patients with a
compressed breast thickness less than 6.4 cm (N=30), a 30 μm thick molybdenum
filter was used, otherwise (N=10) a 30 μm thick rhodium filter was used. CC view
images were used for the analysis.
Twenty phantoms were fabricated and imaged2 on a laboratory system with
an x-ray tube (RAD-71SP, Varian Medical Systems, Inc., Palo Alto, CA) with a
tungsten anode and a 0.3 mm focal spot and an indirect x-ray detector with 148
2with the help of Robert J. Jennings and Hugo de las Heras
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× 148 μm pixels and 500-550 μm thick CsI (Pixium RF 4343, Thales, France).
The source-to-detector distance was set equal to that of the Hologic system used to
acquire the patient data. No anti-scatter grid was used. Two images were acquired
of each phantom, where the phantom was flipped between exposures, to increase
the amount of data available for analysis.
Since the anode material of the experimental setup was different from that
used to acquire the patient data, the kV and filters used in the experimental system
were adjusted to match the mean energy and half value layer (HVL) of photons
absorbed in the detector in the clinical system. Experimentally measured x-ray
spectra with Mo and W anodes [143, 144] were used for the analysis and modified
using the attenuation coefficients and elemental compositions of each component of
the imaging system using the sum rule.
This comparison was performed by first calculating the HVL of photons ab-
sorbed in the detector of the clinical system for a Mo anode, 30 μm thick Mo filter,
5.3 cm thick breast, compression plate, support and cover plate, and an amorphous
selenium detector. The compression plate was included as a 2 mm thick plate of
polycarbonate and the support and cover plate as 3.3 mm of carbon. The experi-
mental system was simulated as a W anode, Mo filter, Al filter, 5.3 cm thick breast,
and a CsI detector. In both cases, a 19.3% breast density was assumed (equivalent
to the mean breast density from Yaffe et al.[145] and the breast composition was
taken from the measured values in Hammerstein et al.[134]. The kV and Mo and
Al filter thicknesses of the experimental system were adjusted until both the mean
energy and HVL of photons absorbed in the detector were matched. The mean
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energy and HVL of photons absorbed in the clinical system for 28.9 kV were calcu-
lated to be 20.18 keV and 0.633 mm Al, respectively. For the experimental system,
a 30 μm thick Mo filter and a 0.13 mm thick Al filter with a 28 kV gave a mean
energy and HVL of photons absorbed in the detector of 20.16 keV and 0.632 mm
Al, respectively.
5.2.3.3 Influence of anti-scatter grid on stationary covariance
To investigate how the stationary covariance would be affected by the presence
of an anti-scatter grid, we created simulated images of one of our phantoms using a
Monte Carlo program as described in Section 5.2.4.1. Two simulated mammograms
with no anti-scatter grid were created, one that included all scatter contributions,
and the other with only primary x-rays and no scatter. The stationary covariance
was calculated for both images and compared.
5.2.4 X-ray scatter
In order to estimate the amount of scatter produced by the phantom in a
mammography geometry, the entire experimental system was simulated using the
Monte Carlo radiation transport subroutines PENELOPE with the penEasy3 main
program [104, 146, 147]. Experimental validation of the Monte Carlo results was
also performed.
3The source code of penEasy is available at http://www.upc.edu/inte/en/descarregues.php;




The experimental setup used to acquire phantom images was reproduced in
the Monte Carlo software. The 28 kV tungsten anode spectrum with 0.13 mm Al
and 30 μm Mo filters as calculated in Section 5.2.3.2 was used as an input to the
program. The focal spot was measured experimentally via pinhole imaging and
approximated in the simulation as a 0.25 mm × 0.25 mm, uniform square source.
The detector was assumed to be ideal (i.e., 100% detection efficiency, noise free)
and had 148 μm × 148 μm pixels to match those of the actual detector. Elemental
compositions of the phantom materials as estimated in Section 5.2.2.2 were used
here. From the simulation, the number of detected primary as well as scattered x
rays was recorded. Images were simulated for a structured phantom as well as for
a homogeneous version of the phantom4. At least 1011 histories were simulated for
each of the structured and homogeneous phantoms until the average uncertainty of
pixels above half the maximum pixel value was below 0.7%.
A structured phantom was included in the simulation by imaging the phantom
in a computed tomography (CT) scanner5 (16 slice 1DT MX 8000, Philips, Andover,
MA) and segmenting the resultant image into the various phantom materials. The
CT data set was acquired with 120 kV and 300 mAs per slice and the reconstructed
data set had a resolution of 0.269 mm × 0.269 mm × 0.4 mm. The reconstructed
data set was segmented by visually examining a histogram of intensity values of
the entire data set and applying thresholds to separate the image into four different
4by Andreu Badal
5with the help of Marios Gavrielides
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Figure 5.1: Results of segmentation algorithm on a central slice of the phantom for
inclusion in the x-ray scatter simulations. For each voxel, the fraction of material
that is made up of air, the jar, lard, and egg whites is indicated in each image.
material types: air, plastic jar, lard, and egg whites. Voxels with intensity values
between the lard and egg white threshold levels were assigned to be a mixture of
egg white and lard based on a linear scaling of the threshold value. In some areas,
the simple thresholding algorithm confused voxels belonging to the jar with adipose
tissue due to partial volume mixing of the jar with air. This was resolved by using
a region growing algorithm with user-selected seed points to isolate the jar voxels
or, in areas identified by the user as obviously belonging to the jar, by forcing all
voxels above a user-selected threshold to be jar-only voxels. The region growing
algorithm classified voxels as being part of the desired region by identifying all
neighboring voxels with an intensity within a user-defined range. Figure 5.1 shows
the segmentation of the central slice of the phantom.
A homogenous version of the phantom was created by replacing all voxels of the
segmented phantom with a mixture of 30% egg whites and 70% lard. This additional
simulation was carried out to facilitate comparison with previously published scatter
simulations for homogeneous phantoms and to highlight the differences in scatter
between homogeneous and heterogeneous phantoms. To the authors knowledge, this
is the first description of scatter of a heterogeneous breast model. Therefore, our
phantom provides a platform for investigation of scatter rejection and compensation
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methods using a more realistic phantom with a complex tissue structure.
5.2.4.2 Experimental validation
The Monte Carlo results were validated by acquiring experimental data using
the same phantom and experimental setup as used in the simulation. Images were
acquired both with and without a set of 5 tungsten discs. The discs (diameter=10.0
mm, thickness=4.0 mm) were attached to the side of the phantom closest to the
x-ray source using a small amount of putty between the disc and the phantom.
Simulated images were also created both with and without the discs. The positions
of the discs were measured during the experimental data acquisition and included in
the same location for the simulations. An estimated scatter to primary ratio (SPR)
for each disc was calculated using the following formula for both the simulated and
experimental data:
SPR (x, y) =
〈
gdisci
gno disci − gdisci
〉
, (5.1)
where x and y indicate the position of the center of the disc, gdisc is the image
with the disc present, gno disc is the image with no discs present, and i runs over
all pixels within half a disc radius from the center of the disc. Reported errors are
two standard deviations of the individual SPR values. These errors include not only
statistical measurement error, but also variation due to the structured background
in the phantom. We expect these estimated SPR values to underestimate the true
SPR since the finite size of the disc will block low-angle scatter; however, since the
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Figure 5.2: Photograph of compressed phantom (left), example x-ray image of phan-
tom (middle), and example patient mammogram (right).




A photograph of a filled, compressed phantom is shown in Figure 5.2 as well
as example patient and phantom mammography images.
5.3.2 Attenuation coefficient
A comparison of the elemental compositions of the phantom materials with
human values reported in the literature is provided in Table 5.1. As expected,
both lard and egg whites provide a reasonable match to the elemental compositions
132
of human breast tissue. Lard is particularly well matched to the breast adipose
tissue values reported by Poletti et al.[139], having carbon, hydrogen, and oxygen
compositions that are within two times the measurement errors reported in the
human tissue study. The only deviation appears to be the concentration of nitrogen,
which is lower in the phantom by about 8 standard deviations. The difference
between human tissue compositions reported in Hammerstein et al.[134] and Poletti
et al.[139] may reflect both the difficulty of the measurement as well as the variation
in human tissue values. Egg whites have similar composition values to the reported
human tissue values, but with a percent carbon about 30% of the human values and
a percent oxygen about 20% higher than the human tissue values. As both of the
human tissue studies reported difficulty separating adipose from glandular tissue in
their glandular tissue samples, it is unclear whether some of this difference is due
to human tissue measurement bias. Overall, both lard and adipose tissue have a
higher carbon concentration and lower oxygen concentration than both egg whites
and glandular tissue.
Figure 5.3 shows a comparison between the human and phantom mass at-
tenuation coefficient values for energies relevant to mammography, tomosynthesis,
and breast CT. The ratio of total mass attenuation coefficient for phantom mate-
rials and patient tissues is shown. Examination of Figure 5.3 shows that the mass
attenuation coefficient for the adipose-mimicking phantom material agrees with all
breast adipose tissues values within at least 20%. Some systematic differences below
about 40 keV are seen as compared with values reported by Hammerstein et al.[134]



































































































































































































































































































measurements from Johns and Yaffe [137] as well as values derived from elemen-
tal compositions from Poletti et al.[139] indicates that this difference could be due
to measurement errors or variation in human tissue properties among subjects or
samples.
In Figure 5.3, data for the glandular-mimicking phantom material (egg whites)
are consistent with all breast glandular values to within at least 15%. There is more
deviation from breast tissue values at energies less than about 20 keV. Interestingly,
at 27 keV, the experimentally measured egg white attenuation coefficient from Rao
and Gregg [141] differs from the breast glandular tissue values in the opposite sense
as the theoretically calculated egg white values. This indicates that the differences
between experimentally and theoretically calculated mass attenuation coefficients of
egg whites is about the same as the difference between the mass attenuation coef-
ficients of egg whites and available breast glandular tissue values. The discrepancy
between the measured and theoretical attenuation coefficients for egg white could
be due to differences in the elemental composition of the egg white measured exper-
imentally and the values provided by the USDA [55] and/or the inherent limitations
in the way PENELOPE calculates linear attenuation coefficients for compounded
materials. As commonly implemented in Monte Carlo codes, PENELOPE essen-
tially ignores the effects of molecular binding on the individual atoms and assumes
that the molecular cross-sections can be approximated by the sum of the atomic
cross sections of all the atoms in the molecule (i.e., the additivity approximation)
[104].
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Figure 5.3: Comparison of x-ray mass attenuation coefficients for breast adipose
tissue and adipose-mimicking phantom material (top) and for breast glandular tissue
and glandular-mimicking phantom material (bottom). The black line represents
where the indicated breast tissue and phantom values would be equal.
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Given the results presented in Figure 5.3, it appears that the mass attenuation
coefficients of the tissue-mimicking phantom materials are consistent with breast
tissue values to within at least 20% for adipose tissue and 15% for glandular tissue
and the largest discrepancies exist at energies below 20 keV.
As an interesting aside, when the attenuation coefficients of the phantom ma-
terials are calculated for energies corresponding to PET (511 keV) and SPECT
(140 keV) (data not shown), they match the estimated human tissue attenuation
coefficients to within 1% for adipose tissue and 2% for glandular tissue. This com-
parison was performed by comparing phantom values with human attenuation co-
efficients derived using the elemental composition from the Hammerstein et al.[134]
and Poletti et al.[139] studies.
5.3.3 Tissue structure
A set of example ROIs taken from the patient and phantom mammograms
are shown in Figure 5.4. Overall, the phantom provides a random structure that is
qualitatively similar to the patient mammograms, but with structures that appear
to be larger than those in the patient data set. Figures 5.5-5.6 show a comparison of
the overall stationary covariance matrices from the patient and phantom data sets.
Figure 5.5 shows the entire overall stationary covariance matrices, while Figure 5.6
shows cuts through the center of the covariance matrices with uncertainty estimates.
The structure sizes are similar in the two data sets, albeit larger on average for
the phantom data in the superior-inferior direction and in the anterior-posterior
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Figure 5.4: Example patient and phantom ROIs. All ROIs represent 3.5 × 3.5 cm
in object space.
Figure 5.5: Overall stationary covariance matrices for the patient and phantom data
sets. The matrices are scaled to have the same intensity at their peak. The phantom
and patient overall stationary covariance matrices have similar structure sizes. The
patient data set does have larger long-scale correlations in the anterior-posterior
direction than the phantom data set.
direction for small distances. The error bars on the phantom covariance matrices
are large in comparison to the differences between the phantom and patient data sets.
In the anterior-posterior direction, the patient data set exhibits longer correlations
than those present in the phantom data set.
Figure 5.7 shows the influence of scatter on the stationary covariance calcula-
tion. Cuts through the stationary covariance matrix of a single phantom are shown
for simulated mammograms with and without scatter. We see that by eliminating
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Figure 5.6: Cuts through the patient and phantom overall stationary covariance
matrices (shown in Figure 5.5) in the anterior-posterior and superior-inferior di-
rections. The patient and phantom overall stationary covariance matrices are the
same to within their error bars. In the anterior-posterior direction, the patient data
appears to have longer correlations on average than the patient data. Error bars
are the standard deviation of the individual patient (N=80) and phantom-specific
(N=40) stationary covariance matrices at each distance.
scatter completely, the stationary covariance is decreased by 15% on average and
as much as 33% at larger correlation lengths in the anterior-posterior direction, and
6% on average and as much as 10% in the superior-inferior direction. Therefore, we
expect that by not using an anti-scatter grid for our phantom images, we are overes-
timating the correlations as measured by the stationary covariance to some extent.
However, the comparison shown in Figure 5.7 is a worst-case scenario since the anti-
scatter grid does not eliminate scatter completely. The use of an anti-scatter grid
for acquisition of the phantom data would improve the match between phantom and
patient correlations in the superior-inferior direction and in the anterior-posterior
direction for small-scale correlations, but potentially exacerbate the differences at
larger correlation lengths for the anterior-posterior direction. The magnitude of the
scatter effect on the stationary covariance matrix is, in any case, smaller than the
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Figure 5.7: Influence of scatter on stationary covariance matrix. Stationary co-
variance matrices were calculated from simulated images of a single phantom with
scatter and with no scatter. Cuts through the resultant stationary covariance ma-
trices are shown in the anterior-posterior and superior-inferior directions. Removal
of scatter decreases correlations by 15% on average and as much as 33% in the
anterior-posterior direction and 6% on average and as much as 10% in the superior-
inferior direction. Since the clinical data was acquired with an anti-scatter grid, but
the experimental data was not, this effect may account for some of the differences
in stationary covariance matrices between the phantom and patient data.
uncertainties in the overall stationary covariance matrices.
5.3.4 X-ray scatter
5.3.4.1 Simulations
Figure 5.8 shows results of the Monte Carlo simulations to estimate the amount
of scatter produced by the phantom. Images including primary and scattered x rays,
primary x rays only, and scattered x rays only are included as well as maps of the
SPR of the phantom and a homogeneous version of the phantom. The image of
primary plus scattered x rays represents an image with no anti-scatter grid in place.
The image of the primary x rays only represents the best possible image that can
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Figure 5.8: Monte Carlo simulations to estimate the amount of scatter produced
by the phantom. Simulated images of (a) phantom with primary and all scattered
x-rays, (b) phantom with primary x-rays only, (c) phantom with scattered x-rays
only, (d) SPR of phantom, (e) SPR of a homogeneous version of the phantom. For
e), all voxels of the phantom were converted in the simulation to 30% egg by volume
to create a homogeneous phantom.
be achieved by any scatter correction. We see, in the image that includes only the
scattered x rays, that the structure of the phantom does have an impact on spatial
distribution of the scattered signal. The structure in the scatter only image comes
primarily from Rayleigh interactions. The SPR is as high as 85% in some areas of
the phantom. For the homogenous version of the phantom, the maximum SPR is
50%, much lower than that of the heterogeneous phantom. Therefore, estimates of
patient SPR based on homogeneous phantoms may underestimate the true SPR.
5.3.4.2 Experimental validation
Results of the experimental validation of the Monte Carlo scatter simulations
are shown in Figure 5.9. SPRs were experimentally measured and simulated at
5 different locations in the phantom using five tungsten discs. The experimental
and simulated SPR values were in good agreement, within the error bars, for all
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Figure 5.9: Validation of the Monte Carlo simulated scatter results for the het-
erogeneous phantom. Experimental measurements were performed of SPR at five
different locations in the phantom using tungsten discs and also simulated with the
same geometry. a) Image of phantom with discs in place. The discs are labelled
1-5. b) Comparison of the estimated scatter-to-primary ratio for each disc location.
Error bars are two standard errors.
locations. Uncertainties due to voxelization and segmentation of the phantom as
well as errors in replication of the experimental geometry and estimation of the
material compositions contribute to the existing differences. Since the discs had a
finite size and blocked some portion of the primary beam that would contribute to
scattered signal, these are underestimates of the SPR values with no discs. Since
the same geometry used for the experiments was reproduced in simulation, this is
an appropriate validation of the SPR generated by the Monte Carlo simulations.
From examination of the Monte Carlo results, we estimate that the measured SPR
values underestimate the true SPR values by approximately 25%.
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5.4 Discussion
In this study, we have presented a detailed analysis of our phantom’s x-ray
imaging properties and their comparison with human tissue properties. These com-
parisons have demonstrated that the phantom is useful for x-ray breast imaging
evaluation and informed the reader as to where and to what extent deviations from
human tissue values occur. The x-ray attenuation properties of the two tissue-
mimicking materials match human data to within the measurement errors, so we
expect images produced with the phantom to have similar contrast to patient im-
ages. Interestingly, attenuation coefficients of the phantom materials also match
human values for energies relevant to PET and SPECT imaging, indicating that the
phantom may also be useful for these modalities. Tissue-structure of the phantom
data was the same as patient data to within the uncertainties, however, on average,
the phantom was made up of somewhat larger structures than the patient data and
has shorter-range correlations in the anterior-posterior direction. These differences
should be confirmed with more data since the error bars were large; however, larger
structures in the phantom data may mean that it is easier to detect larger lesions in
the patient data than in the phantom data. Similarly, the longer correlation lengths
in the anterior-posterior direction of the patient data may mean that it is easier to
detect elongated structures in the phantom than in the patient. While some differ-
ences do exist between the phantom and patient data, they are well-characterized
and, therefore, can be taken into account during lesion detection studies. Better
matching between the phantom and patient image structures may be possible by
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modifying the phantom construction procedures.
In a previous paper, comparisons of MRI T1 and T2 relaxation values and
tissue structure with human data were presented. T1 and T2 relaxation values were
shown to be in the range of human values, with better matching for T1 values,
which are most important for breast DCE-MRI. Tissue structures were shown to be
similar in size, but to be more isotropic in the phantom than in patient data. This
may mean that it is more difficult to detect isotropic lesions in the phantom than
in patient data and vice versa for anisotropic lesions.
X-ray scatter of the phantom was also investigated via Monte Carlo simu-
lations. While the authors are not aware of scatter measurements that have been
performed on breast tissue in a mammography geometry, there are a variety of simu-
lation studies that have investigated mammography scatter. To our knowledge, this
is the first study that has presented scatter results for a non-homogeneous phantom.
A comprehensive simulation study by Boone et al.[148] investigated the SPR of
breast tissue in mammography for a wide variety of system parameters. The mam-
mography system was simulated without an anti-scatter grid and the simulation
code was a Monte Carlo code called SIERRA, which had been previously validated.
SPR was determined as a function of beam spectrum, position in the field, breast
thickness, tissue composition, and area of the field of view. Homogeneous, mathe-
matical phantoms with thicknesses ranging from 2 to 8 cm consisting of 0, 50, and
100% glandular tissue were investigated. X-ray energy and tissue composition had
little effect on the SPR, while position in the field, breast thickness, and area of
the field of view were significant variables. According to their equation for the SPR
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at the center of mass of a semi-circular breast, they predict a SPR of 0.30 for a
phantom with the same diameter and thickness as our phantom.
Another study by Sechopoulos et al.[149] simulated SPR of breast tissue in
tomosynthesis also for a wide range of system parameters. Their results were pro-
duced with a Monte Carlo program based on the Geant4 toolkit. They simulated
semi-circular, homogeneous, compressed breasts in both CC and MLO views and in-
cluded the compression plate, support plate, detector cover plate, and the patient’s
body. The x-ray tube was simulated as a point source 66 cm from the detector.
They calculated SPR at the center of mass of the breast as a function of breast size,
compressed breast thickness, glandular fraction, and energy and predict a SPR of
0.55 for a CC view and a tomosynthesis angle of 0 degrees (equivalent to mammog-
raphy) with a phantom that has the same thickness and average compositions as
our phantom.
Our estimated SPR for a homogeneous version of our phantom is bracketed
by the simulation results of Boone et al.[148] and Sechopoulos et al.[149]. The
larger SPR reported by Sechopoulos et al.[149] as compared with Boone et al.[148]
may be due to the fact that Sechopoulos et al.[149] included a compression plate,
support plate, and detector cover plate in their simulations, whereas the Boone et
al.[148] study did not. For the same reason, we would expect our results to give SPR
values slightly lower than those of Sechopoulos et al.[149]. The larger SPR that we
report, in comparison with Boone et al.[148], may be explained by the additional
components present in our phantom (the jar lid and fill ports) that cause additional
scatter. Another source of variations may be due to the fact that our simulations
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used mixtures of egg whites and lard, whereas the previous studies used human
tissue-equivalent materials.
The most interesting result from our study is that the actual phantom, with
a heterogeneous tissue structure, results in a much larger localized SPR in regions
of with a higher percentage of glandular-mimicking material than the homogeneous
version of the phantom. Interestingly, this is in contradiction with the results from
Boone et al.[148], where they find that the SPR varies by less than 0.05 for a 4 cm
breast and percent glandular fractions from 0 to 100%. Sechopoulos et al.[149]
found a somewhat larger change, with SPR varying by about 0.15 as the glandular
fraction varied from 0 to 100%. Our results indicate that the glandular fraction
may influence SPR more than previously thought. This means that estimates of
patient SPR derived from homogeneous phantoms may give misleading results. In
addition, for small and medium scattering angles, epoxy and plastic based phantoms
produce scatter distributions that are very different from those of breast tissues
[139]. Since our phantom materials have similar molecular structures to human
tissue (see Chapter 4), it may also be true that the scatter distribution produced by
our phantom is more representative of patient scatter than epoxy and plastic based
phantoms, however further studies are necessary to confirm this.
5.5 Conclusion
We have developed a dual-modality, x-ray and MRI, anthropomorphic breast
phantom for the quantitative evaluation of lesion detection. In this study, the x-
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ray attenuation coefficients of the phantom materials as well as the phantom image
structure have been shown to be similar to patient data. Estimations of the scatter-
to-primary ratio of the phantom demonstrated the strong influence of heterogeneity
on the calculated SPR. This platform will allow researchers to not only optimize
and standardize the modalities individually, but also to compare them side-by-side.
Such comparisons may help inform clinical decisions about the appropriateness of




MRI dynamic lesion for the anthropomorphic, dual-modality
phantom
6.1 Overview
Dynamic1 contrast-enhanced MRI (DCE-MRI) of the breast has developed
into an important tool for breast cancer diagnosis and screening of high-risk patients.
Although the use of this technique in the clinic has led to improved sensitivity
for cancer detection, specificity limitations have highlighted a need for improved
standardization. Efforts towards more quantitative approaches to DCE-MRI are
underway, for example the Radiological Society of North America’s Quantitative
Imaging Biomarker’s Alliance2, and there is a need for well-characterized phantoms
to quantitatively assess the large variety of available approaches.
Perhaps the most commonly employed phantoms for quantitative DCE-MRI
are vials filled with contrast-agent-doped solutions with varying contrast agent con-
centrations [150, 151, 152, 153, 154, 155]3. Since MRI sequences do not directly
measure contrast agent concentration, such phantoms can be used to convert sig-
nal intensity in a T1-weighted MRI image to contrast agent concentration, thus
1Manuscript in preparation.
2http://www.rsna.org/Research/QIBA
3and RSNA/Quantitative Imaging Biomarkers Alliance (QIBA) DCE-MRI phantom.
http://qibawiki.rsna.org
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potentially improving determination of perfusion parameters. However, static T1
phantoms inherently do not exhibit dynamic behavior and, therefore, can not be
used to directly evaluate dynamic protocols.
Dynamic MRI phantoms have been presented in the literature for various
applications [156, 157, 158]. Chai et al.[156] developed a perfusion phantom to test
the ability of a new arterial spin tagging protocol to produce tagged images where the
signal attenuation was linearly proportional to the tissue flow rates. Their phantom
consisted of four inlet tubes feeding a plastic cylinder that was filled with a layer
of small plastic beads followed by an area filled with a compressed sponge and,
finally, emptied via a single outlet tube. Water was pumped through the system
at a constant flow rate using a commercially available fluid pump. This phantom
was not developed to produce physiological washout curves, however, one could
imagine modifications to include a bolus injection of contrast agent solution at the
input in an attempt to produce such curves. Further research would be required to
understand whether this design could be modified to produce curves that are indeed
physiological as well as to understand how the presence of the sponge affects the
MRI images.
Ivancevic et al.[157] developed a flow phantom to investigate how flow rate
affects signal intensity in fast gradient-recalled-echo sequences for quantification of
arterial input functions (AIFs). A laboratory-modified, variable-speed pump was
set up in closed-circuit with continuous flow of Gd-DTPA-doped solution with ve-
locities ranging from 0-80 cm/s. To create AIFs, Gd-DTPA was injected into the
water tank of the system. Continuity of the flow was measured using Doppler ultra-
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sound and samples of the circulating solution were taken at the phantom outlet for
every measurement and used to determine Gd-DTPA concentration by comparing
against a static calibration phantom. Although this phantom is able to produce
dynamic curves appropriate for its intended use, it was meant to simulate AIFs, not
physiological washout curves. As a result, the entire wash-in and wash-out behav-
ior is confined to approximately 10 s and there is no mechanism to produce longer
timescale washout curves.
Finally, Ebrahimi, Swanson, and Chupp [158] have presented a microfabricated
dynamic phantom, produced on a silicon wafter, with branching channels that have
similar diameters to human vasculature. Their objective was to simulate blood
perfusion on the microvasculature level. Washout curves were produced by using an
IV pump to feed the supply channels of the phantom and injecting a contrast agent
via a stopcock. Since the geometry of the phantom is well-known, fluid transfer
simulations can be produced to estimate the flow behavior of the phantom. While
this phantom holds promise, there are several issues that limit its applicability to
the evaluation of physiological washout curves. Unfortunately, while the authors
presented simulation results for flow rate in the phantom, no simulated washout
curves were produced. This means that the true behavior of the phantom was
unknown and it was not possible to compare MRI measurements of the phantom
with the true flow behavior. In addition, the washout curves occurred on a timescale
much faster than physiological curves, about 30 s.
The dynamic phantoms discussed above are important tools for the evaluation
of dynamic MRI protocols. However, none of these phantoms produce physiological
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washout curves or have the ability to be easily modified to mimic the variety of
washout curve shapes seen in the clinic. We have previously presented an MR
breast phantom with a static enhancing lesion (see Chapter 4). In this study, we
extend that phantom with a dynamic lesion that is capable of producing washout
curves with similar shapes and timescales as patient washout curves. In addition,
the lesion is confined to a physiologically relevant space and can be modified with
different border shapes to mimic different lesion types.
6.2 Methods
The overall design of the dynamic lesion phantom is diagrammed in Figure 6.1.
A hollow lesion mold made from plastic is inserted in a static breast phantom.
The design of the breast phantom has been previously described in Chapter 4 and
consists of a breast-shaped plastic jar filled with a mixture of coagulated egg whites
and lard that simulates the adipose-glandular tissue structure in human breasts and
has relaxation values that match those of breast tissue. For clarity, in Figure 6.1
the phantom is shown without the egg white and lard mixture. The lesion mold has
two inlets and one outlet (see Sections 6.2.1.1 and 6.3.1 for further discussion of the
inlet/outlet configuration). The two inlets are fed via a fluid pump that has two
separately controlled internal pumps. One of the internal pumps controls the flow
rate of a tissue-mimicking fluid, while the other controls the flow rate of a contrast
agent solution. The total flow rate of fluid exiting both internal pumps is set to a
constant value. After both fluids leave the fluid pump, they are mixed together via
151
a bifurcating tube. This fluid mixture is then separated into two tubes that feed
the two inlets of the hollow lesion mold. As fluid flows through the hollow lesion
mold, it is expelled through the single outlet and discarded in a waste container.
By modifying the relative flow rates of the two internal fluid pumps over time, the
shape of the resultant washout curve in the hollow lesion mold can be controlled.
The following subsections describe the design of the lesion mold itself, the choice
of different washout curves and how they were produced, the x-ray measurements
of the washout curve to provide truth, and the MRI measurements of the dynamic
phantom.
6.2.1 Lesion mold
The lesion molds are hollow plastic molds designed to mimic mass-like lesions
and confine the contrast agent solution to a physiologically relevant area in the
breast phantom. The molds were manufactured using stereolithography and were
produced with the thinnest possible wall for the technology (0.6 mm). A lesion
size of 10 mm was chosen for this study since it is relatively small and difficult to
detect. However, modifying this size for future studies would be trivial. The two
major considerations in the lesion mold design were producing a reasonably uniform
distribution of contrast agent solution in the interior of the mold and simulation of
a realistic tumor morphology. Both of these considerations are discussed in further
detail below.
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Figure 6.1: Dynamic lesion phantom design overview. On the left is an empty
breast phantom jar with a hollow lesion mold inserted. For actual measurements,
the phantom jar will be filled with lard and egg to simulate breast tissue, however, in
this diagram, the phantom jar was left empty for clarity. The fluid pump takes in a
contrast agent solution and a tissue-mimicking fluid and dispenses them separately
with different flow rates as a function of time. The total exit flow rate from the
fluid pump is kept constant, but the relative fraction of contrast agent solution is
varied over time to produce a physiological washout curve. The two fluids are mixed
together after exiting the fluid pump via a bifurcating tube. The fluid mixture is
then separated and enters the two inlets in the phantom lesion mold. As the fluid
exits the phantom via the single outlet tube, it is discarded in a waste container.
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6.2.1.1 Distribution of contrast agent
The distribution of contrast agent in two different lesion mold designs was
investigated using fluid transfer simulations performed with the computational fluid
dynamics software package openFOAM (openCFD, Ltd., Berkshire, UK)4. The first
design was a 10 mm internal diameter sphere with one 2 mm inner diameter inlet
tube and one 2 mm inner diameter outlet tube. The inlet and outlet tubes were
colinear and attached to the sphere through its center. This design was chosen as
the simplest possible design to manufacture. The second design was also a 10 mm
internal diameter sphere, but had two inlets and one outlet, all with 2 mm inner
diameters. In this case, all three tubes attached to the sphere on the same side, but
were separated by 15 degrees. This design is more complex to manufacture, but is
expected to have better mixing properties. Figure 6.2 shows a diagram of the two
different designs.
The simulations were performed with a total inlet flow rate of 1.0 ml/s and a
mesh size of approximately 0.04 mm. The input fluid was simulated as a mixture of
water and GdCl3, where the concentration of GdCl3 started at zero and at a time of
0 s instantaneously jumped to a concentration of 100%. The simulations were run
for a total of 10 s. The density and viscosity of water were assumed to be 1.0 g/ml
and 1.0 cP, respectively. The diffusion coefficient of GdCl3 in water was assumed to
be equal to the self-diffusion coefficient of water (2.66×10−2 m2/s [159]) since the
contrast agent solution would be a solution with a small amount of GdCl3 in the
4by Prasanna Hariharan (FDA/CDRH/OSEL/DSFM)
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Figure 6.2: Two preliminary lesion mold designs. On the left is a 10 mm inner
diameter sphere with a single inlet and a single outlet that are colinear through the
center of the lesion mold. On the right is a 10 mm inner diameter sphere with 2
inlets and 1 outlet. The two inlets are on either side of the outlet at an angle of 15




The border shape of breast mass-like lesions varies widely and is used as a
diagnostic tool [45, 46]. Benign lesions tend to have a more smooth, spherical
shape, whereas malignant lesions tend to have more irregular shapes. Here we
present lesion molds with two different border shapes to demonstrate the ability
of the dynamic lesion to mimic variations in this property. The first border shape
is spherical, whereas the second includes three additional lobulations. Using the
technique selected for producing the lesion molds (stereolithography), a variety of
border shapes could easily be produced.
6.2.2 Washout curve shape
The washout curve shape was controlled via a fluid pump that interfaced with
the lesion molds previously described. In the following subsections we discuss human
washout curve shapes and the design of the fluid pump.
6.2.2.1 Human washout curves
In a study by Fan et al.[160], high temporal resolution dynamic contrast-
enhanced data at 1.5 T were acquired of 22 patients with a variety of lesion types.
Based on pathology, there were 6 benign, 9 ductal carcinoma in situ, two infiltrative
ductal carcinoma, and one infiltrative lobular carcinoma lesions. Four patients either
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had lesions missed by DCE-MRI or no lesions. In that study, the measured signal
intensities were converted to contrast agent concentration and fitted to an empirical
mathematical model given by
C (t) = A
(
1 − e−αt)q e−βt 1 + e−γt
2
, (6.1)
where C (t) is the concentration of the contrast agent as a function of time, A is
the upper limit of the concentration, α is the rate of contrast uptake (min−1), β
is the overall rate of contrast washout (min−1), γ is the initial rate of contrast
washout (min−1), and q is related to the slope of early uptake and the curvature
of the transition from uptake to washout. Their reported average coefficients and
associated errors for all of the benign lesions were A=4.0±2.1, α=1.00±1.96 min−1,
β=0.006±0.011 min−1, and q=0.8±0.7. For all of the malignant lesions, the coeffi-
cients were A=5.7±3.0, α=1.77±0.77 min−1, β=0.020±0.014 min−1, and q=0.8±0.5.
For both benign and malignant lesions, γ was set to zero.
The objective of our phantom is to reproduce washout curve shapes such as
these in the lesion mold. Although these washout curve shapes were derived from
MRI measurements, we expect them to be reasonably close to the true washout
curve shapes since an approximate conversion from MRI signal intensity to contrast
agent concentration was performed [160]. Inaccuracies in this conversion will not
affect our study since we have the ability to measure the true washout curves via
x-ray measurements, as described in the following sections.
There is a considerable amount of overlap in the curve parameters for be-
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nign and malignant lesions, which explains why the specificity of DCE-MRI is not
consistently 100%. This overlap is probably due to both biological as well as instru-
mentational effects. The objective of the current study is to address the instrumen-
tational contributions to the curve distribution overlap. While this will only address
one component of the source of the overlap, it could potentially improve the sepa-
ration between benign and malignant wash-out curves and, consequently, improve
the specificity of DCE-MRI. For the current study, two washout curve shapes were
chosen as representative benign and malignant wash-out curves. The two selected
wash-out curves were generated using Eq. 6.1 with the average coefficient values for
benign and malignant lesions.
6.2.2.2 Fluid pump
The fluid pump was a custom-built, MRI-compatible, programmable, dual-
fluid pump (Shelley Medical Imaging Technologies, London, Ontario, Canada). It
was manufactured to simultaneously pump two different liquids at different fluid flow
rates that could be modified as a function of time. Fluid flow rates of the two liquids
were updated on a timescale of 100 ms. One fluid was a tissue-mimicking fluid and
the second was a mixture of tissue-mimicking fluid and contrast agent. These two
fluids are described in more detail in the following two subsections. After exiting
the fluid pump, the two fluid streams were mixed together via a bifurcated tube.
The fluid pump was programmed to output a constant fluid flow rate. The relative
fluid flow rates of the two liquids over time were varied by the user to the desired
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values. In this way, the concentration of the contrast agent in the combined output
flow could be modified by the user to reproduce any desired curve as a function of
time. For both the x-ray truth and the MRI measurements, the distance between
the fluid pump output and the bifurcation where the two fluids joined was 100 cm,
the distance between the two bifurcation points was 40 cm, and the distance from
the last bifurcation point to the inlets of the lesion mold was 200 cm. The tubing
inner diameter was 4 mm.
6.2.3 X-Ray measurement of washout curve
6.2.3.1 Experimental setup
The x-ray source was a Varian B180 (Varian Corp., Salt Lake City, UT) x-ray
tube with a tungsten anode, 0.3 mm focal spot, and 1.0 mm Al internal filtration.
The detector, which has been previously described (see Chapter 2), was a high-
resolution CCD camera (Quantix 6303 Photometrics 3072 × 2048 array, 9 × 9 μm
pixels, Photometrics, Tucson, AZ) modified with a 4.5 cm length one-to-one fiber
optic faceplate with 4.5 μm fibers. This fiber optic faceplate is bonded to the CCD
on one side and a Hamamatsu CsI screen (0.15 mm thick CsI, Part No. J8734-01,
Hamamatsu Corporation, Bridgewater, NJ) is pressure fitted to the opposite side.
The entire camera assembly is covered with a 0.635 mm thick beryllium window cap.
Measurements of the detector response to a 30 μm wide beam incident perpendicular
to the CsI surface were performed using the same methods described in Chapter 2.
The full-width at half maximum of the response is 62.2 microns, or 6.9 pixels. Since
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the incident beam is 30 μm wide, if we assume that the CsI point response function
(PRF, the detector response to an infinitely thin beam) and the incident beam can
be well represented by Gaussian functions, we expect that the CsI PRF is about
54.5 μm or 6.1 pixels wide. Therefore, we can expect this amount of blur in the
images of the tumor molds.
Data were acquired with the following parameters: 120 kVp, 6.4 mAs, 80 ms
exposure time, temporal resolution that varied between 2.6 and 24.7 s, a single
projection view, and the spherical lesion mold. The lesion mold was imaged with
no surrounding jar or other phantom structure. Data were acquired with a mag-
nification of 1.2, so the interior of the tumor mold was sampled with 1312 pixels,
or approximately 215 (=1312/6.1) resolution elements. This means that, although
data overlap occurs in the direction of the x-ray incidence, good spatial resolution
of the lesion mold was achieved in the perpendicular direction. The lesion mold was
simultaneously imaged with a vial of constant Gd-DTPA concentration to calibrate
the x-ray tube output. Two x-ray experiments were performed and are described in
detail in the following two subsections.
For these experiments, the tissue-mimicking fluid was a mixture of 40% glyc-
erol and 60% deionized water, by volume, as specified by the manufacturer for
appropriate lubrication of the fluid pump. The contrast agent solution was 40%
glycerol by volume, 60% deionized water by volume, and 150 mM Gd-DTPA. The
Gd-DTPA was prepared according to procedures described in Strich et al.[161] using
GdCl36H2O (GFS Chemicals, Columbus, OH), DTPA (Agros Organics, NJ), and
NaOH (Sigma-Aldrich, St. Louis, MO).
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6.2.3.2 Derivation of average lesion contrast concentration
The spatially-resolved lesion concentration was derived using the knowledge
that the number of primary x-rays incident on any given location in the detector is
given by
I = Io exp (−μl) , (6.2)
where Io is the number of x-rays incident on the object being imaged, μ is the
attenuation coefficient of the object material, and l is the size of the object along
the path of the x-rays. Note that all variables in this section are a function of the
position on the detector. The incoming x-rays are assumed to be parallel. In our
case, the object being imaged is the lesion mold filled with a mixture of tissue-
mimicking and contrast agent solutions. Therefore, we can consider the object to
consist of three materials; the plastic making up the lesion mold walls, a, the tissue-
mimicking fluid, b, and the contrast agent solution, c. Table 6.1 summarizes the
variables used in this section and Appendix C. For any given x-ray path through
the lesion mold, Eq. 6.2 can be written as
I = Io exp [− (μala + μblb + μclc)] . (6.3)
Let’s define la + lb + lc ≡ lmold, so we can rewrite this equation as
I = Io exp [− (μafa + μbfb + μcfc) lmold] , (6.4)









































































































































































































































































































































































































































































































































































































































Now, if we have two images, the first of which has no contrast agent solution, 1,
and the second which has an unknown amount of contrast agent solution, 2, then
fa1 + fb1 = 1 and fa2 + fb2 + fc2 = 1. In addition, since the amount of plastic in
the lesion mold never changes, fa1 = fa2 = fa. Io1 and Io2 can also be assumed to
be equal. Although the x-ray tube output does vary over time, the lesion mold was
imaged with a vial of constant Gd-DTPA concentration to allow for normalization
of the x-ray tube output. Calculating I2/I1 and solving for fc2, we find
fc2 =
1




We can now normalize by the maximum fraction of fc2, so that lmold, μa, and μc

















are the image values when there is no contrast agent solution in
the lesion mold, an unknown, variable amount of contrast agent solution, and a
maximum amount of contrast agent solution, respectively. The error incurred by
assuming that the detector efficiency is the same for any concentration of contrast
agent is negligible (see Appendix C for details).
Once the normalized contrast agent fraction, fc2/ (max fc2), was calculated
for all locations in the lesion mold for each acquired image, an average normalized
contrast agent fraction was calculated by averaging the values inside a circular, user-
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selected region-of-interest that included the entire area inside of the lesion mold.
6.2.3.3 Flow rate measurements
X-ray data were acquired for the malignant curve shape and four different
constant fluid flow rates: 1.5, 1.0, 0.5, 0.25 ml/s to determine the lowest possible
fluid flow rate that would reproduce the physiological curves. It is preferable to
reduce this flow rate as much as possible since rapid flow rates can affect MRI
images and an increased flow rate means more fluid waste.
6.2.3.4 Benign and malignant curves
The ability of the fluid pump to repeatably create the benign and malignant
washout curves was evaluated by acquiring x-ray data for five identical runs for
both the benign and malignant curve shapes. Since the x-ray data were acquired
at irregularly spaced time points, the resultant average normalized contrast agent
concentration values were linearly interpolated to a regular grid before the average
and standard deviations were calculated.
6.2.4 MRI measurements
All MRI data were acquired on a 1.5 T Siemens Magnetom scanner with an ex-
tremity coil and a fat-suppressed, 3D spoiled gradient-echo imaging protocol5. The
scan parameters were: repetition time (TR) = 4.4 ms, echo time (TE) = 1.58 ms, flip
angle = 10 degrees, field-of-view = 256 × 256 mm. This imaging sequence was taken
5with the help of Jacco A. de Zwart (NIH/NINDS/AMRI)
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from a routine protocol used at a clinical institution with experience in breast imag-
ing. Data were acquired of a spherical lesion with benign and malignant washout
curve shapes and four different spatial (temporal) resolutions: 0.5×0.5×1.5 mm
(127 s), 0.8×0.8×1.5 mm (79 s), 1.0×1.0×1.5 mm (63 s), 1.3×1.3×1.5 mm (47 s).
There was no pause between temporal samples in a single dynamic acquisition. Note
that the spatial resolution of the MRI data was at least 10 times worse than the
spatial resolution of the x-ray truth data. Washout curves were calculated as the
mean image signal in a hand-selected ROI that contained the entire lesion. Lesion
average signal values were divided by the average signal in a circular ROI including
glandular-mimicking tissue to correct for drift in the MRI signal.
The tissue-mimicking fluid consisted of 5.0 mM Ni-DTPA in a solution of 40%
glycerol and 60% deionized water by volume. Ni-DTPA was used to match the T1
value of the fluid to that of the glandular-mimicking component of the phantom
and was produced following the method described in Tofts et al. [162]. The contrast
agent solution has the same composition as the tissue-mimicking fluid, but with
an additional 4.5 mM Gd-DTPA. A value of 4.5 mM Gd-DTPA was chosen as a
representative maximum contrast concentration in breast lesions during DCE-MRI
studies [160].
6.2.5 MRI signal behavior
In order to put the MRI measurements in context and understand how to
improve them, the signal equation for a spoiled gradient-echo sequence was examined
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for different flip angles and Gd doses. MRI signal intensity can be related to Gd
concentration using the following equation if steady-state and the fast-exchange
limit are assumed [163]








1 − cos α exp−TR(R1,0+r1C) , (6.7)
where Mo is the proton concentration, TR is the repetition time, TE is the echo
time, α is the flip angle, C is the contrast agent concentration, R1,0 and R
∗
2,0 are
the inverses of the pre-contrast longitudinal and effective transverse relaxation times




2,0), and r1 and r
∗
2 are the longitudinal and transverse
contrast relaxitivites. In our analysis, we have chosen TR (=4.4 ms), TE (=1.58 ms),
and α (=10 degrees) values equal to those used to acquire our MRI data. T1,0 and
T2,0 values were measured on the tissue-mimicking fluid, using maximum likelihood
methods that have been previously described [38], and found to be T1,0=449.3 ms
and T2,0=136.2 ms. The measured T1,0 value was used in the equation and T
∗
2,0 was
set to half of the measured T2,0 value. The contrast relaxivity values were assumed
to be equal to r1 = 4.5± 0.04 s−1mM−1 and r2 = 5.49± 0.06 s−1mM−1 as measured
on aqueous Gd-DTPA solutions at 1.5 T [162]. Note that the addition of glycerol to
an aqueous solution of Gd-DTPA is known to modify its relaxivity values because
of the change in fluid viscosity [165]. However, we have chosen to use the relaxivity





Figure 6.3 shows the results of the fluid transfer simulations for two different
planes in the two preliminary lesion mold designs. The contrast agent distribution
is presented between 2 and 10 s for every two s of the simulation for planes A and
B as defined in Figure 6.2. The top row shows the results for the colinear design
and the bottom row for the intersecting design. The contrast agent solution is
distributed throughout the lesion mold on a much faster timescale for the intersecting
design than for the colinear design. This indicates that the intersecting design will
produce a more realistic immitation of actual lesions and, as a result, this inlet/outlet
configuration was selected for all further development. An interesting implication is
that it may be possible to produce different patterns of homogeneity or heterogeneity,
to mimic different lesion types, by modifying the inlet/outlet configuration.
Photographs of lesion molds with two different border shapes are shown in
Figure 6.4 to demonstrate the ability to control the morphology of the lesion. A
spherical lesion mold was create as well as a lesion with three additional lobulations.
6.3.2 X-ray measurements of washout curves
Figure 6.5 shows the results of a series of experiments to determine the optimal
total flow rate for the system. Four different total flow rates were investigated (0.25,
0.5, 1.0, 1.5 ml/s). Measured washout curves are compared with the desired curve
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Figure 6.3: Comparison of contrast agent distribution in two different mold designs
as a function of time (Views: Plane A on left, Plane B on right). The total flow rate
for both mold designs was 1.0 ml/s and the mold began filled with water. At a time
of 0 s, the inlet concentration of contrast agent solution instantaneously increased
to 100%. The contrast solution distributes more evenly in the intersecting design
than the colinear design.
Figure 6.4: Demonstration of ability to produce lesion molds with different border
shapes mimicking different mass-like lesion types. (left) lesion mold with three dif-
ferent irregular border shapes, or lobulations, representing a malignant lesion (right)
lesion mold with smooth, spherical border shape, representing a benign lesion.
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Figure 6.5: (top row) Plots of average normalized contrast agent concentration in
the lesion versus time for four different total flow rates (0.25, 0.5, 1.0, 1.5 ml/s).
The solid lines indicate what the fluid pump was commanded to output and the
circles are values derived from the acquired data. (bottom row) Representative x-
ray images of the lesion mold (inner diameter = 10 mm) for each total flow rate (at
time = 5 min). A total flow rate of 1.0 ml/s is the lowest flow rate that provides
good contrast agent solution mixing and a good reproduction of the desired curve.
shapes and representative x-ray images of the lesion mold for each of the flow rates
are shown. Flow rates of 1.0 and 1.5 ml/s were both able to reproduce the desired
curves and had an even distribution of the contrast agent solution throughout the
lesion mold. Lower flow rates (0.25 and 0.5 ml/s) were unable to counteract the effect
of gravity on the contrast agent solution and resulted in contrast agent solutions
that settled in the bottom of the lesion mold and produced washout curves that
were significantly different from the desired curves. A total flow rate of 1.0 ml/s
was selected for all further studies, since it was the lowest flow rate that reliably
reproduced the desired washout curve shapes.
The ability of the pump to produce benign and malignant curves is demon-
strated in Figure 6.6. Average normalized contrast agent concentrations are com-
pared with fluid pump commands for the benign and malignant curve shapes. In
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Figure 6.6: Average normalized contrast agent concentration curves for two curve
shapes; benign (left) and malignant (right). The commands given to the fluid pump
are shown in red and the measured values in the lesion mold averaged over five
identical runs are shown in black. Error bars were calculated as standard deviations
of the five runs for some of the time points. The high values in the first minute
are due to the pump homing before beginning the curves and introducing contrast
agent solution in the lesion mold. The system is able to reliably reproduce the two
different curve types.
both cases, the desired curves are well reproduced.
6.3.3 MRI measurements
Figure 6.7 shows a comparison between the x-ray truth measurements and
the MRI measurements at different resolutions. In all cases the MRI curves are
flatter than the true curves, as measured by x-ray, making them more difficult to
distinguish than the actual curves. This effect is most likely due to the non-linear
relationship between MRI signal intensity and contrast agent concentration and will
be explored further in the following subsection.
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Figure 6.7: Comparison of x-ray truth measurements (red) and MRI results (black)
acquired with different spatial and temporal resolutions. All curves were normalized
to have the same minimum and maximum values.
6.3.4 MRI signal behavior
Figure 6.8 shows the how MRI signal intensity relates to Gd concentration for
a spoiled gradient-echo sequence and parameters representative of the data acquired
of our phantom. The effect of that signal behavior on the measured washout curves
is also presented. As the flip angle decreases, the relationship between MRI signal
intensity and Gd concentration becomes more non-linear, making it more difficult to
distinguish different Gd concentrations. This effect can be seen in the middle plot of
Figure 6.8, where as the flip angle decreases, the predicted measured washout curves
become flatter. As seen in the right plot of Figure 6.8, the effect of decreasing flip
angle on the measured washout curves can be mitigated somewhat by reducing the
Gd dose. This is possible because data is collected at lower Gd concentrations,
where, even at low flip angles, the MRI signal intensity varies almost linearly with
Gd concentration.
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Figure 6.8: Theoretical curves showing the predicted MRI signal intensity as a
function of Gd concentration are shown for different flip angles for a spoiled gradient-
echo sequence (left). Predicted measured MRI curves for the same set of flip angles
are shown for a dose of 4.5 mM Gd-DTPA (middle). Predicted measured MRI curves
for different doses of contrast agent and a flip angle of 10 degrees are also presented
(right). The true concentration versus time curve used for the calculations is shown
in black in the middle and right plots. (Simulated MR parameters: Mo=1.0, TR=4.4
ms, TE=1.58 ms, T1o=1242 ms, T
∗
2o=339 ms, r1=4.5 mM
−1s−1, r2=5.49 mM−1s−1)
6.4 Discussion
We have produced a dynamic lesion phantom that can mimic physiological
washout curves and border shapes. The shape of the washout curve can be easily
modified by simply adjusting the relative fluid flow rates over time of the tissue-
mimicking and contrast agent solutions. In addition, we have measured the true
lesion washout curves for two specific cases using high spatial and temporal res-
olution x-ray imaging. Therefore, the ability of an MRI system or protocol to
measure true washout curve shapes as well as differences between curve shapes can
be quantitatively examined. Since differences in washout curve shape are used in
the clinic for lesion diagnosis, the ability to quantitatively evaluate this property
gives researchers an important tool for system and protocol optimization and has
the potential to provide radiologists with data that more closely represent the true
physiology.
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In addition, the lesion volumes and border shapes are also known parameters
that can be easily modified in the phantom and allow for quantitative studies of
these properties. The ability to quantitatively evaluate lesion volume and border
shape can lead to improved patient staging and aid radiologists in the differentiation
of benign and malignant lesions.
Although in the current study washout curves were produced using ROIs cov-
ering the entire lesion, ROI placement for clinical exams typically covers only a
small portion of the lesion and is generally a subjective practice. Using the high
spatial resolution x-ray measurements of the contrast agent distribution in the le-
sion, studies examining the effect of differences in ROI placement on washout curve
estimation can also be performed.
In the current study, washout curves measured by MRI were flatter that the
true curves, as measured by x-ray, thus suggesting a more persistent uptake. This
effect is likely due to the non-linear relationship between MRI signal intensity and
Gd concentration. Since the true benign curve already exhibits persistent uptake,
the signal behavior affects the malignant curve to a greater extent, making the
benign and malignant curves appear more similar than they really are. The clinical
implication is that the choice of MRI sequence can make differentiation of benign
and malignant lesions more difficult. Although the current study examined only two
representative curves for benign and malignant lesions, we expect this effect to apply
to any realistic wash-out curve shape. Further studies could examine a larger range
of wash-out curve shapes. Possible approaches to improve the matching between
the measured MRI curves and the true, x-ray, curves include the use of calibration
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vials with known concentrations of contrast agent as discussed in the introduction,
use of a higher flip angle, or use of a lower dose of contrast agent. Each of these
approaches has its own advantages and disadvantages. The use of calibration vials
could allow for the correction of washout curves, however, the noise in the images
would make estimation of the contrast concentration difficult, especially for signal
versus Gd concentration curves that are more strongly saturated. In addition, the
calibration vials would have to be placed outside of the breast, where the MR signal
properties, such as coil sensitivity and flip angle, may change. Therefore, an accurate
calibration would require additional measurements such as coil sensitivity maps and
corrections for variation in flip angle over the image. Use of a higher flip angle would
produce a more linear signal-contrast concentration relationship, however, for the
short repetition times used, the overall signal level would decrease. Lower doses
may also improve the linearity of the MR signal, however, this may detrimentally
affect visualization of lesion morphology, such as thin spiculations. Therefore, the
optimal combination of acquisition parameters must include a careful analysis that
takes into account all aspects of the clinical objective.
Some areas for potential improvement of the current dynamic lesion phantom
include: 1) modification of the interior structure of the lesion to allow a realistic AIF,
and 2) use of an alternative lubricant for the fluids. In its current implementation,
the washout curve shape in the dynamic lesion itself is essentially unchanged from
the output of the fluid pump. This precludes studies examining the effect of AIF
measurement on estimation of pharmacokinetic model parameters, however, the use
of non-model techniques can be investigated [160, 164]. The curve shape could
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also potentially be modified in the phantom to reproduce AIF-like shapes, thus
making studies on estimation of the AIF itself possible, albeit independently from
the estimation of the washout curve itself. The dynamic lesion is currently a hollow,
plastic mold, however, it may be possible to include an internal porous structure to
allow for both AIF and washout curve production at the same time.
In terms of the fluid lubricant, proper operation of the fluid pump requires the
use of lubricant in the fluids themselves. In the present study, we use 40% glycerol
by volume as a lubricant, which is recommended by the fluid pump manufacturer.
Glycerol is known to affect the relaxivity of Gd-DTPA due to its viscosity, with an
approximately three times increased spin-lattice relaxivity for a Gd-DTPA solution
with 40% glycerol as compared with a purely aqueous solution [165]. This means
that the relationship between MRI signal intensity and contrast concentration will
be different for a phantom with Gd-DTPA in a solution of 40% glycerol as compared
with a solution of water only. The viscosities of 100% water and a solution of 40%
glycerol in water are approximately 1.0 and 5.0 cP at room temperature, respectively
[166]. However, the lesion microenvironment is also known to affect relaxivity [167]
and has viscosities that are higher than pure water, approximately 1.8-2.9 cP [168],
meaning that a lower percentage of glycerol may be necessary to appropriately
reproduce physiological viscosity. Phantoms produced with purely aqueous solutions
of Gd-DTPA would have similar limitations.
It is also known that fluid flow rates can affect MRI signal intensity [157]. In
the current phantom, the total flow rate is 1.0 ml/s, which corresponds to a linear
flow rate of approximately 16 cm/s in each of the two inlet tubes, 32 cm/s in the
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outlet tube, and lower values in the lesion itself. A study, using ultrasound Doppler
imaging to measure tumor flow velocities in breast cancer patients, found that peak
tumor flow velocities were in the range of 0 - 49 cm/s [169], which is consistent with
the flow rates in our phantom.
An additional parameter that could be adjusted in future modifications of the
phantom is the internal heterogeneity of the contrast agent uptake, which is also used
by clinicians to aid in lesion diagnosis. As demonstrated in Sections 6.3.1 and 6.3.2,
the configuration of the inlet/outlet tubes of the lesion and the fluid flow rate both
have an effect on the interior spatial distribution of the contrast agent. Therefore, it
may be possible to adjust these parameters to produce lesions with different internal
heterogeneities. Extension of the fluid transfer simulations to the full timescale of
physiological washout curves is currently underway. While the x-ray measurements
provide a planar view of the lesion molds, the fluid transfer simulations can provide
fully three-dimensional results that can be compared with MRI measurements.
In conclusion, we have developed a dynamic lesion phantom capable of re-
producing physiological washout curves and border shapes for mass-like benign and
malignant lesions. Since the phantom washout curves have been independently
measured to provide truth, this phantom is useful for the quantitative evaluation
of dynamic contrast-enhanced MRI protocols. MRI measurements of the phantom
with washout curves representing benign and malignant curves shapes show that a
protocol currently being used in the clinic produces MRI signal intensity curves that
are less specific to lesion type than the true contrast agent concentration curves as
measured by x-ray. Further development of the dynamic lesion may include adjust-
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A variety of imaging modalities, each with its own unique set of advantages
and disadvantages, are currently available or under development for breast cancer
lesion detection, including dynamic contrast-enhanced MRI and x-ray techniques
such as mammography, tomosynthesis, and computed tomography. The optimal
acquisition parameters and clinical application of these techniques is currently an
open research question. In order to provide a platform for quantitative comparison
of these techniques, we have developed a multi-modality anthropomorphic breast
phantom for lesion detection and discrimination. This phantom allows for system
optimizations within a single modality as well as comparisons across modalities.
X-ray properties of the phantom including x-ray attenuation coefficients and
tissue structure were quantitatively compared with human data and found to provide
a good match. X-ray attenuation coefficients for both the glandular and adipose-
mimicking phantom materials matched human values to within their measurement
error. Stationary covariance matrices of phantom and patient images show that the
tissue structures in the phantom have a similar characteristic size to those in patient
data, but are slightly larger on average. Correlations in the patient data appear to be
longer than those in the phantom data in the anterior-posterior direction, however
they are within the error bars of the measurement. Detailed knowledge of x-ray
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detectors was used to facilitate the tissue structure comparison. Simulated scatter-
to-primary ratio values of the phantom images demonstrated the strong influence
of tissue heterogeneity on these values suggesting that SPR may be underestimated
by current techniques that use homogeneous phantoms.
MRI properties of the phantom, including a dynamic lesion, were also eval-
uated. T1 and T2 relaxation values of the phantom materials were found to be
stable over a period of at least 9 months and in good agreement with human values,
particularly for T1 values, which are most relevant for DCE-MRI. Tissue struc-
ture in phantom images, as measured by stationary covariance matrices, matched
patient data structure to within the error bars in the anterior-posterior direction
and to within 2 error bars in the right-left direction. A dynamic, enhancing lesion
with an adjustable border shape and washout curve behavior was also included in
the phantom. Two border shapes representing benign and malignant morphologies
were produced as well as two washout curve shapes typical of benign and malignant
breast lesions. Truth measurements quantifying the concentration of contrast agent
in the lesions over time for both of the washout curve shapes were performed using
a high spatial and temporal resolution x-ray imaging system with knowledge of the
x-ray detector behavior. The x-ray truth measurements were compared with dy-
namic MRI data of the phantom using a clinical protocol. The MRI data produced
signal intensity curves that were more similar than the x-ray derived contrast agent
concentration curves and examination of the spoiled gradient-echo signal equation
indicated that it may be possible to improve lesion diagnosis by adjusting protocols




We have developed a dual-modality, x-ray and MRI, anthropomorphic breast
phantom for quantitative evaluation of breast imaging protocols, performed quanti-
tative comparisons with human data for the main parameters that influence image
contrast and texture, and included a dynamic lesion with associated truth mea-
surements. Several areas where the current work can be extended are discussed
below.
In terms of MRI properties, 3D truth measurements of the dynamic lesion
could be acquired to determine the 3D distribution of contrast agent solution in the
lesion. This would allow for more detailed, spatially-resolved comparisons with the
MRI data. The fluid transfer simulations could also be extended to timescales of the
MRI data collection to produce maps of the 3D distribution of contrast agent in the
lesion for different fluid pump commands and fluid flow rates. Additional studies
of inlet/outlet configurations for the lesion may provide a method to control the
internal heterogeneity of the contrast agent distribution, which is another parameter
used by clinicians to diagnose lesions. One current limitation of the phantom is the
inability to reproduce glandular tissue contrast agent uptake. Methods to simulate
this phenomenon may also be investigated.
In terms of x-ray properties, identification of a tissue-mimicking liquid that
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could be included in the lesion component of the phantom would allow for x-ray
lesion detection studies. Aqueous solutions with dissolved proteins may be an op-
tion since they may have similar x-ray properties to egg whites. One possibility is a
solution of denatured egg white proteins, which can be found in any supermarket.
In addition to the x-ray properties of these solutions, the viscosity and coagulation
properties must be investigated. In addition, while compressed versions of the phan-
tom have been produced, ideally the phantom would be reversibly compressible so
that images of the same phantom could be acquired with modalities that use com-
pression and those that do not. The addition of microcalcifications in the phantom
could also be investigated.
Preliminary evaluation of attenuation coefficients of the phantom materials
also suggests that the phantom may be useful for PET and/or SPECT imaging.
Characterization of the phantom material properties for these modalities would
allow for additional cross-modality investigations.
For both x-ray and MRI, the lesion could be extended to a variety of sizes and
to have additional border shapes. So far two example mass-like lesions have been
produced, but a more careful analysis of lesion shapes in both x-ray and MRI could
be performed and used to inform more realistic lesion models for the phantom. The
breast density of the phantom could also be modified to cover the range of patient
values. These modification would both be trivial given the phantom construction
procedures. Phantom construction procedures could also be modified to improve
the matching between phantom and patient tissue structure.
Numerous protocol comparisons could be performed with the phantom. As
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a follow-up to the dynamic MRI data already acquired of the phantom Chapter 6,
methods for improving the matching between MRI signal intensity and true con-
trast agent concentration could be investigated. Possible approaches are imaging
vials with known contrast concentration simultaneously with the phantom to deter-
mine and apply a post-processing correction to the MRI signal intensity or increasing
the flip angle or reducing the contrast agent dose of the MRI imaging protocol. All
of these approaches have advantages an disadvantages, so a full analysis including
all relevant effects would be required. Other MRI studies that could be performed
include comparisons of imaging protocols and hardware at different institutions,
analysis of the tradeoff between spatial and temporal resolution, and the effect of
(contrast agent and radiation) dose on lesion detection and discrimination. Direct
comparisons between x ray and MRI techniques could also be performed to deter-
mine which modality is appropriate for different patient characteristics, including
breast density and size, and lesion size and morphology.
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Appendix A
Integrating the PRF equation over depth
Here we derive the solution to
PRF (x, y, θ, φ, E) =
∫ zmax
0
PRFz(x, y, z, θ, φ, E) dz, (A.1)
where
PRFz(x, y, z, θ, φ, E) =






[(x − z tan θ)2 + (y − z tan φ)2]
. (A.2)
To simplify the notation we can define a few variables;
p (E) ≡ γENoμpe(E), (A.3)
q ≡ b0, (A.4)
u ≡ tan θ, (A.5)
v ≡ tanφ, (A.6)
m ≡ g20 + 4(u2 + v2), (A.7)
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n ≡ 2g0g1 − 8(ux + vy), (A.8)
and
s ≡ g21 + 4(x2 + y2). (A.9)
Now our integral becomes
PRFz(x, y, z, θ, φ, E) =
∫ zmax
0
p (E) [a0 (E) z + a1 (E)] (qz + b1)
(
g20z
2 + 2g0g1z + g
2
1




For the case of x = y = θ = φ = 0 this integral simplifies to
PRFz(0, 0, z, 0, 0, E) =
∫ zmax
0
p (E) [a0 (E) z + a1 (E)] (qz + b1) dz, (A.11)
whose solution is simply













Otherwise, we can break down the integral by multiplying it out and separating it
into twelve smaller integrals (I-XII) given by




mz2 + nz + s
dz (A.13)
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mz2 + nz + s
dz (A.14)




mz2 + nz + s
dz (A.15)




mz2 + nz + s
dz (A.16)
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mz2 + nz + s
dz (A.18)




mz2 + nz + s
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mz2 + nz + s
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mz2 + nz + s
dz (A.22)




mz2 + nz + s
dz (A.23)
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mz2 + nz + s
dz (A.24)
In order to solve these integrals we make use of standard integral solutions from the
CRC standard mathematical tables and formulae [170]. Since Integrals I-XII have
some standard integrals in common, we can define the solutions to those integrals
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Now the solutions to Integrals I-XII are simply
I = p (E) a0 (E) q g
2
0 S4, (A.41)
II = 2 p (E) a0 (E) q g0 g1 S3, (A.42)




IV = p (E) a0 (E) b1 g
2
0 S3, (A.44)
V = 2 p (E) a0 (E) b1 g0 g1 S2, (A.45)
V I = p (E) a0 (E) b1 g
2
1 S1, (A.46)
V II = p (E) a1 (E) q g
2
0 S3, (A.47)
V III = 2 p (E) a1 (E) q g0 g1 S2, (A.48)
IX = p (E) a1 (E) q g
2
1 S1, (A.49)
X = p (E) a1 (E) b1 g
2
0 S2, (A.50)
XI = 2 p (E) a1 (E) b1 g0 g1 S1, (A.51)
and





Influence of different detectors on covariance comparison of patient
and phantom data
The influence of the use of different detector types in the acquisition of the
patient and phantom data used to calculate the stationary covariances is discussed
and shown to be negligible. A general discussion of how the stationary covariance
matrix is influenced by different imaging systems is followed by specific discussions
of the actual clinical and laboratory systems used in this study and a comparison
of the two systems.
B.0.1 Comparison of covariance matrices
Since the phantom and human data were acquired on two different imaging
systems, the difference between these two systems becomes confounded with differ-
ences in the objects themselves when comparing data covariances. To understand
how the imaging system contributes to the data covariance, let us examine the
governing equations.
We can rewrite Eq. ?? in matrix notation as
Kg =
〈
(g − g) (g − g)t〉 , (B.1)
where the data are assumed to be real-valued and g is a vector containing a single
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image. As defined in Barrett and Myers (2004), g can be related to the original
object via the following equation
g = Hf + n, (B.2)
where f is the object, H is the deterministic system response operator, and n is
additive noise. The data covariance can be broken down into two independent
components and written as
Kg = Kn + Kg, (B.3)
where Kn is the noise covariance matrix averaged over all f , and Kg is the object
variability as seen in the mean image (Barrett and Myers 2004). The noise covariance
term is independent of H and the object variability term can be written as
Kg =
〈[
g(f) − g] [g(f) − g]t〉
f
, (B.4)
where g(f) = Hf and g = Hf . Replacing g(f) and g in Eq. B.4 and rearranging
some terms, we find that
Kg = HKfH
t. (B.5)
Now, plugging Eq. B.5 into Eq. B.3, we find that
Kg = Kn + HKfH
t. (B.6)
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Therefore, in order to directly compare the object covariances, Kf , we must
estimate not only the data covariance, Kg, but also the noise covariance Kn and the
deterministic system response operator, H. The following three subsections describe
how we estimated H and Kn for the clinical and laboratory imaging systems and
how they were taken into account when comparing the data covariances. Note that,
while the above derivation uses the full covariance matrix for simplification of the
mathematical representation, it is also applicable to the stationary covariance matrix
when appropriately averaged.
B.0.2 Clinical detector: H and stationary Kn
A study by Lazarri et al. [171] measured the modulation transfer function
(MTF) and normalized noise power spectrum (NNPS) of a clinical, Lorad Selenia
detector, which is the same detector type used to acquire the patient data used in
our study. For both measurements a Mo-Mo anode-filter combination at 28 kVp
was used and the anti-scatter grid was removed. To estimate the point spread
function (PSF) of the system, which we will assume is equivalent to the stationary
deterministic system response operator, we selected a Gaussian PSF with a FWHM
(=128.8 μm) that provided the lowest RMS difference with the MTF measured in
Lazzari et al. [171].
To estimate the noise covariance matrix, we calculated the stationary covari-
ance matrix of the noise images collected in the Lazzari et al. [171] study which
were used to calculate the NNPS in that paper. Referring to Eq. B.6, the contri-
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bution of the noise stationary covariance to the data stationary covariance can be
considered negligible when the noise stationary covariance values are much less than
the data stationary covariance values. Comparing our calculated noise stationary
covariance values with the patient stationary covariance values, we find that the
noise stationary covariance values are a maximum of 0.5% of the patient data sta-
tionary covariance values. As a result, we can consider the noise covariance to be
negligible compared with the covariance associated with the patient tissue structure
and ignore it for the purposes of comparing patient and phantom covariances.
B.0.3 Laboratory detector: H and stationary Kn
The detector PSF for the laboratory detector was simulated using the mantis
Monte Carlo simulation package1 [90] with parameters equal to those described
in Chapter 2. The thickness of the CsI layer was assumed to be 550 μm, which
is the upper limit of the manufacturer’s specification and, therefore, a worst-case
scenario for investigating the effect of the detector PSF on the phantom stationary
covariance. In addition, a columnar tilt of 5 degrees was assumed and a reflective
substrate was used. The resultant PSF had a FWHM of 70.6 μm.
The noise covariance matrix was estimated from noisy images acquired in the
lab with the same imaging parameters used to acquire the phantom data. A 0.85 mm
thick Al filter was placed between the x-ray source and detector to simulate the x-
ray spectrum when the phantom was in the beam. The x-ray exposure was also
decreased so that the average detector pixel value was the same as with a phantom
1http://code.google.com/p/mantismc
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in the beam. The noise stationary covariance values were a maximum of 0.3% of
the data covariance values. Again, the effect of the noise covariance on the data
covariance can be considered negligible and ignored.
B.0.4 Comparison of clinical and laboratory detectors
The clinical detector has a PSF with a FWHM (128.8 μm) of about twice
that of the laboratory system (70.6 μm). However, we expect that the true PSF of
the laboratory system will be larger than its simulated value. In a previous study,
simulated PRFs for a CsI screen (denoted Screen 3 in that paper; 450 μm thick
CsI screen with a reflective backing), similar to that used here in the experimental
system, were compared with experimentally measured PRFs for a spectrum with
a mean photon energy of 25.6 keV. In that study, it was found that MANTIS
predicted a FWHM of the PRFs that was about 55% less than the experimental
results (see Chapter 2). Therefore, we also calculated a PSF for the laboratory
system that has been corrected for the expected underestimation from MANTIS.
Its FWHM is 129.6 μm. Within the simulation errors of MANTIS, the clinical and
laboratory detectors have comparable FWHM values. Note that the true PSF of
the laboratory detector may be even larger than what is estimated here since the
detector cover and packaging layers were not included in the MANTIS simulation
or its experimental validation.
As a result of the similarity of the estimated clinical and laboratory detector
PSFs, we assume that the differences in the deterministic response operators of the
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two imaging systems are negligible for our purposes and directly compare the left-
hand side of Eq. B.6 to compare tissue-structure of the patient and phantom data.
Although this assumption is not strictly true, it is appropriate for our purposes. The
covariance lengths associated with both the patient and phantom data are much
longer than the covariance length imposed by either detector, so small differences in
the detector PSF will not affect the final tissue structure comparison. As mentioned
in Sections B.0.2-B.0.3, the noise covariance contribution to the data covariance is
negligible when compared with the object variations.
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Appendix C
Estimated error in contrast agent concentration due to detector
efficiency approximation
To derive the spatially-resolved lesion concentration from the x-ray data with
the detector efficiency accurately included, we must start from the following equation
I(x, y, E) = Io(x, y, E) exp [−μ (x, y, E) l (x, y)] , (C.1)
which is equivalent to Eq. 6.2, but has the full spatial and energy dependence ex-
plicitly included. In this equation x and y are the spatial locations in the detector
plane and E is the energy. Now, the number of detected photons can be described
as
N (x, y) =
∑
E
γ E ηphI(x, y, E) [1 − exp (−μcsi(E)tcsi)] , (C.2)
where γ is the number of optical photons generated in the CsI crystal per incoming
x-ray energy, ηph is the efficiency of the optical detector, μcsi(E) is the x-ray linear
attenuation coefficient of the CsI crystal, and tcsi is the thickness of the CsI crystal.
If we express I(x, y, E) as
I(x, y, E) = I(x, y)S(E), (C.3)
where I(x, y) is the total number of x-ray photons incident on the detector at a given
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spatial location and S(E) is the percentage of x-rays at any given energy, then we
can rewrite Eq. C.2 as
N (x, y) = γ ηph I(x, y)
∑
E
E S(E) [1 − exp (−μcsi(E)tcsi)] (C.4)
≡ γ ηph I(x, y) A. (C.5)
We can assume that the quantities γ and ηph are constant with contrast agent
concentration in the lesion mold, however both I(x, y) and A will change with the
contrast agent concentration. Now, let’s examine these two contributions in more
detail to understand their dependence on contrast agent concentration. I(x, y) is
equal to
I(x, y) = Io(x, y) exp [−μ (x, y) l (x, y)] . (C.6)
Following from Section 6.2.3.2, if we consider the object to consist of three materials




= lmold(x, y)fc2(x, y) [μb(x, y) − μc(x, y)] . (C.7)
Now, we can examine how A of Eq. C.5 depends on the concentration of the
contrast agent. The quantity S(E) depends on contrast agent concentration since
the amount of contrast agent present in the lesion will modify the spectral signature
of the x-ray beam. The spectrum of x-rays entering the lesion mold was calculated
using a program called SpekCalc [172] for the x-ray source used in the experimental
setup. This spectrum was modified using the x-ray attenuation coefficients in the
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NIST x-ray mass attenuation coefficients database1 to calculate spectra of the x-
ray beam exiting the lesion mold for different concentrations of contrast agent.
The quantity A was calculated from those spectra and a linear fit was applied to
determine the following relationship
A(fc2) = a0 + a1 fc2, (C.8)











The second term on the right-hand side of this equation has been added by not
assuming that the detector efficiency is constant with contrast agent concentration.
If we estimate fc2 from
N2
N1
using Eqs. 6.5 and C.9 we find that the maximum error in
the estimated fc2 is 5×10−5, where values of fc2 can range from 0 to 1. Therefore, the
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enhanced MRI of the breast: accuracy, value, controversies, solutions,” Eur. J.
Radiol. 24, 94-108 (1997).
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